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ABSTRACT 
 
Parkinson’s disease (PD) is a neurodegenerative disorder particularly 
characterized by the loss of dopaminergic neurons in the substantia nigra pars 
compacta. Its etiology is unknown but likely includes both genetic and 
environmental factors. Since pesticide use has been associated with PD 
occurrence, we conducted a screen to identify pesticides that impair the 
ubiquitin-proteasome system (UPS), a degradative process implicated in PD 
pathogenesis. Benomyl was identified as a UPS inhibitor in this screen and 
became the focus of this dissertation. 
In an epidemiologic study, we used state-mandated Pesticide Use Reports 
to estimate chronic exposures and observed 65-92% increased PD risk in a 
population exposed to the fungicide benomyl. In experimental models, we found 
that benomyl induced selective dopaminergic neuronal loss in vitro with primary 
mesencephalic cultures and selective aminergic neuronal loss in a novel in vivo 
zebrafish system. Benomyl is readily metabolized to S-methyl N-
butylthiocarbamate and its sulfoxide, a potent aldehyde dehydrogenase (ALDH) 
inhibitor. These thiocarbamates inhibited ALDH activity in primary neurons at 
submicromolar concentrations leading to accumulation of the dopamine 
metabolite 3,4-dihydroxyphenylacetaldehyde, the proposed neurotoxicant. This 
model for PD etiology via ALDH inhibition may help explain the selective 
vulnerability of dopaminergic neurons in PD. 
To follow up on this finding, we developed a novel ex vivo neuronal assay 
to screen other pesticides for ALDH inhibitory activity. All dithiocarbamates tested 
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(e.g., mancozeb, maneb, ziram), two dicarboxymides (captan, folpet), and two 
imidazoles (benomyl, triflumizole) inhibited ALDH activity, potentially via 
metabolic byproducts (e.g., carbon disulfide, thiophosgene). Exposures to ALDH-
inhibiting pesticides (i.e., positive hits) applied in our study area were associated 
with dose-dependent twofold to fourfold increases in PD risk. Genetic variation in 
the ALDH2 gene potentiated this risk considerably (up to sixfold) for people 
working where these pesticides were sprayed liberally. 
This is the first report of a pesticide that damages dopaminergic neurons 
by inhibiting ALDH activity. The identification of multiple ALDH-inhibiting 
pesticides associated with increased PD risk supports the potential of ALDH as a 
novel therapeutic target and a subject for consideration by regulators and 
policymakers. 
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CHAPTER I 
Overview 
1. Parkinson’s disease etiology 
Parkinson’s disease (PD) is the second most prevalent neurodegenerative 
disorder, affecting millions of people worldwide 1. Motor symptoms include akinesia 
(inability to initiate movement), bradykinesia (slowness of movement), resting tremor, 
and balance problems, while non-motor symptoms include cognitive impairments, mood 
disturbances, sleep dysfunction, gastrointestinal problems, and dysautonomia. PD is a 
progressive disorder, and despite several effective therapies that treat many of the 
symptoms, there are no treatments that alter disease progression. Elucidating the 
etiology of PD is likely necessary to develop effective disease-modifying therapies. 
Exposure to pesticides has been associated with PD occurrence, so these compounds 
can serve as model toxicants to investigate neurotoxic mechanisms that may be 
relevant. A thorough review of the research associating pesticides and Parkinson’s 
disease is provided in this dissertation (Chapter II). 
 
2. Potential mechanisms of toxicity 
 Two characteristics of PD are the death of dopaminergic neurons and the 
formation of Lewy bodies comprised of synuclein and other protein aggregates. These 
offer two targets for the discovery of therapies against PD. One way healthy cells 
degrade protein aggregates is through the ubiquitin-proteasome system (UPS). UPS 
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dysfunction is an area of active study in PD research. McNaught and Jenner reported 
reduced UPS activity in brains of PD patients 2, and some investigators have used UPS 
inhibitors to recreate some features of PD in vivo, although these models remain 
controversial 3-8. We found that the fungicide ziram damaged dopaminergic cells and 
elevated α-synuclein levels in vitro by inhibiting E1 ligase of the UPS (Appendix A, 9). In 
contrast, here we report that benomyl damaged dopaminergic cells but did not increase 
α-synuclein levels in vitro, suggesting a different neurotoxic mechanism. 
Although other areas of the central and peripheral nervous systems are affected 
10, why dopaminergic neurons in the substantia nigra are particularly vulnerable 
presents another area of active research, focusing on the neurotransmitter dopamine, 
its metabolism, and its receptors and transporters (e.g., D1, D2, VMAT2, DAT1). 
Dopamine and its metabolites have been reported to modify α-synuclein, supporting 
UPS dysfunction as a potential mechanism of toxicity within dopaminergic neurons 11-13. 
Burke et al. reported that administration of the dopamine metabolite 3,4-
dihydroxyphenylacetaldehyde (DOPAL) was on the order of 400 times more toxic than 
dopamine itself in vivo 14. Since DOPAL is a substrate for detoxification by aldehyde 
dehydrogenase (ALDH), ALDH inhibition is another potential toxic mechanism 
particularly relevant to dopaminergic neurons.  
 
2.1 ALDH inhibition 
The ALDH gene superfamily includes about 19 putatively functional genes that 
are ubiquitous throughout the body and important for the detoxification of various 
aldehydes including acetaldehyde in the liver and retinal in the eyes 15. ALDH2 is the 
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predominant ALDH found in neuronal mitochondria; smaller levels of ALDH1A1 are 
present in the cytosol. Two substrates relevant to this study include the dopamine 
metabolite DOPAL and the lipid peroxidation product 4-hydroxy-2-nonenal (4-HNE). 
DOPAL has been described briefly. Increased 4-HNE was found in post mortem PD 
brains as adducts 16 and as a component of Lewy bodies 17. Furthermore, 4-HNE was 
reported to prevent α-synuclein fibrillation and form α-synuclein oligomers, which are 
toxic to dopaminergic neurons 18. 
In this dissertation, we use benomyl as a model compound, because it can inhibit 
both ALDH activity and the UPS 19,20. In this investigation with benomyl (Chapter III), we 
report that benomyl’s ability to inhibit the UPS is conferred by its carbendazim moiety 
(via microtubule inhibition), and its ALDH inhibitory capability is conferred by butyl 
isocyanate and other downstream metabolites including S-methyl N-butylthiocarbamate 
(MBT). We report IC50s that reveal that ALDH inhibition occurs at lower concentrations 
than UPS dysfunction. We also find that carbendazim is not toxic to dopaminergic 
neurons in vitro, whereas MBT recapitulates benomyl’s neurotoxicity at low 
concentration. Although UPS inhibition may also be important at higher concentrations, 
ALDH inhibition damages dopaminergic neurons even at low exposures. We report that 
co-treatment with a MAO inhibitor attenuated this toxicity, suggesting a role for DOPAL 
accumulation as a toxic mechanism. 
 These findings motivated further investigations using three classes of pesticides 
(Chapter IV). We developed a novel assay to study ALDH inhibition in a neuronal 
system; we report that all tested dithiocarbamates and a subset of dicarboxymides and 
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imidazoles inhibit ALDH activity. It had not been evident using other methods that so 
many pesticides inhibit ALDH activity. 
 
3. Epidemiology 
The UCLA Parkinson’s Environment and Genes (PEG) epidemiologic study 
enables us to investigate whether some of these ALDH-inhibiting pesticides are 
associated with increased PD risk (Chapters III, IV). Here we report that high exposures 
to benomyl, captan, mancozeb, maneb, or ziram are associated with twofold to fourfold 
increases in PD risk. (According to state-mandated Pesticide Use Reports, the 
population had not been exposed to the other pesticides found to inhibit ALDH activity.) 
We also report a significant dose-dependent risk associated with aggregate exposure to 
more than one ALDH-inhibiting pesticide. Genetic variation in the ALDH2 gene 
potentiates this risk considerably (up to sixfold) for people working where these 
pesticides were sprayed liberally. 
 
4. Implications 
This is the first report to associate ALDH inhibition, dopaminergic neuronal 
damage, and increased risk of PD with exposure to an environmental toxicant. 
Identification of multiple ALDH-inhibiting pesticides that are associated with increased 
PD risk suggests that modulating ALDH is a potential therapeutic target. This work has 
implications for the regulation of specific pesticides as well as for the elucidation of PD 
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etiology and potential treatments. Some of these are discussed at the end of this 
dissertation (Chapter V). 
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CHAPTER II 
Pesticides and Parkinson’s disease 
1. Introduction 
1.1 Clinical and pathological aspects of Parkinson’s disease  
Parkinson’s disease (PD) is the second most prevalent neurodegenerative 
disorder, affecting millions of people worldwide 1. While some cases of familial PD have 
been reported, the etiology of most cases is still unknown. Significant progress in 
understanding the pathophysiology of PD has been made from genetic and 
epidemiologic studies that have implicated defects in a few key biological processes as 
potential final common pathological pathways. 
PD is a progressive motor disorder characterized by death of dopaminergic 
neurons in the region of the brain called the substantia nigra pars compacta, although 
other areas of the central and peripheral nervous system are involved 10. The loss of 
dopaminergic neurons in PD leads to motor symptoms that include akinesia (inability to 
initiate movement), bradykinesia (slowness of movement), resting tremor, and balance 
problems. Non-motor symptoms can include cognitive impairments, mood disturbances, 
sleep dysfunction, gastrointestinal problems, and dysautonomia. PD is a progressive 
disorder and despite several effective therapies that treat many of the symptoms, there 
are no treatments that alter disease progression. Uncovering the causes of PD is likely 
necessary to find effective disease-modifying therapies.  
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The pathological hallmark of PD is the presence of Lewy bodies, which are 
cytosolic inclusions with several molecular components although α-synuclein (α-syn) is 
the predominant protein 21. Lewy bodies also contain ubiquitin, a polypeptide that 
targets proteins to the ubiquitin proteasome system (UPS) for degradation.   
 
1.2 Genes versus environment 
Despite the elucidation of approximately eighteen genes in familial PD and the 
identification of multiple risk factor genes using genome-wide association studies on 
thousands of patients, only a small fraction of PD risk has been accounted for 22. Thus, 
environmental factors almost certainly play a major role in the pathogenesis of PD. 
One of the first important clues that the environment may contribute to the 
pathogenesis of PD came in 1982 from the observation that a street drug contained a 
contaminant called 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) which caused 
almost overnight a clinical syndrome resembling PD. It was subsequently found that 
MPTP killed dopaminergic neurons by being converted enzymatically to 1-methyl 4-
phenylpyridinium (MPP+), specifically entering dopamine neurons via the dopamine 
transporter, and inhibiting complex I in the mitochondrial respiratory chain. Notably, the 
chemical structure of the MPTP metabolite MPP+ is similar to paraquat, a commonly-
used pesticide. These and other observations led to a series of epidemiologic studies 
probing pesticides as potential contributors to the etiology of PD. 
Although genetics has not found the cause of 95% of PD cases, the identification 
of specific genes and their functions have provided important clues into pathological 
processes that appear to be involved in non-genetic forms of PD. For example, 
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mutations in the α-syn gene led to the finding that α-syn is the major component of 
Lewy bodies. Mutations in other genes have identified dysfunction of protein 
degradation (the UPS and autophagy) as possibly being involved in the pathogenesis of 
PD. Since other PD genes are involved in mitochondrial function and MPTP inhibits 
oxidative respiration, mitochondrial dysfunction also has been implicated in the 
pathogenesis of PD. We believe that environmental toxins may increase the risk of PD 
by causing dysfunction in these cellular processes. Here, we will review the evidence 
that pesticides are associated with the development of PD and the mechanisms by 
which they might act. 
 
2. Pathophysiology of Parkinson’s disease 
2.1 Lewy bodies and α-synuclein homeostasis 
Lewy bodies are the pathological hallmark of PD and the major component of 
these intracytosolic inclusions is α-syn 21. α-syn exists in multiple forms including 
soluble monomers, oligomers and fibrils. The multimeric forms appear to be the toxic 
species and their formation is dependent on several factors including amino acid 
substitutions due to mutations in its gene, α-syn concentration, and the presence of 
dopamine and dopamine adducts 11,23-25.  Exogenous factors such as pesticides have 
also been reported to increase α-syn aggregation. Given that α-syn aggregation 
appears central to the pathogenesis of PD and pesticides appear to promote this 
process via a variety of mechanisms, we will briefly discuss α-syn homeostasis. 
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2.1.1 α-synuclein  
α-syn is a predominantly neuronal protein that was first implicated in the 
development of Alzheimer’s disease. The identification of three mutations—A53T, 
A30P, and G188A—in its gene in a few families with dominantly-inherited PD led to the 
finding that fibrillar α-syn is the major component of Lewy bodies not only in these 
patients but also in sporadic PD 21,26-29. Overexpression of normal α-syn by gene 
multiplication causes fairly typical PD 30, and people who have an α-syn promoter that 
confers a higher level of expression are at higher risk of developing PD 31,32. Thus, 
increased levels of normal α-syn increases one’s risk of getting PD and if it is high 
enough, it causes it. Importantly with respect to this review, certain pesticides can cause 
α-syn levels to increase providing a theoretical mechanism to contribute to PD (see 
below for individual pesticides). Furthermore, pesticides can directly increase the rate of 
α-syn fibril formation adding another method they can contribute to the pathogenesis of 
PD 33. 
 
2.1.2 Ubiquitin-proteasome system dysfunction in Parkinson’s disease 
α-syn concentrations are determined by the relative amount of its expression and 
degradation, and the higher the concentration, the more likely it is to form aggregates. 
Both the UPS and autophagy have been shown to degrade α-syn. The soluble form 
appears to be degraded by the UPS, while the lysosomal pathway appears to degrade 
aggregated forms of the protein 34-37.  The UPS is a highly-regulated, ATP-dependent, 
degradative multi-subunit pathway that helps clear the cell of damaged, misfolded, or 
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otherwise unneeded proteins. Proteins are targeted to the UPS by ubiquitin-activating 
enzymes (E1), ubiqutin-conjugating enzymes (E2), and ubiquitin-protein ligases (E3). 
Once polyubiquitinated, proteins are recognized by the 19S regulatory complex of the 
26S proteasome and translocated to the 20S complex for degradation. Finally, ubiqutin 
is recycled via thiol proteases called deubiquitinating enzymes, which fall into the 
ubiquitin carboxyl-terminal hydrolase (UCH) or ubiquitin-specific processing protease 
(UBP) families 38. 
Three known genetic causes of PD involve aspects of UPS function.  Parkin 
gene mutations cause autosomal recessive PD and is an E3 ubiquitin ligase necessary 
for targeting proteins for degradation. UCH-L1 gene mutations cause autosomal 
dominant (AD) PD, and UCH-L1 is necessary for the recycling of ubiquitin. Finally, α-
syn is a substrate for the UPS, and mutations and duplication of its gene cause AD PD. 
There is also evidence that UPS dysfunction is involved in sporadic PD. Reduced UPS 
activity has been found in brains of PD patients 2, and some investigators have found 
that administration of UPS inhibitors to rodents can recreate some of the features of PD 
although these models remain controversial 39-44. Finally, we have found that several 
commonly-used pesticides inhibit the UPS and are associated with an increased risk of 
developing PD 9,45. 
 
2.1.3 Autophagy and Parkinson’s disease 
Autophagy is a cellular process that involves protein and organelle degradation. 
Dysfunction of autophagy has long been known to be involved in disease but only 
recently has been implicated in the pathogenesis of PD.  Gaucher’s disease is an 
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autosomal recessive lysosomal storage disease caused by mutations in its gene that 
leads to dysfunction of autophagy and are associated with a marked increased risk of 
developing typical PD with Lewy bodies 46-48. Another autosomal recessive 
Parkinsonian disorder (PARK9) is caused by a mutation in another lysosomal gene, 
ATP13A2 49. PINK1 has also been shown to be a modifier of autophagy, and mutations 
in its gene cause PD with Lewy bodies (PARK6) 50,51. Additional evidence for a role of 
autophagy in PD comes from studies of sporadic PD brains where increased numbers 
of autophasomes have been described 52.  
α-syn clearance is likely carried out by both the UPS and autophagy. Large 
aggregates of α-syn proteins are likely degraded by macroautophagy, but soluble α-syn 
can undergo degradation via an alternate lysosomal pathway, chaperone-mediated 
autophagy (CMA) 53. α-syn has also been found to damage lysosomal macroautopaghy, 
and oligomers are resistant to CMA, adding further support for a possible role of protein 
degradation dysfunction in the pathogenesis of PD 54.  
 
2.2 Mitochondrial dysfunction and oxidative stress 
The role of mitochondrial dysfunction in the pathophysiology of PD was first 
suggested by the discovery that MPTP, a neurotoxin selective for nigral dopaminergic 
neurons, acts through inhibition of complex I of the electron transport chain. MPTP is 
converted by monoamine oxidase (MAO-B) to its toxic metabolite MPP+, it is rapidly 
concentrated by dopaminergic neurons into the mitochondria and produces cell death 55-
58. This discovery led to the findings that complex I activity is reduced not only in brains 
of PD patients but also in peripheral mitochondria 59,60. Furthermore, mutations in some 
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genes that code for mitochondrial associated proteins can cause PD (e.g., DJ1 and 
PINK1), and chronic systemic administration of complex I inhibitor (rotenone) in rodents 
reproduces many of the clinical and pathological aspects of PD 61.   
The downstream targets of mitochondrial dysfunction remain unclear. ATP 
depletion is not necessary in the rotenone rodent model for its toxicity, but the 
generation of reactive oxygen species (ROS) appears to be essential. ROS are known 
to oxidize DNA, lipids, and proteins to cause cellular damage. Interestingly, ROS from 
complex I inhibition leads to UPS inhibition 62. Furthermore, the formation of ROS from 
complex I inhibition likely contributes to the Lewy-like bodies observed in the rotenone 
model 63.     
 
2.2.1 Aldehyde dehydrogenase (ALDH) inhibition 
Another form of mitochondrial dysfunction implicated in PD involves the inhibition 
of aldehyde dehydrogenase 2 (ALDH2), a mitochondrial ALDH. This enzyme is 
responsible for the detoxification of aldehydes that could otherwise modify proteins. For 
example, the lipid peroxidation product 4-hydroxy-2-nonenal (4-HNE) is detoxified by 
ALDH2, and increased 4-HNE has been reported in post mortem PD brains as adducts 
16 and as a component of Lewy bodies 17.  Furthermore, 4-HNE has been shown to 
prevent α-syn fibrillation and form α-syn oligomers that are toxic to primary 
mesencephalic cultures 18. Another ALDH2 substrate, the dopamine metabolite 3,4-
dihydroxyphenylacetaldehyde (DOPAL), has also been reported to induce α-syn 
aggregation and be toxic to dopaminergic neurons 11. ALDH involvement in the 
pathogenesis of PD is not yet well-established, but preliminary in vitro and 
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epidemiologic studies have implicated this enzyme as a possible mediator of some 
pesticides’ toxicity (see benomyl below). 
 
2.3 Altered dopamine homeostasis 
Conventional wisdom in the pathophysiology of PD is that dopaminergic neurons 
are selectively vulnerable, although more recent evidence suggests that neuronal loss is 
more widespread. One hypothesis for this possible vulnerability is via the metabolism of 
dopamine itself 64.  
Dopamine and its metabolites are toxic, and dopamine adducts have been 
shown to stabilize α-syn oligomers. DOPAL, a substrate for ALDH2, is particularly toxic. 
Interestingly, DOPAL is formed by the enzyme MAO-B, and blocking this enzyme with 
specific drugs appears to alter the progression of PD 65. Thus, alterations in levels of 
dopamine or its metabolites might contribute to neuronal loss. Increased levels of 
VMAT2, a vesicular transporter that lowers cytosolic dopamine levels, lowers the risk of 
developing PD 66. Further support for altered dopamine homeostasis in PD comes from 
a recent report that polymorphisms in the dopamine transporter (DAT) gene in 
combination with pesticide exposure also increase the risk of PD 67. 
Taken together, dysfunction of several cellular processes appears to contribute 
to the pathogenesis of PD. Aggregation of α-syn (oligomerization and possibly fibril 
formation) is the leading candidate for the final common pathway for neurons to die in 
PD. There is evidence that pesticides cause dysfunction in many of these processes, 
providing potential mechanisms for their toxicity (Figure II-1).  
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3. Epidemiology of Parkinson’s disease 
3.1 Environment and Parkinson’s disease 
Over the past two decades, several epidemiologic studies have identified a 
number of environmental factors that are associated with an altered risk of developing 
PD. Smoking tobacco is almost universally found to be associated with a lower risk of 
developing the disease 68. Caffeine and alcohol consumption have also been associated 
with reduced PD risk 69. Since all of these addictive behaviors are associated with 
reduced incidence, it has been proposed that they may be surrogate markers for a 
common behavioral phenotype of pre-clinical PD patients rather than these exposures 
all being protective. The use of nonsteroidal anti-inflammatory drugs has also been 
found to reduce the risk of PD, suggesting inflammation may be somehow involved in its 
pathogenesis 70. 
A number of studies have found strong associations between an increased risk of 
PD and rural living, well-water consumption, farming occupations, and pesticide 
exposure. These reports have been reviewed extensively by others, so we will not 
review all the studies here 71-76. The association with pesticide exposure has been the 
most provocative association with developing PD to date, although almost all of these 
reports were based on self-reporting pesticide exposure (i.e., potential recall bias) and 
the diagnosis of PD was not confirmed 77. Despite these weaknesses, a meta-analysis 
of case-control studies obtained a combined odds ratio (OR) for PD risk of 1.94 (95% 
CI: 1.49-2.53) 78. Subsequent studies reported ORs up to 7.0 72. 
Recently, the issue of potential recall bias was mitigated by determining pesticide 
exposure in a prospective manner. Petrovitch et al. reported an increased risk of 
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developing PD in Japanese-American men who worked on a plantation and were 
exposed to pesticides 79. Similarly, Ascherio et al. found a 70% increased risk of 
developing PD in those who reported significant pesticide exposure 80. These reports 
add support for a true association between pesticides and PD but still are limited in that 
they did not identify individual toxicants and dose-response relationships could not be 
determined. 
 
3.2 Specific pesticides as risk factors 
There are a few ongoing studies that address both the issue of recall bias and 
identify specific pesticides that confer an altered risk of developing PD. The Agricultural 
Health Study (AHS) is a prospective study, including 84,740 private pesticide 
applicators (mostly farmers) and their spouses, recruited in 1993-1997 in Iowa and 
North Carolina. Pesticide exposure was self-reported but felt to be reliable. The 
diagnosis of PD was also self-reported but later confirmed by direct examination. The 
first report from this study found an association between PD with increasing lifetime 
days of use of any pesticide, but no specific pesticide could be definitively implicated 
due to lack of statistical power 81. Recently, the investigators reported that PD was 
associated with rotenone (OR 2.5, CI 1.3-4.7) and paraquat use (OR 2.5, CI 1.4-4.7) 82. 
The strengths of this study are that it is prospective, the diagnosis was confirmed by 
examination, and specific toxicants were identified. Its primary weakness is that it 
includes only 110 cases, limiting the power to test a number of pesticides individually 
and in combinations, as well as the ability to test gene-environment interactions. One 
additional limitation was that quantitation, types, and length of pesticide exposures were 
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self-reported. Despite these shortcomings, this study adds strong epidemiologic 
evidence that pesticides are associated with an increased risk of developing PD, 
especially for rotenone and paraquat.   
Ritz and colleagues at UCLA have taken another approach to identifying specific 
pesticides that are associated with an altered risk of PD. We took advantage of the 
California Pesticide Use Reporting database and Geographic Information System land-
use maps to estimate historical exposure. All commercial pesticide applications have 
been recorded by compound, quantity, and specific location since 1974. Thus, individual 
subject exposures can be approximated using the subject’s residential and occupational 
addresses for the past 37 years. In this Parkinson’s Environment Gene (PEG) study, 
neurologists specializing in movement disorders went into the field to confirm the 
diagnosis in over 350 incident PD cases in the Central Valley in California where 
pesticides are applied liberally and the risk of PD appears to be increased 83,84. A similar 
number of age- and sex-matched control subjects were also recruited from the same 
communities. In addition to several lifestyle and medical assessments, DNA and serum 
samples were also obtained.  
Individual pesticides were investigated in the PEG study based on previous 
reports implicating the agents as possibly involved in the pathogenesis of PD based on 
previous epidemiologic and/or laboratory studies. Maneb and paraquat were 
investigated because administration of pesticides to rodents produces a nice model of 
PD (see below). Estimates for maneb and paraquat exposures incurred between 1974 
and 1999 were generated based on subjects’ residences. Exposure to both pesticides 
within 500 m of their homes increased PD risk by 75% (CI 1.13-2.73). Subjects aged ≤ 
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60 yo were at much higher risk of developing PD when exposed to either maneb or 
paraquat alone (OR 2.27, CI 0.91-5.70) or to both pesticides in combination (OR 4.17, 
CI 1.15-15.16) 85. PEG investigators have found similar associations with 
organophospate pesticides—diazinon (OR 1.73, CI 1.23-2.45) and chlorpyrifos (OR 
1.50, CI 1.04-2.18) 86—and ziram (OR 3.01, CI 1.69-5.38). In subjects ≤ 60 yo, 
exposure to both ziram and paraquat had a sixfold increase in PD risk (CI 1.94-18.33) 
87. It is important to note that all estimates of exposures were not dependent on subject 
recall for total exposure or duration of exposure. Recent exposure to pesticides (1990 to 
1999) was not generally associated with an increased risk of PD, consistent with the 
theory that PD pathology likely starts several years before it manifests itself clinically.   
The population is exposed to pesticides in a variety of ways, not just inhalation 
from spraying and crop dusters. Gatto et al. looked at five pesticides that were likely to 
be detected in well water 88. Although local well water was not analyzed, these 
pesticides were identified based on their solubility, half-lives, and adsorptive properties. 
These included organophosphates (diazinon, dimethoate, chlorpyrifos), a carbamate 
(methomyl), and a sulfite ester (propargite). Excluding those who did not consume well 
water, potential inhalation and ingestion of each pesticide was associated with 23-57% 
increased risk of PD. Consuming well water potentiated this effect to a 41-75% 
increased risk. Up to a twofold increase was observed for those who consumed water 
with the highest potential contamination of at least one of these pesticides. Finally, 
those with PD were found to have consumed well water an average of 4.3 years longer 
than controls. Because PEG has enrolled over 350 cases, we have statistical power to 
test gene-environment interactions. Not surprisingly, the risk of developing PD in 
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pesticide-exposed subjects is clearly altered based on the subject’s genetic background 
(see below). 
 
3.3 Gene-environment interactions 
Gene-environment interaction analyses for pesticides and PD have been rare 
due to small sample size and difficulty obtaining exposure data 89-92.  Elbaz et al. found 
that pesticides had a modest effect in subjects who were not CYP2D6 poor 
metabolizers, had an increased effect in poor metabolizers (approximately twofold), but 
poor metabolizers were not at increased PD risk in the absence of pesticide exposure 
90. Hancook et al. found a gene-environment association in PD for pesticides and nitric 
oxide synthase 1 polymorphisms 91. Kelada et al. described a very modest risk of 
developing PD with specific DAT alleles but a 5.7-fold increase (CI 1.73-18.53) in 
developing PD in subjects with occupational exposure to pesticides. These studies 
added proof of concept that the effect of environmental exposures on the risk of 
developing PD is at least partially dependent on one’s genetic background 92. 
Unfortunately, exposure assessments were very limited in all of these studies, and 
individual toxins could not be determined.   
Gene-environment analysis in Ritz’s PEG study has only recently begun but has 
already revealed intriguing results. We replicated the DAT polymorphism’s interaction 
with pesticide exposure described by Kelada et al. for at least maneb and paraquat 67. 
Unexposed subjects with more susceptibility alleles had a 30% increased risk of 
developing PD, whereas exposed subjects had an almost fivefold increased risk (OR 
4.53, CI 1.70-12.1). Importantly, there was a gene dose effect as well. In a similar 
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manner, variations in PON1, the gene that encodes Paraoxonase 1 that metabolizes 
chlorpyrifos and diazinon, potentiated the increased PD risks associated with these 
organophosphates 86. For example, diazinon was associated with a 73% increased risk 
of PD (CI 1.23-2.45), but the risk increased to 267% (CI 1.09-6.55) in individuals that 
carry 2 PON1 risk alleles. Variations in the dinucleotide repeat sequence (REP1) within 
the α-syn promoter appear to alter the risk to paraquat exposure93. Finally, we have 
preliminary evidence that variations in ALDH2 gene potentiate the increased risks 
associated with dithiocarbamates and other pesticides that inhibit ALDH activity 94.   
Clearly, the number of potential gene-environment interactions is enormous, but 
we have clear proof of concept that these interactions need to be considered to truly 
understand environmental risks in PD. It will take very large sample sizes and good 
exposure analysis to obtain a better understanding of the many potential interactions 
that confer the bulk of PD risk factors. Alternatively, a candidate gene approach coupled 
with a better understanding of the pharmacokinetics and toxicity of specific pesticides 
may allow us to test gene-environment interactions using smaller sample sizes.   
 
4. From association to causality: Do pesticides cause PD and if so, how? 
Epidemiologic studies have clearly established the association between pesticide 
exposure and the development of PD. The possibility that this association represents 
causality has been strengthened by recent studies that have addressed the problem of 
recall bias and have demonstrated a dose-effect relationship. Now that some individual 
pesticides have been implicated, mechanistic studies could be pursued. These studies 
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are reviewed within the context of our current understanding of the pathophysiology of 
PD.  
 
4.1 Rotenone 
Rotenone is produced naturally in roots of certain plant species such as the 
jicama vine. It is a widely-used domestic garden pesticide, and because it is degraded 
by the sun in a matter of days, users tend to spray rotenone frequently. Rotenone is 
also a well-characterized, high-affinity, specific inhibitor of complex I of the 
mitochondrial respiratory electron transport chain. Low complex I activity had been 
reported to be associated with PD both in brain and peripheral mitochondria, but it was 
not known whether this is causal or a surrogate marker for something else. To further 
investigate this, Greenamyre and colleagues chronically administered the complex I 
inhibitor, rotenone, systemically into rodents. Some of these rats developed selective 
dopaminergic neuronal death as well as many of the motor features of PD. Importantly, 
neurons developed intracytoplasmic inclusions that were found to contain α-syn 61. α-
Syn pathology in the gastrointestinal tract has also been described in the rotenone 
model similar to that seen in PD 95. Even small amounts of rotenone delivered 
intragastrically reproduces many of the same features described in rats given rotenone 
subcutaneously, but in this model the various stages of PD are reproduced in a 
progressive manor 96. 
The mechanisms of rotenone toxicity are not completely clear but likely are more 
dependent on oxidative stress than energy failure 97. The downstream targets of 
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rotenone-induced oxidative damage are likely vast, but the UPS appears to be one of 
them 45,62,63. 
Until recently, there had not been convincing epidemiologic reports linking 
rotenone exposure to PD. Dhillon et al. reported more than a tenfold increase in risk, 
although this study was limited because exposures were self-reported 98.  The 
Agricultural Health Study did find a 2.5-fold increase risk with prospective 
questionnaires, adding further support for rotenone as a PD risk factor 82.  Furthermore, 
many organic farmers in the 1970s used rotenone as a natural pesticide, and a number 
of them have developed PD at a young age, although scientific confirmation of these 
anecdotal reports are lacking. Other pesticides that are complex I inhibitors are used 
even less frequently than rotenone, so little is known about associations with PD, 
although one would predict a similar effect. 
 
4.2 Paraquat 
One of the first pesticides investigated for its potential link to PD was paraquat 
due to its structural similarity to MPTP, the drug that caused acute parkinsonism in drug 
addicts. MPTP kills dopaminergic neurons by being metabolized to MPP+ by MAO-B, 
entering dopamine cells via the dopamine transporter, and then inhibiting complex I in 
the mitochondrial respiratory chain. Paraquat is ubiquitously used as an herbicide to 
control weed growth, and exposure to paraquat is associated with an increased risk of 
PD 99-101.   
Additional support for paraquat increasing the risk of PD comes from animal 
studies. Mice infused with paraquat for three consecutive weeks exhibit dopamine cell 
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loss and cytosolic α-syn aggregates 102-104. The mechanism by which paraquat causes 
dopamine cell death is not clear. Since it is structurally very similar to MPTP, it was 
presumed that paraquat acted in a similar manner. Surprisingly, unlike MPP+, paraquat 
is not a substrate for the dopamine transporter and does not inhibit complex I except at 
very high concentrations 105. Paraquat toxicity does appear to be dependent on 
increasing oxidative stress, and its action as a redox-cycler appears likely involved in its 
toxicity 106. 
 
4.3 Dithiocarbamates (maneb and ziram) 
Dithiocarbamates (DTCs) are a class of some of the most commonly-used 
organic fungicides. They are classified into two groups based on whether there is a 
carbonyl (group 1) or hydrogen on the nitrogen carbamate. Most DTCs are complexed 
with metals including zinc (e.g., ziram and zaneb), iron (e.g., ferbam) and manganese 
(e.g., maneb). DTCs first became relevant to PD researchers in 1985 when Corsini et 
al. found that diethyldithiocarbamate pretreatment enhanced MPTP toxicity in mice 107. 
They proposed that diethyldithiocarbamate would potentiate MPTP toxicity by inhibiting 
superoxide dismutase since they believed at that time that MPTP acted primarily as a 
redox cycler. Thiruchelvam et al. later reported that maneb potentiated the toxicity of 
paraquat preferentially in the nigrostriatal dopaminergic system 108,109. Furthermore, 
maneb and paraquat exposure was found to exacerbate α-synucleinopathy in A53T 
transgenic mice 110.   
The animal models using maneb and paraquat were intriguing, but it was only 
recently that an association between maneb and paraquat exposure and PD was 
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reported 85. Similar to the animal studies, residential exposure to maneb and paraquat 
together is associated with a 114% increased risk of newly-diagnosed PD. Furthermore, 
the risk of PD was increased to 317% for cases ≤ 60 yo. Neither pesticide alone was 
associated with PD, but there were few subjects with maneb-only exposure so the true 
effect for maneb alone could not be assessed. When both occupational and residential 
exposures were taken into account, subjects exposed to maneb and paraquat alone 
had a 126% and 50% increased risk of developing PD, respectively, but for exposure to 
maneb and paraquat together, the risk increased to 8.75% (CI: 2.3-33.2) in the younger 
group 87. These epidemiologic data taken together with the animal data are quite 
compelling that these pesticides truly increase the risk of PD.   
As mentioned above, DTCs are a large group of fungicides with similar 
structures. We identified another DTC, ziram, in an unbiased screen to identify 
pesticides that inhibit the proteasome 45. Maneb and some other DTCs were also found 
to inhibit the UPS but at higher concentrations 9. Ziram selectively killed dopaminergic 
neurons in primary cultures and increased α-syn levels in the remaining neurons. 
Systemic administration of ziram alone into mice caused progressive motor dysfunction 
and dopaminergic neuronal damage 9. Furthermore, subjects exposed to ziram alone 
had a 201% (CI: 1.69-5.38) increase of risk of developing PD and a 598% (CI: 1.95-
18.3) increase of risk when exposed with paraquat in subjects ≤ 60 yo 87. These data 
add further support for the role of DTCs as causal risk factors for PD. 
It is still not completely clear how DTCs act biologically. We have found that they 
do not increase oxidative stress and therefore are unlikely acting through the 
mitochondrial respiratory chain 45. DTCs clearly inhibit the UPS, and their potencies 
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depend on whether they contain a tertiary or a secondary amine group. Ziram was 
studied extensively given its high potency to inhibit the UPS, and we found that it acts 
by interfering with the ubiquitin E1 ligase with an IC50 of 161 nM 9. Zhou et al. reported 
that maneb also inhibited the UPS but at higher concentrations (IC50 of approximately 6 
µM) and increased protein carbonyls suggesting increased oxidative stress 111. We also 
found that maneb inhibits the UPS at much higher concentrations than ziram, but we did 
not find evidence of oxidative stress. Differences may very well be due to differences in 
the techniques used, since we used an in vivo 26S UPS assay and DCF fluorescence to 
detect ROS and Zhou et al. used an in vitro 20S UPS assay and protein carbonyl 
immunohistochemistry for detection of oxidative stress. Recently, we found that both 
maneb and ziram inhibit ALDH2 with IC50s of 220 nM adding another potential 
mechanism of toxicity, especially to dopaminergic neurons 94. Since ziram does not 
contain manganese, it is very unlikely that it is the manganese in maneb that confers its 
toxicity as some have suggested. 
 
4.4 Benomyl 
Another important fungicide implicated in PD pathogenesis is the benzimidazole 
compound benomyl. It was developed as a microtubule inhibitor and is sprayed on 
fruits, nuts, and leaves to prevent fungal growth. Preliminary findings from the PEG 
study revealed benomyl exposure increased PD risk by 138% (CI: 1.33-4.27) 94. 
Benomyl metabolizes spontaneously into another fungicide (carbendazim) and 
enzymatically into several thiocarbmate compounds. We have shown that benomyl and 
carbendazim are UPS inhibitors, although they are not as potent as ziram 45,112. 
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Furthermore, benomyl has also been reported to inhibit mitochondrial aldehyde 
dehydrogenase (ALDH) 19. Although these studies focused on hepatic ALDH, we 
recently reported that benomyl exposure reduced ALDH2 activity ex vivo in rat neuronal 
suspensions 112. We have also found that exposure to benomyl or one of its ALDH2-
inhibiting metabolites (S-methyl-N-butylthiocarbamate, or MBT) causes dopaminergic 
neuronal death in vitro, while the UPS-inhibiting metabolite (carbendazim) did not. 
These findings, combined with the observation that DTCs also inhibit ALDH2, suggest 
that ALDH2 inhibition may be an important mechanism in pesticide toxicity with respect 
to PD. 
The toxicity of ALDH2 inhibition is likely due to the accumulation of toxic 
aldehydes. We would predict that ALDH2 inhibition would lead to increased levels of 
DOPAL and 4-HNE adducts, and preliminary studies in primary cultures support this 
hypothesis. Furthermore, the loss of dopaminergic neurons due to benomyl was 
attenuated by co-treatment with the MAO-B inhibitor pargyline which decreases DOPAL 
formation 112. Since accumulations of DOPAL and 4-HNE have been reported to induce 
α-syn aggregation 11, these findings support ALDH2 inhibition as an important mediator 
of pesticide toxicity in PD.  
 
5. Summary 
The causes of PD are not completely understood, but both genetic and 
epidemiologic studies suggest that dysfunction of one or more biological processes 
leads to α-syn aggregation and neuronal death. Epidemiologic studies have clearly 
shown PD to be associated with pesticide exposure, and specific pesticides conferring 
  
26 
at least some of this increased risk have recently been identified. The fact that 
administration of pesticides to animals recapitulates many of the behavioral and 
pathological features of PD provides evidence that the associations found in 
epidemiologic studies are causal. Elucidating the mechanisms of pesticide toxicity in 
mammals not only strengthens the hypothesis that exposure to these toxicants can 
increase the risk of developing PD, but also furthers our understanding of the 
pathophysiology of the disease in general. It is clear that the list of pesticides discussed 
in this chapter is not complete and that pesticides are not the only environmental 
toxicant that alters the risk of PD, but the preponderance of evidence taken together 
supports an important role for pesticides in the pathogenesis of PD. A better 
understanding of these issues will take us one step closer to a cure. 
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Figure II-1.   Proposed pathophysiology of Parkinson’s disease 
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CHAPTER III 
Aldehyde dehydrogenase as a potential target for toxicant-
induced Parkinson’s disease 
1. Introduction 
 Parkinson’s disease (PD) is the second most prevalent neurodegenerative 
disorder, affecting millions of people worldwide. Symptoms result from the progressive 
degeneration of neurons, most notably the dopaminergic neurons in the substantia nigra 
pars compacta. More than half these neurons are lost by the time symptoms manifest 
themselves,113 so it is crucial to elucidate mechanisms of toxicity to dopaminergic 
neurons so that therapies can be developed to slow or reverse disease progression. 
Yet, the etiology of most PD cases remains elusive. Despite the identification of several 
genes that cause familial PD and polymorphisms that alter risk, only a small fraction of 
total risk can be accounted for genetically.114 Thus, environmental factors almost 
certainly play an important role in the pathogenesis of PD. 
Over the past few decades, epidemiologic studies have consistently reported 
associations between PD occurrence and rural living, well-water consumption, farming 
occupations, and pesticide exposure.79-82,90,91,98,115-117 Most of these studies have been 
limited by the potential for recall bias and the inability to identify specific toxicants as risk 
factors. Despite these shortcomings, pesticide exposure has consistently been 
associated with increased risk of developing PD. We recently developed a novel 
method for investigating potential epidemiologic associations that does not rely on 
subject recall but rather estimates exposures to specific agents using geocoding of 
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occupational and residential addresses and state-mandated commercial pesticide 
application records.118,119 Relying on this method, we found that exposures to a number 
of specific pesticides markedly increased the risk of developing PD.67,85-88,93 
The term “pesticides” refers to a diversity of compounds (including fungicides, 
herbicides, etc.) that differ greatly in their structures and mechanisms through which 
they kill their intended pests. Studies investigating pesticide toxicity in vertebrates 
commonly use acute exposures and rarely consider the effects of chronic low-level 
exposures more relevant to human disease. One proposed mechanism for pesticide 
neurotoxicity is the inhibition of protein degradation via the ubiquitin-proteasome system 
(UPS). We recently found that several pesticides inhibited the UPS in a cell-based 
screen,20 and some of these (e.g., ziram, maneb) were associated with an increased 
risk of PD in an epidemiologic study.85,87 The fungicide benomyl was selected for the 
present study not only because it was identified in our screen as a UPS inhibitor,20 but 
also because it has other activities that might be relevant to the pathogenesis of PD. For 
example, the fungicidal action of benomyl is thought to result from microtubule 
assembly impairment,120 a mechanism that has been implicated in PD.121 Microtubule 
inhibitors have been shown to inhibit the UPS62 and cause selective dopaminergic cell 
death and aggregation of α-synuclein, the predominant component of an intracytosolic 
Lewy body, the pathologic hallmark of PD.121 Furthermore, benomyl has been reported 
to inhibit aldehyde dehydrogenase (ALDH) activity in liver and brain mitochondria,19,122 
although this has not been demonstrated in brain tissue. The mitochondrial-associated 
ALDH2 is of particular interest since it is involved in the metabolism of toxic aldehydes 
in brain tissue, including the dopamine (DA) metabolite 3,4-
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dihydroxyphenylacetaldehyde (DOPAL). This brain-specific function of ALDH2 offers 
potential relevance of its inhibition to the preferential loss of dopaminergic neurons 
observed in PD.  
The present work is the first of its kind to integrate human patients, 
environmental exposure data, and cellular and in vivo models in the study of PD. We 
report that benomyl exposure was associated with increased PD risk in a human 
population and was selectively toxic to dopaminergic cells in vitro and in vivo. By 
conducting experiments with benomyl and several of its metabolites, we determined that 
benomyl’s neurotoxicity was primarily conferred by its ALDH inhibitory activity. This 
investigation suggests that chronic benomyl exposure is a risk factor for PD by inhibiting 
ALDH and resulting in the accumulation of toxic aldehydes in dopaminergic neurons. 
These findings identify ALDH dysfunction as a plausible pathway in PD pathogenesis 
and a novel therapeutic target for developing disease-modifying therapies. 
 
2. Methods 
2.1 Epidemiologic study 
2.1.1 Human subjects 
 This study was conducted as part of the UCLA Parkinson’s Environment & 
Genes (PEG) Study. Subject recruitment methods and case definition criteria have been 
described in detail.87 Briefly, PD cases were recruited through neurologists, large 
medical groups, and public service announcements between January 2001 and 
December 2010. Eligibility criteria for cases (recruited between January 2001 and 
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January 2008) included (1) first PD diagnosis by a physician within three years of 
recruitment, (2) adequate health to be examined, (3) residence in one of the counties of 
interest, and (4) residence in California for at least 5 years prior to recruitment. Eligible 
cases were examined by UCLA movement disorder specialists at least once and 
confirmed as having clinically “probable” PD according to published criteria.123 Of 1167 
PD patients initially invited, 604 did not meet eligibility criteria primarily due to having a 
first physician diagnosis of PD more than three years prior to baseline. Of the remaining 
563 eligible patients, 473 were examined by our movement disorder specialists; 113 did 
not meet published criteria for idiopathic PD. The remaining 360 idiopathic PD patients 
are included in these analyses. 
Population-based controls were recruited between January 2001 and January 
2010, initially from Medicare lists (2001) and predominantly from residential tax 
assessor records from the same three counties. Two sampling strategies were 
implemented to increase enrollment success and achieve representativeness of the 
control population: random selection of residential parcels enrolled via mail and phone, 
and clustered random selection of five households enrolled via in-person visits. 
Eligibility criteria for controls included (2)-(4) above and being at least 35 years of age. 
Of 1996 eligible population controls, 1043 declined participation, were too ill to 
participate, or moved away prior to enrollment. 754 population controls had complete 
data for inclusion in these analyses.  
Cases and controls completed a telephone interview for the collection of 
demographic (age, sex, race/ethnicity, education), risk factor (family history of PD, 
smoking behavior), and detailed residential and occupational history data. Written 
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informed consent was obtained from all enrolled subjects, and all procedures were 
approved by the UCLA Human Subjects Committee. 
 
2.1.2 Ambient pesticide exposure estimates 
Pesticide exposure assessments were performed using Pesticide Use Reports 
(PURs, collected by the California Department of Pesticide Regulation since 1974) and 
a geographic-information-system-based (GIS) computer model that has been described 
in detail.67,87,118,119 PURs provide information on the location and date of application, 
active ingredients, poundage applied, application method, crop type, and acreage of the 
field. Our model combines data from PURs, land-use maps (to determine locations of 
pesticide application more precisely), and geocoded lifetime occupational and 
residential addresses of subjects to derive the pounds of pesticide applied over 26 
years (1974-1999). Occupational and residential exposures were considered 
separately, and a subject’s ambient exposure was assumed to be proportional to the 
amount applied to crop acreage within a 500-meter radius surrounding the subject’s 
occupational or residential address. Exposure was categorized by the median exposure 
in exposed controls resulting in a three-level variable (unexposed, exposure below the 
median, exposure equal to or above the median). For quartile analyses, exposure was 
categorized by quartiles of exposure in exposed controls resulting in a five-level variable 
(unexposed, four quartiles). 
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2.2 In vivo studies 
 All procedures using zebrafish and rats were approved by the UCLA Animal 
Research Committee. Zebrafish expressing GFP tagged to vesicular monoamine 
transporter protein (ETvmat2:GFP) were used to identify aminergic neurons in whole 
larvae.124 Peripheral sensory neurons (trigeminal and Rohon-Beard) were visualized 
using the previously-described Tg(sensory:GFP) transgenic line.125 Whole larvae were 
bathed in 1 µM benomyl or vehicle (0.01% DMSO) from 5 h until 5 d postfertilization, 
anesthetized using 0.02% tricaine methanesulfonate, fixed in 4% paraformaldehyde 
overnight, and mounted in 1.2% agarose for confocal imaging at 20x magnification. For 
aminergic neurons, ~100 optical sections were gathered for each larva, spaced 1.34 µM 
apart, using a Zeiss LSM 5 Pascal inverted microscope. For peripheral sensory 
neurons, ~60 optical sections were spaced 3 µM apart, using a Zeiss LSM 510 inverted 
microscope. Cells were counted blindly in three-dimensional projections, and 
fluorescence in composite images was measured blindly using ImageJ (NIH). 
 Spontaneous zebrafish movement was monitored with ZebraLab (Viewpoint Life 
Sciences, Inc., Lyon, France). Total distance was measured by tracking individual 
larvae for 30 min. Larvae were considered immobile at 0-2 mm/s. 
 
2.3 Primary neuronal cultures 
2.3.1 Preparation and treatment 
Primary neuronal cultures were prepared using a protocol adapted from Rayport 
et al and previously described.9,126 Briefly, cortical glial feeder cells were established on 
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polyornithine/laminin-coated coverslips, which formed the base of 10-mm-diameter 
wells cut into 35-mm culture dishes (MatTek Corporation, Ashland, MA), until they 
reached confluency (~5 d) and 5-fluorodeoxyuridine was added to prevent additional 
glial proliferation. Mesencephalic cells containing the substantia nigra pars compacta 
(excluding the ventral tegmental area) were dissected from coronal sections from brains 
of postnatal day 1 or 2 rat pups. The cells were dissociated in papain and plated onto 
the glial cells at densities of 4x105 per coverslip. Cultures were grown for 6-8 d and then 
treated by exchanging 1 mL of the media in each plate with 1 mL of fresh media 
amended with test compound(s) and DMSO (final concentration 0.01%). 
 
2.3.2 Immunocytochemistry (TH, NeuN, α-synuclein) 
After 48-h treatment, cultures were fixed in paraformaldehyde (4%) for 30 min, 
washed with PBS, blocked with normal donkey serum (5%) and Triton (0.5%) in PBS for 
1-2 h, incubated with antibodies against tyrosine hydroxylase (TH, 1:1500, anti-rabbit, 
Calbiochem) and neuronal nuclei (NeuN, 1:200, anti-mouse, Millipore) overnight at 4°C, 
washed with 3x and 1x PBS, incubated with Alexa Fluor 488 (1:200, Invitrogen) and 555 
(1:1500, Invitrogen) secondary antibodies at room temperature (RT) for 2 h, and 
washed with 0.1% Tween-20 in PBS and then with PBS before coverslipping. All TH-
immunoreactive neurons were counted, and NeuN-immunoreactive neuron counts were 
estimated for each coverslip from neurons quantified in five representative fields of view 
using a 20x objective. Quantification was determined by blinded raters.  
In some experiments, cultures were incubated with antibodies against TH and α-
synuclein (1:500, anti-mouse, BD Biosciences) but not NeuN. Relative levels of α-
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synuclein in TH-positive cells were determined as previously described.9 Briefly, 
exposure time was held constant as digital images were obtained using a 40x objective 
with filters for TH- and α-synuclein-immunoreactivity. Images were stacked into a single 
sequence, a polygonal region of interest was manually drawn around the TH+ neuron, 
and mean and total intensity of the α-synuclein-immunoreactive image were determined 
inside the region of interest using the GNU Image Manipulation Program (GIMP 2.6). 
Analyses of coverslips treated with TH, Alexa Fluor 488, and Alexa Fluor 555 antibodies 
(but not α-synuclein) revealed that bleed-through and cross-reactivity were negligible. 
 
2.3.3 Determination of cellular contents of dopamine and its metabolites 
Some cultures were extracted in perchloric acid (100 mM) and EDTA (0.1%) and 
stored at -80oC until analysis. Samples were separated on a C18 reverse phase column 
(TSKgel Super ODS 2 µm particle size, 10 x 2.1 mm, maintained at 33oC, Tosoh 
Bioscience, Grove City, OH) using a mobile phase (2.5% methanol, 100 mg/L sodium-1-
octane sulfonate, 42 mM citric acid, 38 mM sodium acetate, 50 mg/L EDTA) pumped at 
0.2 mL/min (LC-10AD pump, Shimadzu, Columbia, MD). Monoamines and metabolites 
were oxidized on a glassy carbon electrode against a Ag/AgCl reference (Antec Leyden, 
Palm Bay, FL) with an applied potential of 0.75V. Data were collected using EzChrom 
software (Agilent, Santa Clara, CA). 
 
2.4 ALDH activity assays 
2.4.1 Primary neuronal suspensions 
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Mesencephalic neurons (postnatal day 2) were dissected and dissociated as 
described above (Section 4.3.1). Instead of plating, neurons were resuspended in buffer 
from the Aldefluor® kit (STEMCELL Technologies, Vancouver, Canada). Aldefluor® 
was added (1 µL/mL) to the neuronal suspension, and 300-µL aliquots were 
immediately transferred to culture tubes containing 3 µL of test compounds, resulting in 
final concentrations of 100 nM-20 µM. Culture tubes were incubated at 37oC for 30 min, 
gently shaking at the beginning and after 15 and 30 min. Using flow cytometry 
(Beckman XL-MCL FACs), cells were gated by forward- and side-scatter, and 
intracellular green fluorescence was measured on channel FL1. ALDH inhibition was 
determined by comparing fluorescence in the presence or absence of test compounds. 
 
2.4.2 Enriched mitochondria preparations 
Rat mitochondria were isolated mechanically from liver at 0.25 g/mL in 
homogenization buffer containing 5 mM Tris (pH 7.2), 0.25 M sucrose, and 0.5 mM 
EDTA.127,128 Homogenate was diluted to 0.02 g/mL and centrifuged (480 g, 4oC, 10 
min). Supernatant was recovered and centrifuged (4200 g, 4oC, 7 min). Pellets from 
both centrifugations were combined, centrifuge-washed twice with 25 mL of buffer (4200 
g, 4oC, 7 min), resuspended in 20 mL of buffer, aliquoted, and stored at -80oC.  
Mitochondria preparation (10 µL) was exposed to test compound for 5 min in 170 
µL of 50 mM pyrophosphate buffer (pH 9.0), 50 mM NAD+, 0.1 mM pyrazole, 0.5% w/v 
sodium deoxycholate, and 2 mM rotenone (added in 2.7 µL methanol) and transferred 
to a 96-well plate. Absorbance at 340 nm was monitored for 10 min at 5-s intervals after 
1 mM acetaldehyde (20 µL) was added (SpectraMax® 340PC384 Absorbance Microplate 
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Reader with SoftMax® Pro data acquisition software, Molecular Devices). ALDH activity 
was determined from the slope as the increase in absorbance over time from 1-3 min. 
 
2.5 26S proteasome activity assay 
26S UPS activity was determined by FACs as previously described.20 Briefly, 
neuroblastoma SK-N-MC cells transfected with an EGFP-degron fusion protein and 
passaged multiple times were grown at an initial density of 105 per mL (1 mL/well) in 24-
well plates in DMEM/F12 media amended with 10% fetal bovine serum and 1% Pen-
Strep. After cells reached confluency (3 d), media was replaced with fresh media 
amended with test compounds (2 mL/well). After 48 h, FACs was used to gate 
trypsinized cells by forward- and side-scatter and measure intracellular green 
fluorescence on channel FL1 (Beckman XL-MCL). The level of fluorescence 
corresponded to the level of EGFP-degron fusion protein that was not selectively 
degraded by the proteasome.129 Thus, high fluorescence represents low UPS activity. 
 
2.6 Statistical analyses 
Demographic characteristics were compared for deviation from expected by chi-
square test (categorical variables) or for difference in mean by t-test (age). Logistic 
regression analyses were performed on the epidemiologic data using SAS 9.1 (SAS 
Institute Inc., Cary, North Carolina). Odds ratios and 95% confidence intervals were 
estimated after adjusting for age (continuous variable), sex (male/female), county of 
residence (Fresno/Kern/Tulare), education (less than twelve years of schooling/twelve 
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years or completion of GED/more than twelve years), and smoking status 
(current/former/never). Sensitivity analyses were performed to assess the effects of 
adjustments for race (Caucasian/non-Caucasian) and family history of PD (first-degree 
family history present/absent). Additional sensitivity analyses were performed excluding 
twenty-three controls who had lived at an address for more than two years prior to 1999 
in a cluster already represented during those years, and excluding forty-four cases and 
ninety-five controls who were missing one or more occupational addresses from 1974-
1999. For trend tests, quartile categories were assigned scores of 0, 1, 2, 3, or 4 and 
entered into the logistic regression equation as a linear term. The Wald statistic was 
used as a test for linear trend of the odds ratio. 
In biochemical assays, IC50 values were determined using sigmoidal curve fits of 
percent inhibition at varying concentrations (GraphPad PRISM 5). For all other 
analyses, statistical significance was determined using a paired t-test. Standard error 
values are given in the text and in figure error bars. 
 
3. Results 
3.1 Benomyl exposure is associated with increased incidence of PD  
The Parkinson’s Environment & Genes (PEG) Study is a population-based case-
control epidemiologic study recruiting PD patients (“cases”) and neurologically-normal 
subjects (“controls”), specifically designed to investigate the impact of ambient pesticide 
exposures on risk of PD. Three hundred sixty cases and seven hundred fifty-four 
controls were included in these analyses (Supplementary Table 1). Individuals were 
grouped for analyses in two different ways—unexposed vs. above vs. below median 
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exposure estimates, and unexposed vs. each of four quartiles—based on records of 
benomyl applied over twenty-six years (1974-1999) and estimated for areas within five 
hundred meters of their reported occupational or residential addresses.  
Using occupational addresses, risk of PD increased 65% for individuals with an 
estimated ambient benomyl exposure at their workplace equal to or above the median 
as compared to those who were unexposed (OR=1.65, 95%CI: 1.17-2.32; Table 1). This 
risk increased to almost two-fold for those with estimated exposures in the highest 
quartile (OR=1.92, 95%CI: 1.25-2.96), demonstrating a dose-response trend across the 
quartiles (p<0.01; Supplementary Table 2). We observed no association between 
benomyl exposure and PD based on residential addresses. 
These findings did not change in sensitivity analyses adjusting for race/ethnicity 
or family history of PD, or when excluding subjects potentially over-representing 
particular residential clusters or missing one or more years of occupational data. This 
benomyl-PD association at occupational addresses was present for both males and 
females (ORmales=1.81, ORfemales=1.42; Supplementary Table 3).  
 
3.2 Benomyl causes selective dopaminergic cell damage in vitro and in vivo 
 Following up on this epidemiologic finding, we investigated benomyl’s 
mechanisms of toxicity in vitro and in vivo. Since dopaminergic neurons are particularly 
vulnerable in PD, neurotoxicity was investigated in primary mesencephalic cultures 
using tyrosine hydroxylase immunoreactivity (TH+) as a marker for dopaminergic 
neurons and neuronal nuclei immunoreactivity (NeuN+) as a marker for total neurons. A 
representative field of view is shown at 20x magnification with filters distinguishing each 
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antibody (Figure III-2a-b). Benomyl was selectively toxic to dopaminergic neurons, 
resulting in a 24±6% decrease in TH+ cells at 100 nM and a 35±4% decrease at 1 µM 
after 48-h exposures (Figure III-2b). There was no significant loss of total NeuN+ 
neurons at either concentration, demonstrating selective toxicity of benomyl. The total 
number of NeuN+ neurons (i.e., total neurons) did not significantly change despite the 
loss of TH+ neurons since TH+ cells only contributed on the order of 1% of total neurons 
counted. 
 In order to determine if dopaminergic neurons were selectively vulnerable in an in 
vivo model, we employed transgenic zebrafish (Danio rerio) lines that label specific 
neuronal populations. In the ETvmat2:GFP zebrafish line, neurons expressing vesicular 
monoamine transporter 2 (VMAT2) fluoresce green—these include dopaminergic, 
(nor)adrenergic, and serotonergic neurons.124 ETvmat2:GFP embryos were exposed to 
1 µM benomyl from 5 hr postfertilization until 5 d postfertilization; whole-mounted 
embryos were scanned using confocal microscopy, and images were reconstituted to 
three-dimensional projections in order to count clusters of neurons corresponding to 
anterior (including olfactory bulb and telencephlon) and diencephalic VMAT2+ neurons 
(Figure III-3a-b). Neuronal counts decreased 24±9% in VMAT2+ anterior clusters 
(P=0.041, n=19; Figure III-3g) and 18±9% in VMAT2+ diencephalic clusters (P=0.15), 
constituting an overall 22±8% decrease in VMAT2+ neurons in these clusters (P=0.043). 
Fluorescence similarly decreased 25±13% (anterior, P=0.16; Figure III-3h), 38±13% 
(diencephalon, P=0.061), and 27±12% (overall, P=0.089). In order to determine if non-
dopaminergic neurons were injured by benomyl, we employed the Tg(sensory:GFP) 
zebrafish line in which Rohon-Beard (Figure III-3c-d) and trigeminal (Figure III-3e-f) 
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sensory neurons fluoresce green. In contrast to the ETvmat2:GFP exposed embryos, 
there were no significant differences in GFP+ neuron counts or fluorescence in sensory 
neurons. Even the complex axons of these sensory neurons were unaffected by 
benomyl exposure, adding further support that benomyl is toxic to dopaminergic 
neurons in a selective manner (Figure III-3g-h). 
Benomyl exposure under these conditions was not lethal to zebrafish larvae, but 
swimming behavior was altered. After two weeks of exposure, benomyl-treated 
zebrafish exhibited a 37±5% decrease in spontaneous swimming distance as compared 
to unexposed zebrafish, suggesting that benomyl’s selective toxicity to dopaminergic 
neurons has functional significance in vivo. 
 
3.3 Benomyl inhibits ALDH and UPS activities via different moieties 
 We previously found that benomyl can inhibit both the UPS and ALDH. Its 
decomposition is spontaneous but slow, creating a reservoir for slow release of 
carbendazim and butyl isocyanate (BIC) (Figure III-1). The ALDH inhibitory activity is 
caused by BIC and its downstream metabolites including S-methyl N-
butylthiocarbamate (MBT) which is further converted by P450 enzymes to MBT 
sulfoxide (MBT-SO), a very potent ALDH inhibitor.19 The specific moiety responsible for 
benomyl’s UPS inhibitory activity is less clear, although we do know that carbendazim is 
a well-established microtubule inhibitor130-132 and microtubule inhibitors inhibit the 
UPS.62 We took advantage of these separate metabolic pathways to investigate 
potential mechanisms of action through which benomyl damages dopaminergic 
neurons. 
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 In order to determine ALDH activity in primary neurons, we used a novel cell-
based assay (Aldefluor®, STEMCELL Technologies, Vancouver, Canada) in which 
fluorescence increases with increasing ALDH activity. Exposure of ex vivo suspensions 
of 2-day-old nigral neurons to benomyl for 30 min resulted in concentration-dependent 
ALDH inhibition (Figure III-4a). ALDH activity was inhibited by 19±0.4% (p<10-6, n=3) at 
the lowest concentration tested (100 nM), progressively increasing to 30±0.8% inhibition 
at the highest concentration tested (10 µM; p<10-27, n=10). MBT exposure (10 µM) 
inhibited ALDH activity by 12±1% (p<10-4, n=5). In contrast, carbendazim was 
ineffective at concentrations investigated up to 20 µM (Figure III-4a). 
The ALDH inhibitory IC50s of benomyl and its metabolites were quantitated using 
an enriched mitochondria preparation from rat liver. Benomyl and BIC were essentially 
equipotent with IC50s of 140±20 nM and 120±30 nM, respectively. MBT had a somewhat 
higher IC50 of 1.3±0.2 µM (Figure III-4b). Carbendazim did not inhibit ALDH activity. 
These results are consistent with those observed by Staub et al. for hepatic 
mitochondria prepared from mice.19 
 To determine the moiety responsible for benomyl’s UPS inhibitory activity, we 
used an SK-N-MC neuroblastoma cell line that constitutively expresses a GFPu 
degron.20,129 In this assay, GFP accumulates and fluorescence increases when the UPS 
is not functioning properly. Benomyl inhibited the UPS with an IC50 of 5.7±0.5 µM after 
48 h of exposure (Figure III-4c). Carbendazim exposure had the same effect 
(IC50=5.7±0.3 µM), whereas MBT did not inhibit the UPS. Collectively, these 
experiments revealed that carbendazim is responsible for UPS dysfunction, presumably 
via microtubule inhibition, whereas BIC and its enzymatically-activated metabolites 
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(including MBT) inhibit ALDH activity. Since BIC is an unstable compound, MBT and 
carbendazim were used to distinguish between these mechanisms of action in further 
studies. 
 
3.4 Benomyl neurotoxicity occurs via ALDH inhibition 
 To determine if benomyl’s neurotoxicity is attributable to its ALDH or UPS 
inhibitory activity, cultures were exposed to MBT or carbendazim under the same 
conditions as described for benomyl treatment. MBT exposure (1 µM) resulted in a 
27±6% decrease in TH+ cells (Figure III-2b), comparable to benomyl exposure, and 
similarly had no effect on NeuN+ cells. In contrast, carbendazim exposure (1 µM) alone 
had no significant effect on neuron counts, and there was no synergistic effect when 
cells were exposed simultaneously to MBT and carbendazim. Since MBT represents 
benomyl’s ALDH inhibitory action, these results suggest that benomyl’s neurotoxicity is 
due to ALDH inhibition at the concentrations tested.  
Benomyl inhibited ALDH activity in primary neurons, and benomyl’s ALDH-
inhibiting metabolite recapitulated its toxicity to TH+ neurons in primary cultures, so we 
hypothesized that benomyl’s selective toxicity to TH+ neurons was caused by the effects 
of ALDH inhibition on DA metabolism. A subset of primary cultures treated with benomyl 
was sacrificed at 3 h, and cells were extracted in perchloric acid and EDTA for 
measurement of DA content. It is well-established that DA is oxidized by monoamine 
oxidase (MAO) to form DOPAL, which is then further oxidized to 3,4-
dihydroxyphenylacetic acid (DOPAC) by ALDH (Figure III-1). We were unable to 
measure [DOPAL] directly due to its instability and very low concentrations in cultures, 
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so we measured [DA] and [DOPAC] to determine if DA homeostasis shifted with 
benomyl treatment. [DOPAC] was 42±11% less in benomyl-treated cultures (p<0.05, 
n=16), and [DA] remained relatively unchanged, so [DOPAC]/[DA] was 38±13% less 
(p<0.05), consistent with ALDH inhibition in these neurons. 
 To test the hypothesis that reducing the formation of toxic ALDH substrates (i.e., 
DOPAL) would attenuate benomyl’s neurotoxic effect, we added the MAO inhibitor 
pargyline to primary cultures concurrently exposed to benomyl or MBT. TH+ neuronal 
loss was attenuated by 30±9% (n=13-14; Figure III-5) in cultures co-treated with 
pargyline (200 µM) and benomyl (1 µM). Pargyline completely prevented neurotoxicity 
in cultures treated with MBT (1 µM), a less potent ALDH inhibitor (p<0.05, n=14-15). 
Pargyline alone had no effect on TH+ neuronal counts at this concentration. 
 
3.5 Benomyl neurotoxicity is independent of α-synuclein 
 Since the major pathologic hallmark of PD is the formation of Lewy bodies which 
are comprised primarily of α-synuclein aggregates, α-synuclein levels were measured 
using immunocytochemistry in surviving dopaminergic neurons after benomyl exposure. 
α-Synuclein levels did not change significantly in cells exposed to benomyl, MBT, 
carbendazim, or a combination of MBT and carbendazim (data not shown), suggesting 
that benomyl toxicity is independent of α-synuclein and dominated by alterations in DA 
homeostasis. This is in contrast to ziram toxicity which increases α-synuclein levels and 
causes dopaminergic cell injury by inhibiting E1 ligase activity in the UPS.9 Here, 
investigations with benomyl elucidate a novel mechanism (ALDH inhibition) by which a 
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pesticide may be associated with increased PD risk and dopaminergic cell damage 
independent of α-synuclein levels. 
 
4. Discussion 
 We have been investigating the potential role environmental toxicants play in the 
etiology of PD with the dual goals of reducing risk through determining safer practices 
and gaining novel clues into the pathogenesis of the disease that may be generalizable 
to all PD patients. Epidemiologic associations between PD occurrence and general 
pesticide use have been confirmed in meta-analyses, but most previous studies relied 
on subject recall and did not have sufficient information or statistical power to determine 
associations with specific toxicants. The PEG Study overcomes these limitations with a 
novel GIS model that incorporates historical state-mandated commercial agricultural 
Pesticide Use Reports and land-use maps to determine the amounts of specific 
pesticides applied near subjects’ occupational or residential addresses, providing 
estimates of subjects’ relative ambient exposures in a heavy pesticide use region of 
California. We have used this method to report positive associations between PD onset 
and exposures to ziram, maneb, and paraquat.85,87  
Here we show that exposures to ambient benomyl at the workplace (based on 
benomyl application estimates over a 26-year period) were associated with 65% to 
almost two-fold increases in risk of developing PD, after accounting for known PD risk 
factors (e.g., age, sex). Analyses based on occupational addresses potentially 
incorporate the best estimates of subjects’ ambient benomyl exposures since pesticide 
applications occur during the workday when subjects would have been at occupational 
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rather than residential addresses. Analyses of ambient exposures based on residential 
addresses showed no association with PD, likely because the population was randomly 
distributed at residential addresses during evenings or weekends when commercial 
pesticides were not applied. Notably, this model only estimates relative ambient 
exposures and does not take into account other routes of exposures such as 
occupational handling of pesticides and drinking well water, both associated with 
increased risk of PD, which could potentiate the estimated risk even further.88,133,134  
Our finding that ambient benomyl exposure was associated with increased PD 
risk offered an excellent opportunity to investigate the hypothesis that this association is 
causal and to determine the underlying mechanisms of toxicity. It is very difficult to 
establish causality from an epidemiologic association, particularly for a risk-increasing 
factor such as a toxicant. One approach to this end is to determine if exposure in 
experimental models can recapitulate some of the pathologic features of the disease. 
Since concentrations in the range of 1.3-50 µM are necessary for benomyl’s intended 
use as a fungicide,135-137 we used a conservative concentration range of 0.1-1 µM to 
ensure relevance to actual exposures for humans. Here we report relatively selective 
dopaminergic neuronal damage in both an in vitro and a novel in vivo model. We found 
significant losses of TH+ neurons in primary cultures exposed to benomyl at low 
concentrations, while the survival of other neurons was unaffected. In order to further 
evaluate benomyl’s selective toxicity, we developed a novel in vivo zebafish model. 
Zebrafish are vertebrates with a well-developed dopaminergic system, and since the 
embryos are transparent, we can visualize specific neuronal types using fluorescent 
reporter genes. Two different transgenic lines were used: ETvmat2:GFP zebrafish124 in 
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which the aminergic neurons are labeled with GFP, and Tg(sensory:GFP) zebrafish125 
that label trigeminal and Rohon-Beard sensory neurons. Aminergic neurons in zebrafish 
larvae were selectively damaged while sensory neurons were preserved after benomyl 
exposure, in a similar manner as observed in the mesencephalic cultures. In analyzing 
aminergic neurons, we focused on the most prominent clusters at 5 days 
postfertilization. The anterior clusters shown in Figure III-3a correspond to aminergic 
neurons in the olfactory bulb and telencephalon; the posterior clusters are diencephalic. 
Holzschuh et al. previously reported that these clusters also include (nor)adrenergic 
neurons, although they are predominantly dopaminergic.138 There was significant loss in 
these clusters, whereas the non-aminergic trigeminal and Rohon-Beard neurons did not 
undergo any damage, suggesting selectivity for dopaminergic neurons. 
Benomyl’s action as a fungicide is thought to be due to its ability to impair 
microtubule assembly, interfering with mitosis and other processes.139,140 We found 
previously that microtubule inhibitors such as nocodazole and rotenone also inhibit the 
UPS.62 Here we report that the carbendazim moiety of benomyl, a known microtubule 
inhibitor, confers benomyl’s UPS inhibitory activity. It is unlikely that microtubule or UPS 
dysfunction is responsible for benomyl’s toxicity observed in these primary cultures or 
zebrafish, given the low concentrations used. The IC50 for UPS inhibition by benomyl is 
5.7 µM, which is more than an order of magnitude higher than the concentrations 
needed to damage dopaminergic neurons in primary cultures. Furthermore, 
carbendazim had no effect on neuronal survival at 1 µM, whereas MBT recapitulated 
benomyl’s toxicity. Our data show that benomyl and MBT, but not carbendazim, inhibit 
ALDH activity in primary neurons. Since MBT is the toxic metabolite, ALDH inhibition 
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likely confers benomyl’s neurotoxicity. Wey et al. recently reported TH+ neuronal loss in 
Aldh1a1-/-xAldh2-/- mice.141 Although environmental investigations like ours can be 
confounded by multiple simultaneous toxic mechanisms, their genetic approach 
targeting ALDH1 and ALDH2 yielded a result similar to what we observed in vitro and in 
vivo, supporting our hypothesis that benomyl exposure damages dopaminergic neurons 
via ALDH inhibition. The present work adds an epidemiologic PD association to 
demonstrate the relevance of this mechanism to PD pathogenesis. 
Our observed alterations in DA metabolites after benomyl exposure add further 
support for ALDH inhibition as the cause of benomyl’s neurotoxicity. Wey et al. also 
reported DOPAL accumulation concomitant with TH+ neuronal loss and behavioral 
deficits in mice lacking cytosolic and mitochondrial ALDHs.141 Burke et al. reported that 
DOPAL is 400-fold more toxic to dopaminergic neurons in vivo than its precursor (DA) 
or its ALDH product (DOPAC).14,142,143 Thus, ALDH inhibition leads to the accumulation 
of DOPAL and provides a mechanism for benomyl’s selective toxicity to dopaminergic 
neurons. Consistent with this hypothesis, reducing DOPAL synthesis with an MAO 
inhibitor mitigated benomyl’s toxicity. 
In summary, pesticide exposure has been suggested to be a major risk factor for 
PD, and here we report an epidemiologic association between chronic benomyl 
exposure and increased PD risk. We found that dopaminergic neurons are selectively 
vulnerable to benomyl exposure both in neuronal cultures and in a novel in vivo 
zebrafish model. Benomyl and its metabolites are potent ALDH inhibitors, and several 
converging lines of evidence reveal ALDH inhibition as a mechanism of toxicity by which 
benomyl and other environmental toxicants may be associated with PD risk. 
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Augmenting ALDH activity may be a new therapeutic target for designing disease-
modifying therapies for PD. 
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Figure III-1. Aldehyde dehydrogenase inhibition as a potential mechanism of benomyl-
induced Parkinson’s disease. Benomyl is efficiently metabolized to several potent ALDH 
inhibitors, so exposure leads to the accumulation of the toxic dopamine metabolite 
DOPAL. This offers a possible explanation for the selective toxicity to dopaminergic 
neurons observed in PD pathogenesis. ALDH is a potential therapeutic target to alter 
disease progression. 
Abbreviations: BIC, butyl isocyanate; MBT, S-methyl N-butylthiocarbamate; MBT-SO, S-
methyl N-butylthiocarbamate sulfoxide; DA, dopamine; DOPAL, 3,4-
dihydroxyphenylacetaldehyde; DOPAC, 3,4-dihydroxyphenylacetic acid; GSH, 
glutathione; CYP, cytochrome P450; MAO, monoamine oxidase; ALDH, aldehyde 
dehydrogenase; Cys, cysteine residue 
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Figure III-2. Dopaminergic neuronal damage in primary mesencephalic cultures 
exposed to benomyl or its metabolites. Representative field of view (20x) shows 
immunoreactive (a) dopaminergic neurons (TH+) and (b) neuronal nuclei (NeuN+). (c) 
Exposure to 100 nM or 1 mM benomyl results in 24±6% (P=0.0017, n=16) and 35±4% 
(P=5.5x10-10, n=47) respective losses of TH+ neurons as compared to untreated 
cultures. MBT exposure recapitulates this effect (P=5.5x10-5, n=28), whereas 
carbendazim does not significantly damage dopaminergic neurons (P=0.73, n=10). 
Since MBT is either the proximal or penultimate benomyl metabolite that inhibits ALDH 
activity, there appears to be an association between neuronal damage and ALDH 
inhibition; proteasomal inhibition by the carbendazim moiety is not sufficient to kill cells 
under the same conditions. *P<0.05, **P<0.01, ***P<0.0001
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Figure III-3. Aminergic neuronal damage in Danio rerio larvae exposed to benomyl. 
Representative confocal images of zebrafish larvae (a,c,e) unexposed or (b,d,f) bathed 
in 1 µM benomyl from 5 hours postfertilization until 5 days postfertilization are shown. 
(g) Neuronal counts (a-b) decreased in VMAT2+ anterior and diencephalic clusters of 
ETvmat2:GFP zebrafish exposed to benomyl (solid bars) but were unaffected in (c-d) 
Rohon-Beard and (e-f) trigeminal neurons in Tg(sensory:GFP) zebrafish. (h) 
Measurement of total fluorescence yielded the same results. *P<0.1, **P<0.05 
Abbreviations: LC, locus coeruleus; De, diencephalon; OB, olfactory bulb; Te, 
telencephalon 
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Figure III-4. Inhibitory actions of benomyl and its metabolites. (a) Exposure to benomyl 
or MBT inhibited ALDH activity ex vivo in mesencephalic neurons dissociated from 2-
day-old rat pups (n=3-11). (b) Benomyl inhibited in vitro ALDH activity in rat hepatic 
mitochondria preparations with an IC50 of 140±19 nM (n=2-4). BIC had essentially the 
same effect (IC50=120±32 nM; n=3-4); MBT was somewhat less potent with an IC50 of 
1.3±0.2 µM (n=4-8). Carbendazim did not significantly inhibit ALDH activity at up to 20 
µM (n=4). (c) A reporter protein revealed that benomyl inhibited 26S UPS activity in SK-
N-MC neuroblastoma cells with an IC50 of 5.7±0.5 µM (n=4-14). Carbendazim exposure 
had the same effect (IC50 of 5.7±0.3 µM, n=4-14), whereas MBT exposure up to 10 µM 
had no effect (n=5). (d) Benomyl and its BIC/MBT metabolites inhibit ALDH activity at 
lower concentrations than benomyl and its carbendazim moiety inhibit the 26S UPS. 
*P<0.01, **P<0.0001 
Abbreviations: SE, standard error; 26S UPS, ubiquitin-proteasome system 
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Figure III-5. Neuroprotection via reducing DOPAL accumulation with MAO inhibitor. The 
neuronal loss resulting from 1 µM benomyl or MBT exposure was mitigated by co-
treatment with the MAO inhibitor pargyline (200 µM, n=13-28). Because MAO-B 
inhibition reduces the metabolism of dopamine to DOPAL, this suggests that DOPAL is 
toxic to dopaminergic neurons, and that benomyl is toxic via DOPAL accumulation as a 
result of ALDH inhibition. *P=0.0027, **P=2.4x10-4, ***P=6.1x10-5 
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Table III-1. Associations between PD and estimated ambient occupational or residential 
benomyl exposures  
Exposurea 
Cases  
(n=360) 
Controls  
(n=754) ORb (95%CI) P-valuec 
Occupational, n(%)     
No 217 (60.3) 531 (70.4) 1.00  
Low 49 (13.6) 106 (14.1) 1.06 (0.71-1.59) 0.78 
High 94 (26.1) 117 (15.5) 1.65 (1.17-2.32) 0.004 
     
Residential, n(%)     
No  209 (58.1) 467 (61.9) 1.00  
Low 72 (20.0) 143 (19.0) 1.01 (0.70-1.45) 0.96 
High 79 (21.9) 144 (19.1) 1.00 (0.70-1.43) 0.99 
 
Abbreviations: OR = unconditional logistic odds ratio; CI = confidence interval 
a “Low” exposure defined as below the median value in exposed controls; “High” 
exposure defined as equal to or above the median value in exposed controls. 
b  adjusted for age (continuous), sex (male/female), smoking status (current, former, 
never), county (Fresno, Kern, Tulare), and education (<12 yrs, =12 yrs, >12 yrs). 
c For multiple testing considerations, six tests were performed and a p-value of 0.008 
was considered statistically significant. 
  
57 
Supplementary Table III-1. Demographics of the Parkinson’s Environment & Genes 
(PEG) Study 
Parameter  
Cases 
(n=360) 
Controls  
(n=754) P-valuea 
Gender, n (%)    
Female 154 (42.8) 402 (53.3)  
Male 206 (57.2) 352 (46.7) 0.001 
Ageb    
Mean (sd) 68.3 (10.2) 66.9 (11.2) 0.036 
Range 34-88 35-99  
Racec, n (%)    
Caucasian, non-Hispanic 290 (80.6) 526 (69.8)  
Caucasian, Hispanic 47 (13.1) 144 (19.1)  
Native American 16 (4.4) 35 (4.6)  
African American 3 (0.8) 25 (3.3)  
Asian American 4 (1.1) 22 (2.9) 0.002 
County, n (%)    
Fresno 163 (45.3) 310 (41.1)  
Kern 129 (35.8) 322 (42.7)  
Tulare 68 (18.9) 122 (16.2) 0.087 
Smoking, n (%)    
Never 188 (52.2) 364 (48.3)  
Former 152 (42.2) 213 (28.3)  
Current 20 (5.6) 177 (23.5) <0.001 
Education, n (%)    
< 12 years 67 (18.6) 111 (14.7)  
= 12 years 96 (26.7) 156 (20.7)  
> 12 years 197 (54.7) 487 (64.6) 0.007 
Family history of PDd, n (%)    
No 307 (85.3) 691 (91.6)  
Yes 53 (14.7) 63 (8.4) 0.001 
 
a P-value for chi-square test or t-test 
b age at diagnosis for cases; age at interview for controls 
c race information unrecorded for two controls 
d defined as first-degree relative with PD; data unrecorded and assumed negative for 
27 controls 
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Supplementary Table III-2. Associations between PD risk and estimated ambient 
occupational or residential benomyl exposures, by quartiles in exposed controls 
Exposurea 
Cases  
(n=360) 
Controls  
(n=754) ORb (95%CI) P-valuec 
Occupational, n(%)     
No 217 (60.3) 531 (70.4) 1.00  
1st Quartile 23 (6.4) 55 (7.3) 0.98 (0.57-1.68) 0.93 
2nd Quartile 26 (7.2) 51 (6.8) 1.14 (0.67-1.94) 0.62 
3rd Quartile 40 (11.1) 62 (8.2) 1.38 (0.87-2.18) 0.18 
4th Quartile 54 (15.0) 55 (7.3) 1.92 (1.25-2.96) 0.003 
   p-value for trend 0.0029 
     
Residential, n(%)     
No 209 (58.1) 467 (61.9) 1.00  
1st Quartile 31 (8.6) 71 (9.4) 0.86 (0.53-1.39) 0.53 
2nd Quartile 41 (11.4) 72 (9.5) 1.17 (0.75-1.85) 0.49 
3rd Quartile 31 (8.6) 73 (9.7) 0.83 (0.51-1.34) 0.45 
4th Quartile 48 (13.3) 71 (9.4) 1.17 (0.75-1.81) 0.50 
   p-value for trend 0.72 
 
Abbreviations: OR = unconditional logistic odds ratio; CI = confidence interval 
a Exposure quartiles defined using distributions of exposed controls, separately for 
occupational or residential estimates  
b adjusted for age (continuous), sex (male/female), smoking status (current, former, 
never), county (Fresno, Kern, Tulare), and education (<12 yrs, =12 yrs, >12 yrs). 
c For multiple testing considerations, six tests were performed so a P-value of 0.008 
was considered statistically significant. 
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Supplementary Table III-3. Associations between PD risk and estimated ambient occupational or residential benomyl 
exposures, stratified by sex 
 Males Females 
Exposurea 
Cases 
(n=206) 
Controls 
(n=352) ORb (95%CI) P-valuec 
Cases 
(n=154) 
Controls 
(n=402) ORb (95%CI) P-valuec 
Occupational, n(%)         
No 112 (54.4) 235 (66.8) 1.00  105 (68.2) 296 (73.6) 1.00  
Low 30 (14.6) 54 (15.3) 1.16  (0.68-2.00) 0.59 19 (12.3) 52 (12.9) 
0.91  
(0.49-1.69) 0.76 
High 64 (31.1) 63 (17.9) 1.81  (1.15-2.84) 0.010 30 (19.5) 54 (13.4) 
1.42  
(0.83-2.43) 0.20 
Residential, n(%)         
No 114 (55.3) 216 (61.4) 1.00  95 (61.7) 251 (62.4) 1.00  
Low 44 (21.4) 61 (17.3) 1.24  (0.75-2.02) 0.40 28 (18.2) 82 (20.4) 
0.80  
(0.46-1.38) 0.42 
High 48 (23.3) 75 (21.3) 1.06  (0.65-1.71) 0.82 31 (20.1) 69 (17.2) 
0.92  
(0.53-1.58) 0.76 
 
Abbreviations: OR = unconditional logistic odds ratio; CI = confidence interval 
a “Low” exposure defined as below the median value in exposed controls; “High” exposure defined as equal to or above 
the median value in exposed controls. 
b adjusted for age (continuous), sex (male/female), smoking status (current, former, never), county (Fresno, Kern, 
Tulare), and education (<12 yrs, =12 yrs, >12 yrs). 
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c For multiple testing considerations, six tests were performed and a p-value of 0.008 was considered statistically 
significant. 
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CHAPTER IV 
Aldehyde dehydrogenase dysfunction increases 
Parkinson’s disease risk via gene-environment 
interactions 
1. Introduction 
1.1 Pesticides and Parkinson’s disease (PD) 
Parkinson’s disease (PD) is the second most prevalent neurodegenerative 
disorder, affecting millions of people worldwide 1. PD is a progressive motor 
disorder characterized primarily by death of dopaminergic neurons in the 
substantia nigra pars compacta; other areas of the central and peripheral 
nervous systems have demonstrated cell death as well 10. A pathological 
hallmark of PD is the formation of intracytosolic Lewy bodies containing 
synuclein, ubiquitin, and other protein aggregates. 
Although some familial cases have been reported, the etiology of most 
cases remains unknown. Rare Mendelian and high-risk genes account for only a 
small percentage of cases. Common but low-risk genetic variants have been 
detected by genome-wide association studies, but these only account for a small 
increase in risk.  If an individual has all of the confirmed polymorphisms that have 
been associated with PD, the odds ratio would still be only 2.51, leaving the 
majority of the risk unaccounted for 114. A number of epidemiologic studies have 
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found associations between PD occurrence and rural living, well-water 
consumption, farming occupations, and pesticide exposure 79-82,85,87,90,91,98,115-117. 
The mechanisms through which pesticides contribute to PD pathogenesis remain 
to be elucidated. 
 
1.2 Aldehyde dehydrogenase (ALDH) inhibition 
The UCLA Parkinson’s Environment and Gene (PEG) Study, a case-
control epidemiologic study, is unique in its ability to exploit state-mandated 
Pesticide Use Reports (PURs) rather than relying on subject recall to estimate 
lifetime occupational and residential pesticide exposures 77. Because this study is 
based in a heavily agricultural region, it has the statistical power to investigate 
specific pesticides. Previously, we reported results for specific pesticides 85,87 and 
for gene-pesticide interactions in PD with maneb/paraquat 67,88,144 and the 
organophosphates diazinon, chlorpyrifos, and parathion 86. 
We recently showed that the fungicide benomyl damaged dopaminergic 
neurons by inhibiting ALDH activity, and was associated with increased PD risk 
(Chapter III). These findings motivated the present study in which we identify 
fourteen compounds that inhibit ALDH activity in neurons. More than 50% of the 
PEG study population had been exposed to one or more of these pesticides over 
26 years; here we report increased PD risks associated with increased 
exposures to these pesticides. Furthermore, we report potentiation of increased 
risk when considering contributions of both aggregate pesticide exposure and 
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genetic variants in the ALDH2 gene. This study provides strong evidence for the 
relevance of ALDH inhibition to PD pathogenesis. 
 
2. Methods 
2.1 Chemicals 
All chemicals were obtained with the highest available purity. Pesticides 
were from Chem Service, Inc. or Sigma-Aldrich. 
 
2.2 Measurement of ALDH activity in neuronal cell suspensions (ex vivo) 
ALDH activity was measured in suspensions of neurons derived from the 
substantia nigra of newborn rats, in the presence or absence of test compounds, 
as previously described (Chapter III). Briefly, neuronal suspensions were derived 
from rat pups (postnatal day 2 to 9) anesthetized with ketamine. Mesencephalic 
blocks (1 mm3) containing the substantia nigra pars compacta were dissected 
from coronal sections. This tissue was dissociated in papain using a method 
adapted from Rayport et al. 126; neurons were resuspended in defined media and 
buffer; and ALDH inhibition was measured after 30-min exposure to test 
compounds and Aldefluor® (STEMCELL Technologies, Vancouver, Canada). 
The proprietary compound fluoresces upon ALDH activation, so intracellular 
fluorescence was measured with flow cytometry (FACs) on channel FL1 
(Beckman XL-MCL). The higher the fluorescence, the higher the ALDH activity 
during incubation. 
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2.3 Measurement of ALDH activity in enriched rat hepatic mitochondria 
preparations (in vitro) 
Rat hepatic mitochondria were isolated and mALDH activity was 
determined using a published method 127,128, as previously described (Chapter 
III). Briefly, mitochondria were isolated in sucrose. Absorbance was measured by 
spectrophotometry as NAD+ was converted to NADH after the addition of 1 mM 
acetaldehyde (SpectraMax® 340PC384 Absorbance Microplate Reader with 
SoftMax® Pro data acquisition software, Molecular Devices). In vitro mALDH 
activity was determined from the slope as the increase in absorbance over time 
from 1-3 min; inhibition was determined by comparing to the untreated control. 
IC50 values were calculated using a sigmoidal curve fit of inhibition at varying 
concentrations (GraphPad PRISM 5). 
 
2.4 Human subjects 
This study was conducted as part of the UCLA Parkinson’s Environment 
and Genes (PEG) Study, a population-based case-control study recruiting 
incident cases and neurologically-normal controls from three rural California 
counties (Fresno, Tulare, Kern). Written informed consent was obtained from all 
enrolled subjects, and all procedures were approved by the UCLA Human 
Subjects Committee. Subject recruitment methods and case definition criteria 
have been described in detail 67,83. Briefly, incident PD cases were recruited 
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between January 2001 and December 2007 through neurologists, large medical 
groups, and public service announcements. Cases were examined by UCLA 
movement disorder specialists at least once and confirmed as having clinically 
“probable” PD according to published criteria 123. Population-based controls were 
recruited from the same three counties, initially using Medicare lists and later, 
after implementation of the Health Insurance Portability and Accountability Act, 
from randomly-selected residential parcels identified from publicly-available tax-
collector records providing addresses for all zoned living units in the three 
counties. More than 75% of control subjects were recruited using this latter 
method. There were no statistically-significant genotype or allele frequency 
differences between the Medicare-based and random parcel-based controls. 
Eligibility criteria for cases included (1) having received a first PD 
diagnosis no longer than 3 years prior to recruitment, (2) being sufficiently 
healthy to be examined, (3) currently residing in one of the counties of interest, 
and (4) residing in California for at least 5 years prior to recruitment. Of the 563 
eligible cases, 473 (84%) were examined on multiple occasions by a UCLA 
movement disorder specialist, 46 (8%) potential cases withdrew, 27 (5%) were 
too ill or died, and 17 (3%) moved out of the area prior to the exam. After 
examination, 113 (24%) patients were excluded due to diagnoses other than 
idiopathic PD; 360 cases were enrolled in the study. Eligibility criteria for controls 
included (1) not having PD; (2), (3), and (4) as above; and (5) being at least 35 
years of age. Of the 688 eligible population controls, 285 (41%) declined 
participation, were too ill, or had moved out of the area before interview; 403 
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controls were enrolled in the study. Cases and controls completed a telephone 
interview for the collection of demographic (age, sex, race/ethnicity, education), 
risk factor (family history of PD, smoking behavior), and detailed occupational 
and residential history data. 
 
2.5  Pesticide exposure assessment 
Pesticide exposure assessments were performed using Pesticide Use 
Reports (PURs, collected by the California Department of Pesticide Regulation 
since 1974) and a geographic-information-system-based (GIS) computer model 
that has been described in detail 67,118,119. PURs provide information on the 
location and date of an application, the active ingredients, poundage applied, 
application method, crop type, and acreage of the field. Briefly, our model 
combines data from PURs, land-use maps (to determine locations of pesticide 
application more precisely), and geocoded lifetime residential and occupational 
addresses of subjects to estimate the pounds of pesticide applied over 26 years 
(1974-1999). A subject’s ambient exposure was assumed to be proportional to 
the amount applied to crops within a 500-meter radius surrounding the subject’s 
occupational or residential address (considered separately). 
 Pesticides were analyzed individually, and in terms of an Aggregate 
Exposure Score (AES) assessed for each individual to account for the number 
and amount of pesticides to which a subject was exposed. Exposure was 
categorized by quartiles of exposure in exposed controls, resulting in a five-level 
variable (unexposed plus four quartiles). The AES for an individual (i) was the 
  
67 
sum of the quartiles (0 for unexposed, or 1, 2, 3, 4) of exposure to each pesticide 
(j), for up to 10 pesticides specified in Section 3.2: 
 
 
 
Thus, the AES for each subject had a minimum of 0 (subjects unexposed to the 
10 pesticides of interest) and a potential maximum of 40 (subjects exposed to all 
10 pesticides at the 4th quartile), although no subjects reached this maximum. 
 
2.6 Genotype assessment 
Relevant genetic contributions to PD risk were investigated using 
haplotypic cladistic analysis. Haplotype tagging single nucleotide polymorphisms 
(SNPs) 145-147 for aldehyde dehydrogenase 2 family (mitochondrial) (NCBI 
geneID:217, ALDH2) were selected using Haploview v.4.2 148. Haplotypes are 
groups of associated polymorphic genetic markers (i.e., SNPs) that capture 
global gene structure in the form of chromosomal blocks that have remained 
unbroken by recombination events over the population history of the gene 147. 
The blocks can be identified by the high linkage disequilibrium between the SNPs 
146,147,149. Within the haplotype block, one SNP may carry the same information 
as that one SNP plus many others; this one SNP is labeled a “tagSNP” 145. Using 
tagSNPs, it is possible to represent most of the variation in a region and minimize 
the number of SNPs for genotyping. 
€ 
AESi = qi, j
j
∑
  
68 
Most study participants provided blood or buccal samples for the 
extraction of DNA and consented to participation in genetic analyses. Of the 360 
cases and 403 controls enrolled in the study, 350 cases and 336 controls were 
genotyped for five haplotype-tagging SNPs in ALDH2 (rs737280, rs968529, 
rs16941667, rs16941669, rs9971942) as well as rs671 (ALDH2*2), a genetic 
variant in ALDH2 associated with alcohol sensitivity in persons of East Asian 
ancestry 150. Genotyping was performed using the Applied Biosystems SNPlex 
array 151; overall genotyping rate for included subjects was 95%. Haplotypes 
were derived using Phase 2.1 152. Because of the multi-allelic nature of 
haplotypes, we used cladistic methods as implemented in the eHap v2.0 
software 153 to cluster haplotypes based on shared recent ancestry. 
 
2.7 Statistical analysis 
All genetic markers were assessed for Hardy-Weinberg equilibrium in the 
controls using a chi-squared test. Genetic variants (5 SNPs and the haplotypic 
clade) were evaluated under an additive model. AES was evaluated as a 
continuous variable in logistic regression in all subjects combined. A single 
statistical interaction model was assessed by including the AES, the ALDH2 
clade (under an additive model), and their interaction term (score*clade) in a 
logistic regression model. For trend tests, quartile categories were assigned 
scores of 0, 1, 2, 3, or 4 and entered into the logistic regression equation as a 
linear term. The Wald statistic was used as a test for linear trend of the odds 
ratio. Odds ratios and 95% CIs were estimated after adjusting for age 
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(continuous variable), sex (male/female), and smoking status (ever/never). The 
p-values presented are uncorrected unless stated otherwise. We used SAS 9.1 
(SAS Institute Inc., Cary, North Carolina) to perform logistic regression analyses. 
 
3. Results 
3.1 Identification of ALDH inhibitors using biochemical screen 
 We screened three classes of pesticides—dithiocarbamates, imidazoles, 
and dicarboxymides—for their abilities to inhibit ALDH activity in a neuronal 
model. We used a concentration of 10 µM since the EC50 values of pesticides 
against their targeted species are typically well above this concentration 135-137,154-
157. All nine dithiocarbamates included in the screen inhibited ALDH (Figure IV-
1c). Ziram was the most potent dithiocarbamate, eliciting 20±1.3% less 
fluorescence as compared to untreated cells, reflecting lower ALDH activity. 
Ziram’s sodium salt (sodium dimethyldithiocarbamate) and ultimate sulfur 
metabolite (carbon disulfide) elicited 8±1.4% and 7±2.4% less fluorescence, 
respectively, while its zinc metabolite (zinc chloride) did not affect ALDH activity. 
Among the imidazoles, benomyl elicited 30±0.8% and triflumizole 13±2.4% less 
fluorescence, while carbendazim and thiophanate-methyl did not inhibit ALDH. 
The dicarboxymides captan and folpet respectively elicited 18±1.5% and 
17±1.9% less fluorescence; vinclozolin had no effect. 
 We enriched hepatic mitochondria to determine IC50s of five pesticides 
selected according to criteria described in 3.2 (Figure IV-2, Table IV-1). Benomyl 
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was the most potent with an IC50 of 140±19 nM. Captan had an IC50 of 5.7±0.6 
µM. Structurally-similar mancozeb and maneb had similar potencies (2.9±0.9 and 
4.6±0.3, respectively); however, ziram did not inhibit mALDH, suggesting the 
importance of pesticide metabolism to ALDH inhibition. We found ziram’s sodium 
salt and zinc metabolite (zinc chloride) did not inhibit mALDH either (data not 
shown).  
 
3.2 Targeting pesticides in the PEG study 
 The UCLA PEG study is a population-based case control study designed 
to investigate the individual and combined impact of genes and pesticides on risk 
of idiopathic PD. The study subjects contributing to these analyses are 338 cases 
(58% male, mean age 68.2) and 325 controls (50% male, mean age 67.3). PEG 
subjects are predominately Caucasian, almost equally divided between smokers 
and non-smokers, and have an expected prevalence of family history of PD (see 
Supplemental Table IV-S1).  
 We targeted pesticides based on the results of the ALDH screen. 
Benomyl, captan, mancozeb, maneb, and ziram each inhibited neuronal ALDH 
significantly; since 20-40% of the studied population (cases and/or controls) was 
exposed to each of these pesticides, there was sufficient statistical power to 
perform the analyses on each pesticide individually. Only 0.2-7% of the 
population (i.e., 1-46 individuals) was exposed to ferbam, folpet, thiram, 
triflumizole, or zineb; while the study did not have statistical power for individual 
analyses of these pesticides, they were included in determining Aggregate 
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Exposure Scores (see Section 2.5). The population was not exposed directly to 
carbon disulfide, metam sodium, or sodium dimethyldithiocarbamate, and 
disulfiram is not used as a pesticide, so these were excluded from epidemiologic 
analyses.  
 
3.3 Increased PD risks associated with pesticide exposures 
 For each of the five pesticides analyzed independently (i.e., benomyl, 
captan, mancozeb, maneb, ziram), exposures were associated with increased 
PD risk (Figure IV-2, Supplemental Table IV-S2 & IV-S3). Exposures to the 
dithiocarbamates mancozeb, maneb, and ziram were associated with twofold to 
fourfold increases in risk of PD, comparing subjects at the fourth quartile level of 
exposure to those unexposed, and strong trends (i.e., dose-response) for 
increasing risk of PD with increasing quartile of exposure (p-values for trend 
<0.05 for one or both occupational or residential exposure). Benomyl and captan 
exposures at the 4th quartile were associated with 60-80% increased risks of PD, 
although we did not observe statistically-significant trends over all quartiles. 
 In addition to individual pesticides, we probed the data to determine 
whether PD risk increased with increasing exposures to multiple ALDH-inhibiting 
pesticides. We assessed each subject an AES, which weighted the number and 
amount (quartile) of pesticides to which each subject was exposed (see Section 
2.5). Using occupational addresses, each additional quartile of pesticide 
exposure increased PD risk by 6%, after adjusting for age, sex, and smoking 
history (Table IV-2). That is, a typical individual exposed to the 4th quartile of all 
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ten ALDH-inhibiting pesticides would experience (6%)(4)(10)=240% increased 
PD risk, or 2.4-fold increased risk, in addition to other risk factors. Using 
residential addresses, this increase in risk was 4%. These are greater increases 
in risk than commonly observed for age, the well-established risk factor for PD. In 
this population, age only had an odds ratio of 1.01 (Table IV-2)—that is, a 1% 
increase in risk per year of age. 
 
3.4 ALDH2 genetic variation and gene-environment interaction 
 We observed little evidence of association between individual ALDH2 
SNPs and PD (Table IV-3). We were unable to assess rs671, the single known 
functional SNP in ALDH2, due to its rarity in our population (< 2% of subjects 
carried the minor allele). In haplotypic cladistic analysis (Table IV-3, 
Supplemental Figure IV-S1), we observed a suggestive 10-20% decrease in risk 
for the less prevalent ALDH2 clade (“Clade 2”). These associations did not 
change when we limited our study sample to Caucasians only. In gene-
environment interaction analyses (Figure IV-4), this suggestive protection 
conferred by Clade 2 was present only in subjects unexposed to pesticides or 
with an AES less than 4; for subjects with occupational AESs greater than 8, 
Clade 2 potentiated the risk conferred by pesticide exposure up to a sixfold 
increase in risk at highest AESs. 
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4. Discussion 
4.1 Pesticides and ALDH inhibition 
 This is the first study to investigate the effects of several pesticides on 
ALDH activity in neurons. Previous studies have shown different capacities for 
dithiocarbamates to inhibit ALDH, but these were in vitro systems. For example, 
S-ethyl N,N-dipropylthiocarbamate (EPTC), metam, methyl isothiocyanate, 
dazomet, and related compounds inhibited ALDH activity in hepatic mitochondria, 
and EPTC in brain mitochondria, using an assay with excess acetaldehyde as 
the substrate 127,158,159. Leiphon and Picklo reported that mancozeb and maneb—
but not EPTC, ferbam, nabam, or zineb—inhibited brain mitochondrial ALDH 
after artificially inducing state 3-like respiration and using excess 4-hydroxy-2-
nonenal (4-HNE) as the substrate 122. In the present study, each of the nine 
dithiocarbamates inhibited ALDH activity. In cases such as ferbam and zineb, 
intact cells appear able to metabolize the compounds to more potent metabolites, 
as would be expected in vivo. Similarly, we found ziram and sodium 
dimethyldithiocarbamate to be ineffective at inhibiting hepatic mALDH but potent 
inhibitors of neuronal ALDH ex vivo. Much of the inhibitory function of 
dithiocarbamates is likely attributable to the metabolite carbon disulfide, which we 
also found to inhibit ALDH ex vivo. One potential mechanism is through cross-
linking ALDH, as carbon disulfide has been reported to cross-link proteins in vitro 
by bonding with amino groups to form dithiocarbamate residues which ultimately 
are converted to thiourea cross-linking structures 160. 
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 We previously reported that benomyl inhibits ALDH activity but not via its 
benzimidazole moiety, also known as carbendazim (Chapter III). Similarly, 
another carbendazim pre-cursor, thiophanate-methyl, did not inhibit ALDH. 
However, the imidazole triflumizole did inhibit ALDH activity. Because 
carbendazim and thiophanate-methyl do not alter ALDH activity, the imidazole 
ring likely does not confer ALDH inhibitory ability. Benomyl inhibits ALDH after 
metabolizing into thiocarbamate compounds 19, which inhibit ALDH with similar 
mechanisms as described for dithiocarbamates. How triflumizole inhibits ALDH is 
a subject for further investigation. 
 Of the three dicarboxymides investigated, the two that inhibited ALDH 
activity (captan and folpet) contained SCCl3. Again carbon disulfide offers a toxic 
mechanism. Furthermore, carbon tetrachloride was reported to inhibit mALDH by 
JNK-mediated phosphorylation 161,162. Moreover, the trichloromethane radical can 
stimulate lipid peroxidation 163,164, which yields the endproduct 4-HNE. 4-HNE 
has been reported to inhibit ALDH activity 165,166 and is itself a substrate for 
detoxification by ALDH. This may be relevant to PD since increased 4-HNE was 
found in post mortem PD brains as adducts 16 and as a component of Lewy 
bodies 17. Furthermore, 4-HNE was shown to prevent α-synuclein fibrillation and 
form α-synuclein oligomers, which are toxic to primary mesencephalic cultures 18. 
Taken together, these findings suggest several mechanisms through which 
pesticides can contribute to PD pathogenesis via ALDH inhibition. 
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4.2 Pesticides, ALDH2, and PD risk 
We used the results of our ALDH screen to investigate a possible 
association between ALDH inhibition and PD risk. Each of the three 
dithiocarbamates applied in the PEG study area (mancozeb, maneb, ziram) was 
associated with a twofold to fourfold increase in PD risk in a dose-dependent 
manner. Two other pesticides applied in the PEG study area (benomyl, captan) 
inhibited ALDH activity and were suggestively associated with 60-80% increased 
PD risks when considered independently. More than 50% of our study population 
was exposed to at least one of these five ALDH-inhibiting pesticides, suggesting 
the broader relevance of this mechanism to other populations exposed to 
pesticides. 
Taking into account aggregate exposures to these pesticides applied near 
occupational addresses, risk of PD increased 6% with each additional quartile of 
exposure that a subject encountered. Using residential estimates, this 
association was attenuated to 4%, possibly because occupational exposure may 
be a more accurate assessment of a subject’s exposure since pesticides are 
applied during the workday. These are substantial findings, since these risks are 
greater than that for age, which is a major risk factor in PD but confers 1% 
increase in risk for each increasing year in age. This means that a typical 
individual exposed to the highest quartile of just one of these pesticides is 
subjected to 24% increased risk. This is the same increase in risk an 84-year-old 
experiences over a 60-year-old. Being exposed to two pesticides at high levels is 
like the risk of a 104-year-old versus a 60-year-old. Moreover, this risk is 
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dramatically potentiated by genetic variation in the ALDH2 gene, giving the 
highest-exposed individuals in this study a sixfold increase in risk. Again for 
comparison, all the known genetic risk factors only amount for a total 2.51-fold 
increase in risk, so the gene-environment consequence is substantial. 
 
5. Conclusion 
 In summary, we found that various classes of pesticides inhibited neuronal 
ALDH activity and were associated with increased PD incidence in a dose-
dependent manner. Genetic variation in ALDH2 might confer some protection to 
unexposed populations but was associated with dramatically-increased PD risk 
for people working and living in areas where these pesticides had been sprayed. 
This report demonstrates the broad importance of ALDH as a potential 
therapeutic target in PD, and identifies pesticides that should be avoided to 
reduce risk of developing PD. 
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Figure IV-1. Ex vivo neuronal ALDH inhibition by (a) imidazole, (b) 
dicarboxymide, and (c) dithiocarbamate pesticides 
 
(a) 
 
 
 
 
 
(b) 
 
 
 
 
(c) 
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Figure IV-2. In vitro mitochondrial ALDH inhibition by pesticides. ALDH activity in 
rat hepatic mitochondria preparations was determined spectrophotometrically by 
measuring absorbance at 340 nm as NAD+ was converted to NADH and 
acetaldehyde was converted to acetic acid in the presence of a potential inhibitor. 
Inhibition was determined relative to ALDH activity in preparations unexposed to 
pesticide.  
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Figure IV-3. Risk of PD (odds ratios and 95% confidence intervals) by quartiles 
of pesticide exposure, using residential (left) or occupational estimates (right):  
(a) benomyl, (b) captan, (c) mancozeb, (d) maneb, (e) ziram 
 
(a)  
 
(b) 
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(c) 
 
(d) 
 
(e) 
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Figure IV-4. Gene-environment interaction analysis of aggregate exposure score 
and ALDH2 clade 
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Table IV-1. IC50 values of ALDH-inhibiting pesticides applied in PEG Study area 
 
IC50 [µM] (SE) mALDH 
benomyl 0.14 (0.02) 
captan 5.7 (0.6) 
mancozeb 2.9 (0.9) 
maneb 4.6 (0.3) 
ziram ND* 
 
*ND = not determined because no inhibition up to 10 µM, revealing importance of 
metabolites to ziram’s function as an ALDH inhibitor 
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Table IV-2. Associations between aggregate pesticide exposure and PD risk  
 Cases Controls     
Aggregate 
Exposure Score1 n % n % OR2 LCI UCI 
p-
value 
                
  OCCUPATIONAL 
Age3     1.01 1.00 1.02  
No exposure 168 48.0 189 56.3     
Any exposure 182 52.0 147 43.8 1.06 1.02 1.09 0.0004 
         
Mean AES (stdev) 4.44 (6.11) 2.82 (4.46)     
Maximum AES 25  25      
         
  RESIDENTIAL 
Age3     1.01 0.99 1.02  
No exposure 115 44.3 166 49.4     
Any exposure 195 55.7 170 50.6 1.04 1.01 1.07 0.012 
         
Mean AES (stdev) 4.28 (5.88) 3.12 (4.95)     
Maximum AES 24  24      
 
1 Pesticides contributing to the Aggregate Exposure Score (AES) include benomyl, captan,  
ferbam, folpet, mancozeb, maneb, thiram, triflumizole, zineb, and ziram. 
2  Logistic regression odds ratios for each one point increase in Aggregate Exposure Score  
adjusted for age (continuous), sex (male/female), and smoking status (ever/never). 
3 Logistic regression for age is provided for comparison. 
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Table IV-3. Associations between genetic variation in the ALDH2 gene and PD  
risk 
    All Subjects w/ Complete data 
  Cases Controls     	   	  
  (n=350) (n=336)    trend 	   	  
    n % n % OR* LCI UCI p-value 	   	  
Clade 1/1 168 48.0 150 44.6     	   	  
 1/2 143 40.9 147 43.8 0.93 0.74 1.17  	   	  
 2/2 39 11.1 39 11.6 0.87 0.69 1.09 0.5404 	   	  
          	   	  
ALDH2_rs737280 TT 162 47.1 147 44.6 1.00 reference  	   	  
 CT 143 41.5 144 43.6 0.95 0.75 1.19  	   	  
 CC 39 11.3 39 11.8 0.90 0.71 1.13 0.6322 	   	  
 missing 6  6      	   	  
          	   	  
ALDH2_rs968529 CC 296 87.8 275 85.9 1.00 reference  	   	  
 CT 40 11.9 44 13.8 0.86 0.55 1.35  	   	  
 TT 1 0.3 1 0.3 0.74 0.47 1.17 0.5106 	   	  
 missing 13  16      	   	  
          	   	  
ALDH2_rs671 GG 330 97.9 305 99.4 1.00 reference  	   	  
 AG 6 1.8 2 0.6 n.c. n.c. n.c.  	   	  
 AA 1 0.3 0 0.0 n.c. n.c. n.c. 0.1006 	   	  
 missing 13  29      	   	  
          	   	  
ALDH2_rs16941667 CC 297 87.6 270 85.7 1.00 reference  	   	  
 CT 39 11.5 45 14.3 0.94 0.61 1.47  	   	  
 TT 3 0.9 0 0.0 0.89 0.57 1.38 0.7863 	   	  
 missing 11  21      	   	  
          	   	  
ALDH2_rs16941669 TT 262 78.7 252 79.2 1.00 reference  	   	  
 GT 69 20.7 62 19.5 1.01 0.71 1.46  	   	  
 GG 2 0.6 4 1.3 1.03 0.72 1.48 0.9368 	   	  
 missing 17  18      	   	  
          	   	  
ALDH2_rs9971942 CC 192 60.6 175 57.6 1.00 reference  	   	  
 CT 107 33.7 111 36.5 0.92 0.70 1.21  	   	  
 TT 18 5.7 18 5.9 0.85 0.65 1.11 0.5478 	   	  
  missing 33   32           	   	  
  
* odds ratios adjusted for age (continuous),  
sex (male/female), and smoking status (ever/never) 
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Supplemental Figure IV-1. Cladogram for determining Clade 1 (left) or Clade 2 
(right) from single nucleotide polymorphisms in ALDH2 gene 
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Supplemental Table IV-1. Demographics of PEG study subjects 
 
  Cases Controls  
  (n=338) (n=325)  
    n % n % p-value 
Gender Female 142 42.0 162 49.8  
 Male 196 58.0 163 50.2 0.043 
       
Age mean (sd) 68.2 (10.1) 67.3 (12.5) 0.363 
 range 34 - 88  35 - 92   
       
Smoking Never 177 52.4 146 44.9  
 Former 142 42.0 150 46.2  
 Current 19 5.6 29 8.9 0.081 
       
Smoking Never 177 52.4 146 44.9  
 Ever 161 47.6 176 55.1 0.055 
       
Family History No 287 84.9 292 89.8  
 Yes 51 15.1 33 10.2 0.056 
       
Race Caucasian 272 80.5 260 80.0  
 Latino 43 12.7 26 8.0  
 Native American 16 4.7 16 4.9  
 African American 3 0.9 13 4.0  
 Asian American 4 1.2 10 3.1 0.011 
  Unspecified 0 0.0 0 0.0   
 
  
87 
 
Supplemental Table IV-2. Risk of PD by quartiles of pesticide exposure, 
estimated with occupational addresses 
 
  OCCUPATIONAL 
  Cases Controls     
  (n=350) (n=336)     
    n % n % OR  LCI  UCI p-value 
Benomyl Unexposed 215 61.4 223 66.4 1.00 ref   
 1st Q 28 8.0 28 8.3 1.11 0.63 1.96 0.713 
 2nd Q 22 6.3 26 7.7 0.86 0.47 1.57 0.615 
 3rd Q 37 10.6 30 8.9 1.28 0.76 2.16 0.356 
 4th Q 48 13.7 29 8.6 1.64 0.99 2.72 0.055 
        p for trend 0.073 
          
Captan Unexposed 210 60.0 224 66.7 1.00 ref   
 1st Q 29 8.3 28 8.3 1.14 0.65 2.00 0.641 
 2nd Q 19 5.4 28 8.3 0.69 0.37 1.28 0.234 
 3rd Q 43 12.3 27 8.0 1.67 0.99 2.82 0.054 
 4th Q 49 14.0 29 8.6 1.71 1.03 2.82 0.037 
        p for trend 0.023 
          
Mancozeb Unexposed 279 79.7 307 91.4 1.00 ref   
 1st Q 12 3.4 7 2.1 1.85 0.71 4.80 0.208 
 2nd Q 15 4.3 7 2.1 2.30 0.92 5.77 0.076 
 3rd Q 26 7.4 7 2.1 3.86 1.64 9.09 0.002 
 4th Q 18 5.1 8 2.4 2.43 1.04 5.71 0.041 
        p for trend 0.0001 
          
Maneb Unexposed 278 79.4 293 87.2 1.00 ref   
 1st Q 13 3.7 11 3.3 1.25 0.55 2.84 0.602 
 2nd Q 15 4.3 10 3.0 1.49 0.66 3.40 0.340 
 3rd Q 23 6.6 12 3.6 1.94 0.94 4.00 0.073 
 4th Q 21 6.0 10 3.0 1.95 0.89 4.24 0.094 
        p for trend 0.012 
          
Ziram Unexposed 264 75.4 283 84.2 1.00 ref   
 1st Q 11 3.1 12 3.6 0.97 0.42 2.26 0.941 
 2nd Q 17 4.9 14 4.2 1.33 0.64 2.76 0.450 
 3rd Q 29 8.3 14 4.2 2.13 1.10 4.14 0.026 
 4th Q 29 8.3 13 3.9 2.26 1.14 4.50 0.020 
        p for trend 0.0019 
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Supplemental Table IV-3. Risk of PD by quartiles of pesticide exposure, 
estimated with residential addresses  
 
  RESIDENTIAL 
  Cases Controls     
  (n=350) (n=336)     
    n % n % OR  LCI  UCI p-value 
Benomyl Unexposed 204 58.3 214 63.7 1.00 ref   
 1st Q 28 8.0 31 9.2 0.95 0.55 1.64 0.844 
 2nd Q 34 9.7 30 8.9 1.18 0.69 2.01 0.550 
 3rd Q 36 10.3 31 9.2 1.18 0.70 1.99 0.536 
 4th Q 48 13.7 30 8.9 1.62 0.98 2.67 0.058 
        p for trend 0.064 
          
Captan Unexposed 234 66.9 234 69.6 1.00 ref   
 1st Q 27 7.7 26 7.7 1.01 0.57 1.80 0.961 
 2nd Q 23 6.6 25 7.4 0.88 0.48 1.61 0.680 
 3rd Q 31 8.9 26 7.7 1.19 0.68 2.07 0.540 
 4th Q 35 10.0 25 7.4 1.33 0.77 2.31 0.308 
        p for trend 0.338 
          
Mancozeb Unexposed 266 76.0 282 83.9 1.00 ref   
 1st Q 28 8.0 14 4.2 2.30 1.18 4.49 0.015 
 2nd Q 18 5.1 13 3.9 1.39 0.67 2.92 0.379 
 3rd Q 10 2.9 14 4.2 0.75 0.32 1.73 0.496 
 4th Q 28 8.0 13 3.9 2.28 1.15 4.51 0.019 
        p for trend 0.031 
          
Maneb Unexposed 264 75.4 288 85.7 1.00 ref   
 1st Q 14 4.0 12 3.6 1.14 0.51 2.53 0.752 
 2nd Q 23 6.6 12 3.6 1.93 0.94 4.00 0.075 
 3rd Q 20 5.7 12 3.6 1.81 0.86 3.79 0.119 
 4th Q 29 8.3 12 3.6 2.59 1.29 5.20 0.007 
        p for trend 0.001 
          
Ziram Unexposed 259 74.0 278 82.7 1.00 ref   
 1st Q 18 5.1 14 4.2 1.33 0.64 2.75 0.439 
 2nd Q 16 4.6 15 4.5 1.08 0.52 2.24 0.836 
 3rd Q 30 8.6 15 4.5 2.08 1.09 3.98 0.027 
 4th Q 27 7.7 14 4.2 1.91 0.97 3.75 0.060 
        p for trend 0.007 
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CHAPTER V 
Implications 
1. Implications for pesticide regulation 
The findings presented in this dissertation have implications for pesticide 
regulation. Commercial pesticides undergo rigorous toxicological assessments 
before they can be used in agriculture. However, there are serious limitations to 
these risk characterizations. For example, the California Department of Pesticide 
Regulation (CA DPR) performs neurotoxicity assessments 167 that focus chiefly 
on acute effects, although chronic exposures appear to be relevant to PD 
pathogenesis. Also, they do not specifically look at relevant characteristics like 
protein aggregation or dopaminergic neuron survival. Although risk assessment 
procedures could potentially be improved, it would be infeasible to test for all 
possible sporadic disorders. Regardless, PD etiology remains ambiguous, so 
development of the most appropriate protocol would be contentious. However, 
sufficient evidence exists about the association between pesticide exposure and 
PD occurrence to warrant more stringent regulations. 
In this dissertation, we identify multiple pesticides that are associated with 
PD occurrence in the UCLA Parkinson’s Environment and Genes (PEG) 
epidemiologic study. We estimate relative ambient pesticide exposures based on 
occupational and residential addresses within 500 m of applications, because we 
expect inhalation to be the primary route of exposure. Fungicides like benomyl 
and the dithiocarbamates degrade in a matter of days, so they are not likely to be 
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toxic through consumption of food or drinking water. In fact, most pesticides are 
not detectable deep in soils or in drinking or surface waters. Moreover, because 
these compounds are labile, they need to be applied multiple times, effecting 
chronic exposures. This precludes acute toxicity and likely contributes to the 
chronic pathogenesis of PD. This estimation method likely underestimates the 
risk for people with occupations involving pesticides. The CA DPR identifies 
particular elevated exposures for employees who mix, load, and apply pesticides, 
as well as field workers and harvesters 167. They are subject to exposure through 
absorption in addition to inhalation. Because applications occur most often during 
the workday, we expect occupational addresses (rather than residential) to elicit 
more accurate estimates of the actual relative exposures. 
According to the most recent Statewide Report available from the CA 
DPR, five of the pesticides found to inhibit ALDH activity in this study were 
included on the list of the top 100 pesticides applied (by poundage) in California 
in 2009 (Table V-1) 168. These were applied to such crops as almonds, grapes, 
tomatoes, and strawberries, which topped the list of crops by acreage treated 
with pesticides. Only maneb was also on the list of the top 100 pesticides by 
acreage in addition to poundage. Thus, metam sodium, ziram, captan, and 
mancozeb were applied liberally to smaller areas, so people working or residing 
near these fields were more likely to be exposed to higher concentrations. Over 
the course of the year, they were subjected to multiple applications of high 
concentrations. Acreage is recorded as the sum of the areas of the fields 
exposed for each application, so the high acreage associated with maneb 
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application could mean either a larger area with similar application profiles, or a 
similar area with more applications. The former would place more people at risk 
of exposure, while the latter would mean more days of potential exposure for the 
local inhabitants. Either way, these risks are substantial. Given their association 
with PD occurrence reported here, the liberal use of these pesticides should be 
reconsidered urgently. 
 
2. Implications for Parkinson’s disease etiology 
Although this study focuses on only a few pesticides, these findings also 
have broader implications for the etiology of a spectrum of disorders that include 
Parkinson’s disease (PD) and parkinsonisms. By using these pesticides as 
model compounds, we have identified a mechanism that may contribute to PD 
pathogenesis and result in dopaminergic cell loss and Lewy body formation.  
Figure V-1 shows a simplified schematic of some of the potential 
mechanisms through which pesticide exposure may be neurotoxic. In this 
dissertation, investigation of ziram and its metabolites suggests that 
dithiocarbamates inhibit ALDH at least partially through the liberation of carbon 
disulfide (CS2). CS2 may also form from the dicarboxymides captan and folpet, 
and the imidazole benomyl which is metabolized into thiocarbamate compounds 
(e.g., MBT). CS2 was reported to cross-link proteins 158,160, which may irreversibly 
inhibit ALDH. Liberation of carbon tetrachloride (CCl4) from chlorinated pesticides 
(e.g., captan, folpet) may inhibit ALDH directly 161,162 or indirectly by inducing lipid 
peroxidation 163,164, which yields the endproduct 4-hydroxy-2-nonenal (4-HNE). 
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Since 4-HNE itself can inhibit ALDH activity 165,166 and is a substrate for 
detoxification by ALDH, its accumulation can result in a toxic feedback loop with 
respect to ALDH inhibition.  
Regardless of the mechanism, ALDH inhibition results in the accumulation 
of toxic aldehydes like 4-HNE and 3,4-dihydroxyphenylacetaldehyde (DOPAL), 
which may induce protein aggregation and inhibit the ubiquitin-proteasome 
system 11,14,18,169. 
Thus, there are multiple potential mechanisms by which pesticides can 
inhibit ALDH activity and contribute to the pathogenesis of PD. Developing 
therapies to prevent ALDH inhibition or otherwise stimulate ALDH activity could 
potentially reduce PD progression. 
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Figure V-1. Schematic of potential mechanisms by which pesticides may 
contribute to the pathogenesis of Parkinson’s disease 
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Table V-1. Agricultural application data for five pesticides found to have ALDH 
inhibitory capability 
 
 Rank in Top 100 Poundage 
Applied 
Number of 
Applications1  by poundage by acreage 
metam sodium 4   8,824,058 1,258 
maneb 28 50 692,329 32,526 
ziram 32   538,446 3,862 
captan 46   325,464 5,233 
mancozeb 52   277,572 7,162 
  
1 The number of applications includes only production agricultural applications 
and excludes post-harvest fumigation, structural pest control, landscape 
maintenance, and other applications. 
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The etiology of Parkinson disease (PD) is unclear but may
involve environmental toxins such as pesticides leading to dys-
function of the ubiquitin proteasome system (UPS). Here, we
measured the relative toxicity of ziram (a UPS inhibitor) and
analogs to dopaminergic neurons and examined themechanism
of cell death. UPS (26 S) activity was measured in cell lines after
exposure to ziram and related compounds. Dimethyl- anddieth-
yldithiocarbamates including ziram were potent UPS inhibitors.
Primary ventral mesencephalic cultures were exposed to ziram,
and cell toxicity was assessed by staining for tyrosine hydroxylase
(TH) and NeuN antigen. Ziram caused a preferential damage to
THneurons and elevated-synuclein levels but did not increase
aggregate formation. Mechanistically, ziram altered UPS function
through interfering with the targeting of substrates by inhibiting
ubiquitin E1 ligase. Sodium dimethyldithiocarbamate adminis-
tered tomice for 2weeks resulted inpersistentmotordeficits anda
mild reduction in striatal TH staining but no nigral cell loss. These
results demonstrate that ziram causes selective dopaminergic cell
damage in vitro by inhibiting an important degradative pathway
implicated in the etiology of PD. Chronic exposure to widely used
dithiocarbamate fungicidesmay contribute to the development of
PD, and elucidation of its mechanismwould identify a new poten-
tial therapeutic target.
Parkinson disease (PD)2 is a commonneurodegenerative dis-
ease characterized by relatively selective degeneration of dopa-
minergic (DA) neurons in the substantia nigra (nigrostriatal
neurons). The etiology probably involves both environmental
and genetic factors including pesticide exposure (1–3). Hun-
dreds of pesticides are used alone or in combinations making it
difficult to separate individual effects. Because no individual
pesticide has been established by epidemiologic studies, we
chose to perform an unbiased screen of potential toxicants for
their ability to interfere with the ubiquitin-proteasome system
(UPS), a biological pathway implicated in the etiology of PD.
Impaired UPS activity has been reported in the brains of
patients with PD, and mutations in two UPS genes, Parkin and
UCHL-1, cause rare genetic forms of PD (4). Although these
results are not universally reproduced (5–7), in some studies
administration of UPS inhibitors to rodents recapitulates many
of the clinical and pathological aspects of PD (8–10). We
hypothesized that chronic pesticide exposure may increase the
risk of developing PD by inhibiting the UPS. We screened sev-
eral pesticides for their ability to inhibit the UPS and found a
number of toxicants that can lower activity at relevant concen-
trations (11). We then focused on dithiocarbamate fungicides
because they were found to be one of the most potent UPS
inhibitors and are widely used in crop protection.
In the present study, zinc dimethyldithiocarbamate (ziram)
was one of several dimethyl- and diethyldithiocarbamates
found to inhibit the UPS at 0.15–1 M. Furthermore, ziram
increased -synuclein expression in DA cells, induced rela-
tively selective DA cell damage in vitro, and inhibited the UPS
by interfering with ubiquitin E1 ligase activity. In vivo, systemic
administration of the more soluble sodium dimethyldithiocar-
bamate (NaDMDC) inmice resulted inmotor deficits and dam-
age to the nigrostriatal pathway. These findings help explain
howchronic pesticide exposure could increase the risk of devel-
oping PD.
EXPERIMENTAL PROCEDURES
Chemicals—The test compounds (see Table 1) were from
Chem Service (West Chester, PA), Sigma-Aldrich, or other
commercial sources as the highest available purity, except for 7
and 8, which were synthesized by Karl Fisher in the Casida
laboratory.
Measurement of 26 S Proteasome Activity and Cell Death in
Cell Lines—26 and 20 S UPS activity and cell death were meas-
ured in human embryonic kidney (HEK) and neuroblastoma
SK-N-MC cells by flow cytometry as previously described (12).
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variance.
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Fluorescence of the green fluorescent protein degron fusion
protein (GFP-U) was measured and expressed as a percentage
of control.
Rat Primary Ventral Mesencephalic Cultures (VMC)—VMC
were prepared by using a protocol adapted from Rayport et al.
(13). Briefly, the cultures were prepared in two stages. In the
first stage, cortical glial feeder cells were established on polyor-
nithine/laminin-coated coverslips, which formed the base of a
10-mm-diameter well cut into 35-mmculture dishes, until they
reached confluency in 6 days. Fluorodeoxyuridine was then
added to prevent additional glial proliferation. In the second
stage, postnatal day 2 or 3 pups were anesthetized, and 1 mm3
mesencephalic blocks containing the ventral tegmental area
were dissected from sagittal sections taken along themidline of
the brain. The cells were dissociated and plated onto pre-estab-
lished glial feeder cells at densities of 1  105/coverslip. The
mixed cultures were grown in chemically defined media con-
taining fluorodeoxyuridine for 10 days before treatment and
analysis.
Immunocytochemistry in VMCs and Cell Counts—At the
conclusion of the experiment, the cultures were immediately
washed and fixed in 4% paraformaldehyde for 30 min. The cul-
tures were then incubated with anti-tyrosine hydroxylase (TH)
antibodies (1:500; Calbiochem) and anti-NeuN antibodies
(1:100; Chemicon) overnight at 4 °C. The cells were stained for
2 h with fluorescein isothiocyanate- and Cy3-conjugated sec-
ondary antibodies (Jackson ImmunoResearch). In some exper-
iments, the cells were stained with anti-TH and anti--
synuclein (1:500; Zymed Laboratories Inc.) antibodies. After
staining and prior to counting, the coverslips were randomly
assigned an identification number. TH- and NeuN-immunore-
active neuron counts were then determined manually by raters
blinded to the experimental conditions. For TH, the entire cov-
erslip was counted but for NeuN neurons, representative
fields from each coverslip were counted and averaged because
of their large number.
Determination of Dopamine Content in VMCs—VMCs were
homogenized in 0.1 M perchloric acid containing 0.1% EDTA.
Insoluble debris was removed by centrifugation, and the super-
natant was filtered through a Millipore MC cartridge. The fil-
trate was analyzed for dopamine by high pressure liquid chro-
matography with electrochemical detection (Antec Leyden,
Leiden, The Netherlands) using a mobile phase consisting of
sodium acetate (75mM), sodiumdodecane sulfonate (0.75mM),
EDTA (10 mM), triethylamine (0.01%), acetonitrile (12%),
methanol (12%), and tetrahydrofuran (1%), pH 5.5, pumped at a
rate of 200 l/min (model LC-10AD; Shimadzu, Columbia,
MD) through a 100  2 mm column (3 m, Hypersil C18;
Keystone Scientific, Bellefonte, PA). The data were collected
and analyzed using ChromPerfect software (Justice Innova-
tions, Mountain View, CA).
Quantitation of -Synuclein Expression—TH-positive cells
in each coverslip were identified under 10, and digital images
were obtained using a 40 objective for TH and -synuclein
immunoreactivity. Exposure times were held constant
between coverslips. After acquisition, the images were ran-
domly assigned an identification number, and the experi-
mental conditions were blinded. All of the images were
stacked into a single sequence, a polygonal region of interest
was manually drawn around the neuron, and the mean image
intensity, total image intensity, and the area inside the region
of interest were evaluated for each cell. Data analysis was
performed with IPLab ver 3.x for Windows (Scanalytics Inc.)
compensating for bleed-through between fluorescein isothio-
cyanate and Cy3 channels.
To determine whether ziram treatment leads to high molec-
ular weight -synuclein species, we performed Western blots
on the detergent-soluble fractions of culture lysates. VMCs
treated with either 1M ziram or 5M lactocystin were lysed in
buffer containing 1% Triton X-100 and 0.1% SDS. The lysates
were sonicated, and insoluble debris was removed by centrif-
ugation. The protein concentrations were determined, and
10g/lane were subjected to SDS-PAGE. The separated pro-
teins were transferred to nitrocellulose membranes and
incubated with an anti--synuclein antibody (BD Transduc-
tion Laboratories; 1:1000) followed by an anti-tubulin anti-
body for normalization.
Evaluation of E1 Ligase Activity—The effects of ziram on E1
ligase activity were investigated using Western blot analysis of
treated cellular extracts to determine E1/E1-ubiquitin ratios
and using purified enzyme preparations. Ziram-treated
SK-N-MC cells were washed with phosphate-buffered saline
and then lysed in a thiol stabilizing buffer using the method of
Jha et al. (14). The samples were sonicated for 10 s, centrifuged
for 15 min at 13,000 g, mixed with 2 parts thiol gel buffer (33
mM Tris-HCl, pH 6.8, 2.7 M urea, 2.5% sodium dodecyl sulfate,
and 13% glycerol), and boiled for 2 min, and 10 g of protein/
lane was loaded on a 12% SDS-PAGE gel (15). The proteins
were electrophoretically transblotted onto nitrocellulose
paper, and immunoblots were performed as previously
described (16) using anti-E1 ligase antibody (BIOMOL, Plym-
outh Meeting, PA). Antigen-antibody interactions for immu-
noblots were visualized using horseradish peroxidase-conju-
gated secondary antibody and chemoluminesence substrate
(Pierce).
For purified enzyme assays, human recombinant ubiq-
uitin-activating E1 enzyme and biotinylated ubiquitin (both
from BIOMOL) were incubated for 5 or 10 min in thiolester
buffer as per the manufacturer’s protocol. The reactions
were stopped using thiol-stabilizing buffer, and the proteins
were subjected to SDS-PAGE and transblotted onto nitro-
cellulose paper. E1-ubiquitin conjugates were determined
using streptavidin-horseradish peroxidase and an enhanced
chemiluminescence kit. Band densities were measured using
a scanning densitometer.
Animal Studies—Male C57BL/6 mice were treated for 2
weeks by subcutaneous osmotic minipumps with NaDMDC 50
mg/kg/day) in phosphate-buffered saline or with phosphate-
buffered saline only. The behavior of the mice was evaluated
using the pole test as described by Fleming et al. (17) except that
a cut-off time of 60 s was used. One week after the last behav-
ioral testing, the mice were perfused with fixative, and their
brains were sectioned for TH staining. Fiber density was meas-
ured with a computer-assisted image analysis system as previ-
ously described (18).
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For stereological analysis in the substantia nigra pars com-
pacta (SNc), the neurons were counted using the optical
fractionator method with the Stereo Investigator software
(Microbrightfield, Colchester, VT) coupled to a Leica
DM-LB microscope with a Ludl XYZ motorized stage and z
axis microcator (MT12; Heidenheim, Traunreut, Germany).
The SNc was delineated at 5 objective using previously
reported criteria (19, 20). After delineation at low magnifi-
cation, every fourth section throughout the SNc was counted
at 100 magnification.
Statistical Analysis—Statistical analysis was performed with
GraphPad Prism software. Statistical significance was deter-
mined using one-way ANOVA with Dunnett’s multiple com-
parison post-test and Bonferroni’s multiple comparison post-
test as appropriate. For histochemistry and behavior, statistical
analysis was performed with GB-Stat software (Dynamic Micro-
systems, Inc., Silver Spring, MD, 2000) for Macintosh. A 2  3
mixed design ANOVA was followed by post hoc analysis with
Fisher’s least significant difference. To maintain homogeneity of
variance, an inverse transformwascalculated (21) for each score in
the pole test. The level of significance was set at p 0.05.
RESULTS
Ziram Inhibits 26 S Proteasome Activity in HEK Cells—We
reported earlier that ziram inhibits 26 S UPS in SK-N-MC cells
expressing a GFP-degron reporter system (11). To determine
whether ziram causes a similar inhibition in a non-neuronal cell
line, HEK cells were exposed, andGFP accumulationwasmeas-
ured using flow cytometry. We found that HEK cells were sim-
ilarly sensitive to the 26 S inhibitory effects of ziram with an
IC50 of 161 nM (Fig. 1).
Structure-Activity Relationships of Ziram-related Com-
pounds for UPS Inhibition—Ziram and 14 related compounds
were tested at 1 and 10 M for their ability to inhibit 26 S UPS
activity in GFP-U-transfected SK-N-MC cells (Table 1). Ziram
(1) and the other DMDC derivatives (sodium DMDC (2), free
acid (3), and bis-disulfide (4)) were similarly very active. Two
diethyldithiocarbamates (5 and 6) were also very potent.
Thiram (4) and disulfiram (6) are cleaved into DMDC (3) and
diethyldithiocarbamate (5), respectively. Ziram in aqueous
solution dissociates to zinc ion (7) and forms dithio acid (3),
which breaks down into carbon disulfide (8) and dimeth-
ylamine (9), all of which were inactive. The disulfide func-
tionality of etem (10) (an ethylenebis(dithiocarbamate) fun-
gicide oxidation product) can cleave to a dithiocarbamic acid
possibly associated with its activity, whereas that of the phe-
nyl analog (11) cannot give a dithiocarbamate. The carbon
disulfide progenitor enzone (12) was also inactive. Environ-
mental degradation converts ethylenebis(dithiocarbamate)
fungicides to ethylenethiourea (13) and sodium methyldi-
thiocarbamate (14) to methyl isothiocyanate (15), all of
which were inactive. Thus, the dialkyldithiocarbamate moi-
ety is required to alter UPS activity. Furthermore, preincu-
bation of ziram with the reducing agents GSH, dithiothrei-
tol, or N-acetylcysteine completely abolished its inhibitory
activity (data not shown).
Ziram Causes Dopaminergic Cell Damage in Primary
VMC—Because proteasome inhibition has been implicated in
the etiology of PD and ziram causes UPS dysfunction, dopa-
minergic cells might be selectively vulnerable to the toxicity of
ziram. Primary VMC were exposed to ziram for 48 h, and then
cellular toxicity was measured by counting TH immuno-posi-
tive (TH) cells and NeuN immuno-positive (NeuN) cells (a
nonspecific neuronal marker). Ziram at 5 and 10Mwas highly
toxic to all cells, including the glial bed, causing the cell layers to
lift off the coverslip after treatment or during immunostaining
FIGURE 1. Ziram inhibits UPS in HEK cells with 24-h incubation prior to
analysis by flow cytometry. The IC50 for ziram was 161 nM.
TABLE 1
Structure-activity relationships for ziram-related compounds on 26 S
UPS with 24-h treatment of SK-N-MC cells
S
S
S NH
H
N
S
 
a  
N
N
S
S
S
     
    10          11       13 
 
compound 10 is an oxidation product of maneb 
and other ethylenebis(dithiocarbamate) 
fungicides; 11 is an analog of 10 with phenyl 
instead of dihydroimidazole moiety; 12 
decomposes readily to CS2; 13 is a degradation 
product of ethylenebis(dithiocarbamate) 
fungicides  
 
 
                                   Compound_________________ 
Fluorescence as percent of control 
(mean ± SD, n=4)b 
Name Structurea 1 uM 10 uM 
    
Dimethyldithiocarbamates    
1  Ziram [(CH3)2NC(S)S]2Zn 274 ± 21** 466 ± 42** 
2  Sodium dimethyldithiocarbamate  (CH3)2NC(S)SNa•H2O 200 ± 47* 337 ± 67* 
3  Dimethyldithiocarbamate  (CH3)2NC(S)SH•H2O 195 ± 9** 363 ± 40** 
4  Thiram [(CH3)2NC(S)S]2 303 ± 34** 408 ± 22** 
Diethyldithiocarbamates    
5  Diethyldithiocarbamate (C2H5)2NC(S)SH 167 ± 24* 184 ± 31* 
6  Disulfiram [(C2H5)2NC(S)S]2 258 ± 25** 265 ± 38** 
Others    
7  Zinc chloride  ZnCl2 95 ± 3 93 ± 5 
8  Carbon disulfide   CS2 108 ± 8 101 ± 6 
9   Dimethylamine hydrochloride   (CH3)2NH•HCl 91 ± 4 96 ± 2 
10  Etem heterocyclica 98 ± 5 190 ± 10** 
11  3H-1,2-Benzodithiole-3-thione heterocyclica 95 ± 1 100 ± 6 
12  Enzone or GY-81 NaSC(S)SSNaa 91 ± 4 89 ± 4 
13  Ethylenethiourea heterocyclica 89 ± 3 94 ± 3 
14  Sodium methyldithiocarbamate  CH3NHC(S)SNa 101 ± 6 98 ± 3 
15  Methyl isothiocyanate CH3N C S 91 ± 1 94 ± 2 
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(data not shown). At lower doses Ziram exposure had a signif-
icant overall effect on TH cell survival (F4,110  4.52, p 
0.005) reducing TH cell number at 0.5 and 1 M (p  0.05,
Dunnet’s post-hoc test versus control; Fig. 2). The small, non-
significant decrease in total NeuN cells measured after ziram
treatment therefore represents primarily the loss of the TH
subset of the entire NeuN pool. The loss of TH cells is likely
reflective of cell death and not simply the loss of expression
because TH levels were increased in the surviving positive cells
(data not shown).
The 20 S proteasome inhibitor lactacystin is reported to
cause selective DA cell death in VMC, but this has not been a
universal finding (28–32). In the present study lactacystin was
toxic toNeuN neurons (F4,110 13.12, p 0.0001) and to the
TH subset of such neurons (F4,110 4.26, p 0.003), but the
TH/NeuN ratios revealed that the effects of lactacystin
were not specific to dopaminergic neurons (F4,110  0.90, p 
0.05; Fig. 2). Because ziram caused preferential loss of TH
neurons and lactacystin did not, they appear to act via different
mechanisms, despite the fact that they are both UPS inhibitors.
Ziram Toxicity Is Not Dopamine-dependent—One possible
mechanism for the relative selective effect to TH neurons is
that ziram interacts with dopamine metabolism to produce
preferential toxicity. To test this hypothesis, ziram toxicity was
measured in the presence of -methyl L-tyrosine, an inhibitor
of dopamine synthesis. Treatment of VMCs with -methyl
L-tyrosine (250 M) for 48 h resulted in a decrease in dopamine
content of 62 6% compared with controls (p 0.05) but did
not significantly alter the number of TH cells. Reducing do-
pamine content with -methyl L-tyrosine was ineffective in
attenuating the toxicity of ziram to TH neurons (Fig. 3).
-Synuclein Expression in VMCs—Several converging lines
of evidence support a role for-synuclein in the pathogenesis of
PD. Mutations in the -synuclein gene or increased expression
of wild-type -synuclein cause PD in familial PD, and
-synuclein is a major component of Lewy bodies in sporadic
PD (22). To determine whether ziram alters the levels of
-synuclein in VMCs, the neurons were stained for both TH
and-synuclein, and relative fluorescencewasmeasured. TH
neurons showed robust and punctate-synuclein staining, sug-
gesting that they are mature and terminally differentiated (23,
24). Ziram at 0.5 M resulted in increased -synuclein expres-
sion, whereas lactacystin at 5 M decreased expression (Fig. 4).
The sizes of the regions of interest were the same among all of
the conditions varied in all of the experiments (data not shown).
An important pathological marker in PD is the formation of
-synuclein inclusions or aggregates. TH cells from ziram-
and lactacystin-treated VMCs were determined to be either
positive or negative for nuclear, perinuclear, or cytoplasmic
-synuclein inclusions by blinded raters. Aggregates were rela-
tively common in both treated and untreated cells, but surpris-
ingly no significant differences were found with ziram com-
pared with controls. Interestingly, a decrease in nuclear and
perinuclear aggregates was seen in the lactacystin-treated cul-
tures (Table 2).
To determine whether ziram treatment results in increased
formation of detergent-soluble -synuclein oligomer forma-
tion, we subjected VMCs lysates toWestern blot analysis. Both
monomeric and oligomeric forms of-synucleinwere apparent
FIGURE 3. Inhibition of dopamine synthesis by -methyl-L-tyrosine did
not attenuate ziram-induced dopamine cell death (n 14–44 wells per
condition). *, p  0.05, ziram versus dimethyl sulfoxide (DMSO) control. ,
not significant.
FIGURE 4.Ziram increases and lactacystin decreases-synuclein levels in
TH neurons. The cells were exposed for 48 h prior to analysis. The relative
intensities were measured in a blinded manner in cells that were selected
randomly (n  21–97 cells/condition). Representative -synuclein-stained
cells are shown on the right. Scale bars, 10 microns. **, p 0.01. Con, control.
FIGURE 2. Ziram- and lactacystin-induced tyrosine hydroxylase cell dam-
age in primarymesencephalic cultures. TH neurons were selectively vul-
nerable to ziram- but not lactacystin-induced damage. Shownbelow are rep-
resentative photomicrographs of TH- (red) and NeuN-stained (green)
mesencephalic cultures. A, control. B, ziram (1 M).
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in detergent-soluble fractions as previously described (25).
Ziram treatment resulted in a nonsignificant trend for an
increase in oligomeric forms of -synuclein compared with
controls (170 120% optical density units of controls, n 8 for
ziram and n 5 for controls, p 0.18). Oligomeric-synuclein
was unchanged in lactacystin-treated VMCs, and monomeric
-synuclein levels were similar in all three conditions (data not
shown).
Ziram Inhibits E1 Ligase Activity—Ziram was found to
inhibit the UPS using an assay that requires the substrate (i.e.
degron) to be ubiquitinylated via ubiquitin ligases and recog-
nized by the 26 S proteasome before it can be degraded by 20 S
proteases (12). Disruption of any of these steps would be
detected in the screen. It has been suggested that another
dithiocarbamate fungicide, maneb, inhibits the 20 S compo-
nent of the UPS (26). To determine whether ziram acted in this
manner, HEK cells were treated with ziram (1 and 10 M) for
24 h, but there was no change in 20 S chymotryptic activity
(data not shown). The amount of -subunit of the 20 S protea-
some was also measured using Western blot analysis, and no
differenceswere found (data not shown). Furthermore, our ear-
lier study showed that ziram had no effect on 20 S UPS activity
when added directly to cell lysate (11). Because 20 S proteolytic
activity was not altered by ziram, Western blot analysis on
lysates was performed from ziram-treated cells to determine
whether ubiquitinated proteins accumulated. As expected,
inhibition of the 20 S UPS by lactacystin and rotenone resulted
in the accumulation of high molecular weight ubiquitin conju-
gates (Fig. 5). Conversely, ziram treatment resulted in a signif-
icant decrease in these proteins, suggesting that it inhibits the
UPS by interfering with ubiquitin ligation. Polyubiquitin is
added to proteins targeted for UPS degradation by a series of
ligases (E1, E2, and E3 ligases). Dithiocarbamates can lead to
GSH oxidation (27), and GSH depletion results in the loss of E1
ligase activity (14). Ziram does not appear to act by lowering
GSH, because depleting cellular GSH using buthionine sulfoxi-
mine (1 mM) had no effect on UPS activity, and ziram did not
alter the amount of reducedGSH in the cells at concentrations
up to 50 M (data not shown). Ubiquitin is activated by E1
ligase in an ATP-dependent manner forming an E1-ubiq-
uitin adduct before the ubiquitin is transferred to E2 ligase.
Because activated ubiquitin binds covalently to a cysteine of
E1, the thiol group of ziram might interfere with this reac-
tion. Indeed, ziram markedly reduced E1 ligase activity as
measured by a reduction of endogenous E1-ubiquitin conju-
gates and the reduced formation of E1-ubiquitin conjugates
in a purified preparation (Fig. 6).
Motor Deficits in NaDMDC-treated Mice—NaDMDC was
used for in vivo experiments because of its greater solubility
than the zinc DMDC salt, ziram, with a similar effect on pro-
teasomal function (Table 1). The treatment of male C57BL/6
mice for 2 weeks with NaDMDC resulted in increased time to
turn in the pole test, a deficit also seen inmice with dysfunction
of the nigrostriatal pathway (Fig. 7). The effect persisted 8
weeks after cessation of drug treatment, indicating that it was
not because of an acute drug effect. Striatal TH fiber densitywas
nonsignificantly reduced across striatal regions at 2 weeks, with
a significant reduction in the ventrolateral quadrant 9 weeks
after drug treatment in the NaDMDC-treated animals (Table
3). Stereological TH immunoreactive neuron counts in the SNc
of treated mice were not changed (Table 3). Thus, 2 weeks of
treatment of mice with NaDMDC, an E1-activating enzyme
inhibitor, resulted in amotor deficit with aminor loss of nigros-
triatal dopaminergic fibers.
DISCUSSION
Pesticides, Ziram, and PD—Themost consistent and strong-
est association between a group of environmental toxicants and
the development of sporadic PD has been with chronic pesti-
cide exposure, although no specific agents have been identified
TABLE 2
Ziram does not induce the formation of -synuclein aggregates
n 21–97 cells/condition.
Cells with inclusions
Nuclear Perinuclear Cytoplasmic
%
Control 32 5 22 4 4.3 2.1
Ziram
0.5 M 38 6 24 5 6.6 2.9
1.0 M 19 9 14 8 4.8 4.8
Lactacystin (5 M) 19 4a 8.6 3.1b 7.4 2.9
a p 0.04.
b p 0.01.
FIGURE 5. Anti-ubiquitin Western blot analysis of lysates from cells fol-
lowing treatmentwith 5M lactacystin, 0. 1M rotenone, or 1M ziram.
The relative densities were determined using the NIH Image program, nor-
malized to tubulin immuoreactivity in the same blot, and expressed as per-
centages of untreated controls (n  4). 20 S inhibition using lactacystin
resulted in an increase in high molecular weight ubiquitin conjugates,
whereas ziram treatment reduced them. **, p 0.01; *, p 0.05.
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(3). Preliminary data from our population-based study in cen-
tral California that determined pesticide exposure using a state
application registry has revealed some intriguing results. Sub-
jects living within 500 meters of where ziram was applied were
at an over 3-fold higher risk of developing PD compared with
those with lower exposure.3 Chronic inhibition of the UPS has
been implicated in the pathogenesis of PD, and some pesticides
might increase the risk of developing PD by causing UPS dys-
function. The widely used pesticide ziram is one of the most
potent inhibitors of 26 S UPS (11). This study further demon-
strates that ziram kills TH cells in a relatively selective man-
ner, increases -synuclein levels, and inhibits El ligase activity,
thus interfering with the targeting of proteins destined for UPS
degradation. If these preliminary epidemiology findings are
confirmed, and taken together with the results of this study,
chronic ziram exposure would be a strong candidate as a PD-
associated toxicant. The results presented here add a biologi-
cally plausible mechanism (at relevant concentrations) by
which ziram may increase the risk of developing the disease.
Mechanism of Ziram Effect on the UPS—Uncovering how
ziram causes UPS dysfunction and cell death might provide
important clues to the selective vulnerability of DA neurons.
Some of the results in primary cultures were surprising.
Although ziram damaged (and probably killed) TH cells in a
selective manner, this was not the case for the 20 S proteasome
inhibitor lactacystin. Even though TH staining was used as a
marker of DA cell survival, it is possible that the cells were still
alive but simply lost their TH phenotype. However, this is
unlikely because TH levels were actually increased in the
remaining cells after ziram exposure (but not for lactacystin).
Conflicting results on proteasome inhibitor-induced selective
DA cell deathmay be due to differences in culturing techniques
and conditions (28–32). Cultures in the current study con-
tained DA neurons of the ventral tegmental region to increase
the number of TH cells/well and power analysis. Because
ventral tegmental region neurons are believed to be more
resistant to stressors, the results likely underestimate the effects
of ziram on SNc DA neurons. Indeed, pilot experiments using
predominantly nigral cultures yielded similar results. The fact
that different effects were found with ziram compared with
3 B. Ritz, J. M. Bronstein, and S. Costello, unpublished data.
FIGURE 6. Effect of ziram on E1-ubiquitin conjugates and E1 ligase activ-
ity. A, endogenous E1-ubiquitin conjugates in lysates of ziram-treated HEK
cells. Ziram resulted in a dose-dependent reduction in the E1-Ub/E1 ratio
compared with untreated controls. The Western blot is shown in the inset.
B, E1 ligase activity was inhibited by ziram in purified preparations after 5 and
10 min of incubation (n 4, p 0.05).
FIGURE 7.Motor deficits in mice determined by the pole test following 2
weeks of subcutaneous minipump treatment with NaDMDC at 50
mg/kg/day followed by an 8-week post-treatment period (10 weeks
from thebeginningof the experiment). Inverse Transform, reciprocal of the
original data point. Baseline, 1 because untreatedmice turn in less than 1 s. **,
p 0.01 compared with saline-treated mice at the same time point.  rep-
resents p 0.01 comparedwith a base linewithin the same treatment group
(2 3 Mixed design ANOVA, Fisher’s LSD).
TABLE 3
Effect of subcutaneous treatment with NaDMDC on TH
immunoreactivity (IR) fiber density in striatal subregions and
stereological estimates of TH-IR neurons in the SNc
DL, dorsolateral; DM, dorsomedial; VL, ventrolateral; VM, ventromedial.
Region
Mean S.E. (n 5)
2W 2 9W
Control Treated Control Treated
TH-IR fiber density
DL striatum 1515 207 1456 221 1934 299 1951 269
DM striatum 1048 149 843 117 1435 199 1358 130
VL striatum 1439 142 1290 140 1833 254 1409 166a
VM striatum 815 103 696 62 1073 174 946 152
TH-IR-positive
neurons
SNc 7980 491 7832 574 8251 214 7897 247
a p  0.05 compared with corresponding region in control mice at the same time
point; ANOVA followed by Fisher PLSD.
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lactacystin suggests that they act through different mecha-
nisms. As opposed to lactacystin, a 20 S protease inhibitor, we
show that ziram acts upstream by interfering with ubiquitin
ligation. Because ubiquitinylation is also important in many
cellular processes in addition to the UPS, including modifica-
tion of protein function, facilitation of cell surface receptor
turnover, and control of gene transcription, it is possible that
some of the actions of ziram may be via alternative pathways
(33).
Themolecular basis of the ability of ziram to inhibit E1 ligase
activity was studied by determining the relative potencies of
several of its analogs. Themost potent 26 SUPS inhibitors were
dimethyl- and diethyldithiocarbamates and their salts and dis-
ulfides. These compounds may act by copper or iron chelation
(34) or undergo oxidative activation to the S-oxides of the
dithiocarbamic acids (35) or of the S-methyl thiocarbamates
(36), which are reactive with GSH and potentially with a thiol
group of the UPS E1 ligase (Fig. 8).
Maneb and Ethylenebisdithiocarbamate Fungicides—The
effect of ziram onUPS activity has not been observed by others,
but the structurally related fungicide maneb is reported to
inhibit 20 S protease activity (26). Although ziram and maneb
have many structural features in common, our results with
ziram differ significantly from those of Zhou et al. (26) using
maneb. In our studies, ziram did not inhibit the 20 S protea-
some at concentrations up to 10 M, did not cause oxidative
stress as measured by 6-carboxy-2	,7	-dichlorodihydrofluores-
cein diacetate fluorescence (11), and did not induce
-synuclein aggregates in primary cultures. These observa-
tions may be due to differences in the compounds and/or cell
assays used. Maneb is an ethylenebis(dithiocarbamate) and
contains manganese, which possibly could contribute to
some of its effects, but manganese by itself did not alter 26 S
UPS activity (data not shown).
Another difference between the effects ofmaneb and ziram is
thatmaneb is reported to induce-synuclein aggregates in a rat
embryonic mesencephalon murine neuroblastoma-glioma
hybrid cell line (26). The present study did not find an increase
in aggregate formation in primary mesencephalic cultures but
did not evaluate aggregates in immortalized cell lines because
neither HEK or SK-N-MC cells expressed significant levels.
Several lines of evidence support a mechanism for ziram
upstream of the 20 S: inhibition of the formation of highmolec-
ular weight ubiquitin conjugates, reduction of the
E1-ubquitin/E1 ratio, and direct inhibition of purified E1 ligase
activity. Ziram effects on E2 or E3 ligase activities were not
studied because they are dependent on E1 ligase, but because
they transfer ubiquitin in a manner similar to that of E1, it is
possible that ziram would have similar inhibitory effects on
these enzymes.
Animal Studies on Dithiocarbamate Fungicides—Further
support for the potential role dithiocarbamates in PD comes
from animal studies. Chronicmaneb exposure given with para-
quat recapitulatesmany of the behavioral and pathological hall-
marks of PD (37). Two week subcutaneous minipump treat-
ment with NaDMDC at 50 mg/kg/day resulted in persistent
motor abnormalities typically seen in mice with dysfunction of
the nigrostriatal pathway (38). Abnormalmotor behavior in our
study was associated with a mild, delayed dopamine nerve
terminal damage in the ventrolateral region of the striatum
but not with nigral cell death. Motor dysfunction without
dopamine cell loss may indicate functional damage to these
neurons, but we cannot exclude the possibility that the
behavioral tests were detecting abnormalities in other areas
involved in motor control.
In summary, we show that ziram and structurally related
dithiocarbamates induce dysfunction of the UPS by inhibiting
E1 ligase. We demonstrate that ziram exposure increases
-synuclein levels and selectively damages dopaminergic neu-
rons in primary cultures. Furthermore, chronic systemic expo-
sure to NaDMDC causes persistent motor deficits and mild
injury to the nigrostriatal pathway. This study, along with
emerging epidemiological investigations, suggests that chronic
exposure to dithiocarbamate fungicides can contribute to the
pathogenesis of PD.
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E-mail address: Janet.Hering@eawag.ch (J.G. HerinThe fate and transport of As was examined at an industrial site where soil- and groundwater contamina-
tion are derived from the application of As2O3 as a herbicide. Application of arsenical herbicides was dis-
continued in the 1970s and soils in the source area were partially excavated in 2003. Arsenic
contamination (up to 280 mg/kg) remains in the source area soils and a plume of As-contaminated
groundwater persists in the surficial aquifer downgradient of the source area with maximum observed
As concentrations of 1200 lg/L near the source area. The spatial extent of As contamination as defined
by the 10 lg/L contour appears to have remained relatively stable over the period 1996–2006; the
boundary of the 1000 lg/L contour has retreated over the same time period indicating a decrease in total
As mass in the surficial groundwater.
In column experiments conducted with source area soil, the As concentrations in the column effluent
were comparable to those observed in groundwater near the source area. A substantial fraction of the As
could be leached from the source area soil with ammonium sulfate and ammonium phosphate. Exhaus-
tive extraction with background groundwater removed most of the total As. These results indicate that As
in the source area soils is geochemically labile. Source area soils are low in extractable Fe, Mn and Al, and
characterization by X-ray absorption spectroscopy and electron microscopy indicated that As is present
primarily as arsenate sorbed to (alumino)silicate minerals. Batch sorption experiments showed much less
sorption on surficial aquifer sediments than on sediments from the Jackson Bluff Formation (JBF), a pre-
sumed confining layer. This limited capacity of the surficial aquifer sediments for As sorption is consis-
tent with the similar As contents observed for these sediments within and upgradient of the As plume.
The apparent stability of the As plume cannot be explained by sequestration of As within the surficial
aquifer. Sorption to JBF sediments may contribute to As sequestration, but As enrichment in JBF sedi-
ments within the plume (i.e., as compared with JBF sediments upgradient) was not observed. These
results indicate that neither the persistence of As in the source area soils or the apparent stability of
the plume of As-contaminated groundwater at this site can be explained by geochemical controls on
As mobility. The absence of demonstrable geochemical bases for such observations suggests that possible
hydrologic controls should be further investigated at this site.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Arsenical pesticides and herbicides were widely used in the USA
throughout the 20th century until As was placed on the US Envi-
ronmental Protection Agency’s (USEPA) Priority List of Hazardous
Substances. In 2001, concerns regarding the toxicity and carcinoge-ll rights reserved.
, Swiss Federal Institute of
133, CH-8600 Dubendorf,
44 823 53 98.
g).nicity of As prompted the USEPA to lower the maximum contami-
nant level (MCL) for As in drinking water from 50 to 10 lg/L
(USEPA, 2001). The leaching of As from soils previously treated
with arsenical pesticides poses a potential threat to human health
through contamination of drinking water supplies.
Arsenical pesticides are known to be effective for years after
application (Norman et al., 1950), suggesting that they are not eas-
ily leached from soils. After the cessation of pesticide application,
As has persisted at high concentrations in some soils despite dec-
ades of rainfall and irrigation (Sadler et al., 1994; McLaren et al.,
1998; Folkes et al., 2001; Robinson and Ayuso, 2004; Smith et al.,
A.G. Fitzmaurice et al. / Applied Geochemistry 24 (2009) 2152–2162 21532006; Yang and Donahoe, 2007). Leaching of As applied in organic
form has, however, been inferred from the accumulation of As in
the sediments of lakes receiving surface runoff or groundwater dis-
charge from treated soils (Whitmore et al., 2008).
Immobility of As in soils under oxic conditions is often attrib-
uted to the association of As with Fe-bearing solid phases through
sorption or co-precipitation (Smedley and Kinniburgh, 2002; Stol-
lenwerk, 2003). Evidence has also been reported for precipitation
of As(V)-containing salts in soils (Bothe and Brown, 1999; Yang
and Donahoe, 2007). Mobilization of As from such solids can occur
when the solids or the association of As with them are destabilized
due to changes in geochemical conditions. Such geochemical con-
trol of As mobility is often assumed when As is persistent in soils
over long periods.
In this study, the mobilization of As from a sandy soil where it
has persisted for 3 decades, after the use of As2O3 as a herbicide
was discontinued, was examined. The controls on As mobilization
have implications both for the occurrence of As in groundwater
and the fate and transport of As in the subsurface environment.2. Site description
Tyndall Air Force Base (AFB) is located in the Florida Panhandle
between Panama City and Mexico Beach on a strip of barrier land
that separates East Bay (the eastern portion of St. Andrew’s Bay)
from the Gulf of Mexico (Fig. 1). An electrical substation was con-
structed on the base in 1960. Arsenic trioxide was applied as a her-
bicide at the substation until the mid-1970s.
In 1992, As contamination in groundwater was identified at the
Tyndall site with a maximum As concentration of 1700 lg/L mea-
sured at a monitoring well (MW-1) located at the substation and
screened from the water table at 1.5 m below ground surface
(bgs) to 4.5 m; an even higher As concentration (2400 lg/L) was
observed at MW-1 in 1993 (SCS, 1999). By 1996, 18 monitoring
wells were installed at the site (two additional wells were installed
later); all wells were screened over 3-m intervals at varying depths
as indicated in Fig. 2. Groundwater monitoring in 1996 showed a
plume of As-contaminated groundwater extending SW from the
substation in the direction of groundwater flow.
In 2003, soil within the substation was partially excavated to
depths ranging from 0.6 to 1.5 m. Approximately 800 t of contam-
inated soil was removed from the site and replaced with clean soil
(SCS, 2003). Some areas of the energized substation could not be
safely excavated and thus those soils remained in place. CrushedGulf of Mexico
Panama City
St. 
Andrew 
Bay
Tyndall AFB
Study 
Site
Fig. 1. Tyndall Air Force Base, FL and substation study site locations.gravel covers the entire substation ground surface where equip-
ment is not positioned, allowing for infiltration of rainwater.
The stratigraphy of the study site is defined by three primary
units: recent sands (surficial aquifer), the Jackson Bluff Formation
(JBF), and the Intracoastal Formation (Schmidt and Clark, 1980;
SCS, 1999). The surficial aquifer sediments are well-sorted fine-
to medium-graded sands. A distinct peaty zone, 15–30 cm thick,
occurs at an approximate depth of 0.9–1.5 m. Below this, the sands
are tan to grayish-white, well-sorted, slightly silty, and fine-
grained. At a depth of approximately 14 m, the sands grade into
the JBF, which is characterized by dark greenish-gray, very fine-
grained, clayey, silty sand. The thickness of the JBF varies but ap-
pears to be approximately 2.5 m thick near the substation. The
JBF is underlain by the upper Intracoastal Formation, which is dark
greenish-brown, fine-grained, clayey, silty sand.
Groundwater flow is generally to the SW. The water table is typ-
ically within 0.9–1.5 m of the land surface, and the aquifer is re-
charged by direct infiltration into the porous sands. Groundwater
is lost by discharge into springs and streams or drainage ditches,
subsurface flow to the ocean, evaporation, transpiration and with-
drawal. In addition, some groundwater may flow downward
through the intermediate leaky aquitard. The average hydraulic
conductivity estimated from six slug tests (Brouwer-Rice method)
is 0.02 cm/s (MW-2, 3, 5, 8, 9, and 10), and the effective porosity is
estimated to be 0.2. The estimated horizontal flow rate toward the
Gulf of Mexico in the surficial aquifer is 0.8 m/d based on a gradi-
ent of 0.01, but this hydraulic gradient is not uniform across the
site (SCS, 1999).3. Methods
3.1. Chemicals and analytical methods
All chemicals used were reagent grade or better, and used with-
out further purification: OmniTrace Ultra HNO3, HNO3, HCl, H2SO4,
pyridine, and CertiPUR ICP standards were obtained from EMD
Chemicals; NaAsO2 and CaSO4 from J.T. Baker; NaOH, (NH4)2SO4,
and NH4H2PO4 from EM Science; Na2HAsO47H2O, EDTA,
MgSO47H2O, and NaCl from Sigma; NH4CH3COO, CH3COOH, and
CH3OH from BDH; 1,10-phenanthroline and H2O2 from Alfa Aesar;
NH2OHHCl from Fisher Scientific.
Solutions were prepared with 18.2-MX cm deionized water
(Millipore Milli-Q 18.2-MX system) and stored in plastic contain-
ers that had been washed with 10% HCl. All volumetric flasks were
washed with 10% HCl and rinsed several times with deionized
water prior to use. All analyses were conducted in triplicate,
including instrument and field blanks.
Dissolved As, Al, Mn and Si were determined by inductively-
coupled plasma-mass spectrometry (ICP-MS, Hewlett–Packard
4500). Samples were diluted with Ultra HNO3 (OmniTrace) to 1%
acid.
Iron was determined as Fe(II) and total Fe using the colorimetric
1,10-phenanthroline method without boiling (adapted from Eaton
et al., 2005) with a UV–Visible Spectrophotometer (Cary 480) at
510 nm.
Arsenic speciation was determined by quantifying As(III) and
As(V) using coupled liquid chromatography (LC) and ICP-MS, in
which As(III) and As(V) were separated by an HPLC column (Hew-
lett Packard 1100 series) with a 3-mM phosphate mobile phase
(pH 6.0) at 0.9 mL/min flow rate and HPLC outflow was directly
connected to the ICP-MS for As measurement.
Major cations and anions were quantified by ion chromatogra-
phy (Dionex Model DX-500) following standard methods (Eaton
et al., 2005). Colorimetric determinations of P by USEPA Method
365.1 (USEPA, 1993) and determinations of total and dissolved or-
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Fig. 2. Groundwater monitoring data showing extent of As contamination in surficial aquifer in February 1996 and April 2002, prior to the partial excavation of source area
soils in 2003. Approximate iso-concentration contours shown based on historical monitoring data for total As concentrations (lg/L), which are shown next to the location of
the monitoring wells (nd = non-detect). All screened intervals were 3 m starting at depths of 1.4 m (MW-1, 4), 1.6 m (MW-2, 3, 5, 6), 18.1 m (MW-7), 5.4 m (MW-8. -9),
10.6 m (MW-10, -11), 11.5 m (MW-12), 11.3 m (MW-13), 8.1 m (MW-14, -18), 8.4 m (MW-15–17). Source: (SCS, 1999; Gulf Power, 2004).
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2005) were performed by MWH Environmental Laboratories (Pas-
adena, CA). To avoid excessive holding times, analyses of NO3 and
NO2 by ion chromatography were performed by Quality Analytical
Laboratories (Panama City, FL).
Specific surface areas of selected samples were determined
using the Brunauer–Emmett–Teller (BET) N2 adsorption/desorp-
tion method (Gemini 2360 surface area analyzer, Micromeritics).
3.2. Sample collection
Three types of samples were collected at the Tyndall site: sur-
face area soils, aquifer sediment cores and groundwater. Drilling
was performed at the site in August 2005 using a direct-push drill
rig to collect sediment cores and to install a new monitoring well,
MW-1R, replacing well MW-1, which was removed during excava-
tion of the source area. Well MW-1R was installed immediately
downgradient of the substation boundary and screened from 1.5
to 4.5 m bgs.
3.2.1. Source area soils and aquifer sediment cores
Surficial soil samples were collected by hand trowel from 0.3 to
0.6 m bgs from two locations (denoted S3 and S27) within the sub-
station in April 2005. An additional sample was collected at loca-
tion S27 in July 2006. Soil samples were shipped on ice and
stored in the dark at 4 C until analysis or frozen for later use.
In August 2005, sediment cores were collected within the As
plume (ASB-1, ASB-2, ASB-3) and in background areas cross- and
upgradient of the substation (BSB-1, BSB-2, BSB-3). Upon collec-
tion, cores enclosed in acetate core sleeves were cut into intervals
of 0.3–0.6 m and sealed with plastic end caps secured with duct
tape; selected sections were shipped on ice and stored in the dark
at 4 C until they were sectioned into 0.15 m intervals, homoge-
nized under N2 in a glove box, and frozen until use.
3.2.2. Groundwater samples
In April 2005, background groundwater was collected upgradi-
ent of the substation from MW-2. Samples were shipped on ice,stored at 4 C until analysis (which was conducted within 10 d of
sample collection), and then frozen until used in leaching experi-
ments. Additional groundwater was collected at MW-2 in July
2006 for use in leaching experiments. In August 2005, groundwater
samples were collected from 18 monitoring wells using low-flow
sampling techniques. Field parameters including pH, dissolved O2
(DO), temperature, turbidity and oxidation–reduction potential
(Eh) were measured at the time of collection. Samples for analysis
of NO3 plus NO

2 were analyzed at a local commercial laboratory.
Other samples were preserved appropriately for the intended ana-
lyte (USEPA, 1983) and shipped on ice. Note that unpreserved sam-
ples were used for determination of As speciation. Some samples
were filtered through a 0.22 lm mixed cellulose ester (Millipore)
filters before analysis.3.3. Characterization of source area soils and aquifer sediment samples
3.3.1. Sample handling
Source area soil samples collected in April 2005 and July 2006
were stored frozen. Samples were thawed and homogenized with-
out drying (April 2005) or after air-drying in the dark for 1 d (July
2006). Samples were then sieved successively through 18-mesh
(1 mm), 32-mesh (500 lm), 60-mesh (250 lm), and 250-mesh
(63 lm) sieves. Water content was determined gravimetrically
for the April 2005 samples. Sub-samples of whole and sieved soils
collected in July 2006 were freeze-dried for 2 d.
For aquifer sediments (collected August 2005), frozen samples
were similarly homogenized, dried, and sieved, but under a N2
atmosphere in the glove box. Sub-samples were transferred to
15-mL centrifuge tubes and loosely capped in the glove box before
being freeze-dried for 2 d.3.3.2. Scanning electron microscopy (SEM)
A soil representative of the source area (S3, collected April
2005) was ground to a powder and allowed to dry under N2 in a
glove box. A dried sample was mounted on C tape and imaged in
a FEI Quanta 200 SEM with an EDAX Genesis 2000 energy disper-
sive spectrometer (EDS) for elemental analysis. The microscope
A.G. Fitzmaurice et al. / Applied Geochemistry 24 (2009) 2152–2162 2155was operated at an accelerating voltage of 20 kV, with a working
distance of 10 mm and magnifications of 600–5000.
3.3.3. X-ray absorption spectroscopy (XAS)
Two representative source area soils (S3 and S27, collected
April 2005) were analyzed by X-ray absorption spectroscopy
(XAS) (performed in June 2005). Arsenic K-edge absorption spec-
tra were collected at the Stanford Synchrotron Radiation Labora-
tory (SSRL) on wiggler beamline 11–2 at cryogenic temperature
(4 K) under dedicated conditions (3 GeV, 70–100 mA) using an
unfocused beam. Powdered samples were loaded into 2-mm-
thick Teflon sample holders and sealed with Kapton film. Arsenic
K-edge and EXAFS fluorescence spectra (S3 only) were collected
using a Si(2 2 0) monochromator crystal and a 30-element solid-
state Ge array detector. Beam energy was calibrated on As foil
at 11,867 eV. Multiple scans (6–8) were collected and averaged
for each sample. Structural information was determined by non-
linear least-squares fitting of the normalized EXAFS of sample
S3 with the program EXAFSPAK (George and Pickering, 2000)
using theoretical phase-shift and amplitude functions for single
and multiple-scattering calculated with the program FEFF (Rehr
et al., 1992).
3.3.4. Total elemental analysis
Freeze-dried samples of source area soil (S3 and S27, collected
April 2005, and the 0–250 lm size fraction of S27, collected July
2006) and whole and size-fractionated aquifer sediment (collected
August 2005) were sent to SGS Minerals Services (Toronto,
Ontario) for total elemental analyses. Major elements were deter-
mined by X-ray fluorescence (XRF) after meta/tetraborate fusion
(method XRF76Z) and reported as% oxides. Total As content was
determined for source area soils by XRF on pressed pellets (method
XRF75 V) and for aquifer sediments by hydride generation atomic
absorption spectroscopy after sodium peroxide fusion (method
HAS90A).
3.3.5. Method 3050B extractions
Sub-samples of homogenized source area and aquifer soil
(whole and size-fractionated fractions) were extracted following
Method 3050B, a strong acid digestion that mobilizes solid-associ-
ated ‘‘environmentally available” metals (USEPA, 1996). Elements
bound in silicate structures are not extracted by this method. In
brief, 1.0-g samples were reacted in 50-mL tubes in triplicate at
95–99 C on a heating block with 35% HNO3 for 15 min, 50%
HNO3 for 4.5 h, and 5% H2O2 for 4 h.
3.3.6. Sequential extractions
For source area soil (S27, collected July 2006), 1.0-g sub-sam-
ples of 0–250 and 63–250 lm size fractions were sequentially ex-
tracted twice with 25 mL solutions of 50 mM (NH4)2SO4 for 4 h and
twice with 50 mM NH4H2PO4 for 16 h following a method adapted
from Wenzel et al. (2001) and then subjected to 3050B extraction.
Extractions were performed in triplicate. For each extraction step,
samples were shaken on a shaker table at 20 C and subsequently
centrifuged for 15 min at 2000g. The supernatant was filtered and
retained for measurement, while the solid was subjected to succes-
sive extraction steps.
3.4. Mobilization and sequestration experiments
3.4.1. Exhaustive extraction with groundwater
Using the 0–250 lm size fraction of source area soil (S27, col-
lected July 2006), a 100-g sample was leached with 1 L of back-
ground groundwater (MW-2, collected July 2006). The
suspension was divided into 4 opaque bottles which were sha-
ken on a shaker table at room temperature for at least 24 hand subsequently centrifuged at 3500g for 10 min. The superna-
tant was decanted, and background groundwater was replaced.
This process was repeated 14 times. The soil was air-dried,
and aliquots were extracted in triplicate following Method
3050B.3.4.2. Batch leaching experiments
Batch leaching experiments were performed with 0–250 and
63–250 lm size fractions of source area soil (S27, collected July
2006) using a synthetic groundwater based on the composition
of background groundwater (well MW2). The synthetic groundwa-
ter consisted of 44 lM NaCl, 75 lM CaSO4 and 82 lM MgSO4, buf-
fered to pH 5.2 with 10 mM pyridine. Soils were leached in 15-mL
centrifuge tubes at solids concentrations of 5, 40, 100, 250 and
500 g/L. Suspensions were mixed by end-over-end rotation in the
cold room (dark, 12.5 C) for 3 d and then centrifuged at 14,000g
for 10 min. Supernatants were filtered through 0.2 lm Acrodisc
nylon-membrane syringe filters (Pall) and acidified before analysis.
Experiments were performed in triplicate.3.4.3. Static column leaching experiments
Using the 63–500 lm size fraction of source area soil (S27, col-
lected April 2005), 300 g of soil was distributed evenly into three
11-cm long Plexiglas cylindrical reactors with a 9-cm inner diam-
eter (ID) fitted with a medium porosity (10–16 lm) fritted filter
disc (Chem Glass, NJ) to retain soil. The outlet (outer diameter
(OD) 90 mm) was located at the bottom of the column on the side.
Approximately 100–150 mL of background groundwater (MW2,
collected April 2005) was added to the reactors and allowed to sat-
urate the soil. The reactors were left in the cold room (dark,
12.5 C) for 4 d. The leachate was then pumped out, discarding
the first 50 mL, filtering and retaining the next 15 mL, and discard-
ing the remaining leachate. The reactors were then left in the cold
room for 1 d. This process of wetting for 4 d and drying for 1 d was
performed six times.3.4.4. Flow-through column leaching experiments
Using the 0–250 lm size fraction of source area soil (S-27, col-
lected July 2006), 220 g of soil was distributed evenly into two 20-
cm long Plexiglas cylindrical reactors (5-cm ID) with outlet holes
(OD, 90 mm). Nylon mesh was used to retain the soil. Columns
were eluted with synthetic groundwater (see Section 3.4.2) in an
upflow direction under the following flow conditions: 5 mL/h for
24 h, 20 mL/h for 16 h, no flow for 48 h, 5 mL/h for 24 h. Columns
were kept in the cold room (dark, 12.5 C) throughout the experi-
ment and samples were collected with an automatic fraction
collector.3.4.5. Sorption experiments with aquifer sediments
Sediment samples (0.75 g) were added to 25 mL of background
groundwater (MW-2, collected July 2006) spiked at t = 0 h with
As(V) at initial concentrations ranging from 0.5 to 170 lM in 50-
mL centrifuge tubes in a glove box. Note that, for experiments with
ASB-1 sediments, 0.50 g of sediment was added to 16.67 mL solu-
tion. Suspensions were prepared in triplicate and rotated end-over-
end in the cold room (dark, 12.5 C) for 36 h before centrifugation
at 14,000g. Supernatants were filtered and acidified for analysis. At
t = 36 h, the pH of the filtered supernatants was measured before
acidification. Solid-associated As was calculated as the difference
between the total As in the suspension (i.e., As spike plus the ambi-
ent As content of the solid) and the measured, dissolved As concen-
tration. Sorption experiments were performed with whole and
size-fractionated sediments from cores obtained within and upgra-
dient of the As plume.
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4.1. Groundwater composition
Groundwater sampling conducted in August 2005 confirmed
the extent of As contamination as observed in previous monitor-
ing events (Figs. 2 and 3). The As concentration measured at the
newly-installed well MW-1R located at the substation boundary
(and replacing well MW-1) was 1160 lg/L. This value is lower
than that previously measured at well MW-1 (e.g., 2400 lg/L in
1993) before its removal in 2003, which may reflect the decrease
in the source strength due to the partial excavation of contami-
nated soil.
Determination of As speciation demonstrated that As is present
in the groundwater primarily in the +V oxidation state (Fig. 3). The
highest As(III) concentration measured was 108 lg/L at well MW-
10 corresponding to 13% of the total dissolved As; As(III) was unde-
tectable in 15 of the 18 wells sampled. In a previous study con-
ducted at Tyndall, groundwater discharging into a ditch was
collected approximately 1 m below the surface using shallow piez-
ometers. The observed ratio of As(III):As(V) was roughly 1:1 with
approximately 10% of the total dissolved As present as methylatedBSB-3
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Fig. 3. Concentrations of total dissolved As and As(III) in lg/L determined in Tyndall grou
in brackets (nd = non-detect). Approximate iso-concentration contours are drawn for tota
the contaminated zone (ASB-1, -2, -3) and upgradient background area (BSB-1, -2, -3) aspecies (Miller, 2001). Since only As2O3 was applied at the site,
these observations indicate that both As(III) oxidation and, to a les-
ser extent, methylation occurred in situ.
In general, the Tyndall groundwater was moderately acidic with
relatively low conductivity and a major ion composition domi-
nated by Ca, Mg and SO4 (Tables 1 and 2). Dissolved organic C
(DOC) measured at MW2 was high (10.2 mg/L) for groundwater,
possibly due to the influence of the peaty organic layer in the sub-
surface. It is likely that DOC contributes to the observed acidity of
the groundwater.
Comparison of Fe (andMn) concentrations within the zone of As
contamination (Table 2) and outside it (Table 1) does not suggest
that As mobilization is associated with the reductive dissolution
of Fe-containing carrier phases despite the importance of this
mechanism for As mobilization in many other locations (Ravens-
croft et al., 2009 and references therein).
4.2. Soil and sediment characterization
Soils collected from the source area (i.e., the substation) and
sections of sediment cores collected both within and upgradient
of the As plume were analyzed.BSB-2
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Table 1
Groundwater composition for wells outside zone of contamination.
Analytea Units MW-2 (April 2005) MW-2 (August 2005) MW-3, 7, 8, 11, 15, 16, 17, 18 (August 2005)
Mean Minimum Maximum
As lg/L <1 0.15 ± 0.04 2.6 <1 7
As(III) lg/L NMb <1 <1
Mn lg/L 9 8 ± 0.07 11 <1 73
Alc lg/L <1 557 ± 16 86 <1 316
Fe lg/L <0.25 11 ± 0.01 45 4 93
Na mg/L 1.75 1 ± 0.05 5 2 8
Ca mg/L NM 3 ± 0.29 5 1 18
Mg mg/L NM 2 ± 0.06 1 1 2
K mg/L 0.38 1 ± 0.02 2 <0.1 4
Cl mg/L 9.8 2 ± 0.14 10 3 15
SO4 mg/L as SO4 14 12 ± 0.5 13 6 20
Br mg/L <0.1 3 ± 0.1 <1
TOC mg/L NM 18 9 3 30
DOC mg/L 10.2
pH (unfiltered) 4.93
pH (filtered) 4.79 NM 5 4 6
a All samples (except for TOC, DOC and unfiltered pH samples) were filtered through 0.22 lmmixed cellulose ester (Millipore) filters after delivery to Caltech. Samples for
DOC analyses were filtered through 0.2 lm nylon (PALL Life Sciences) filters. Nitrate and NO2 were measured for all samples but were not detected. For MW-2 (August 2005)
samples, standard deviations are reported for triplicate analyses.
b NM = not measured.
c The discrepancy between the Al concentrations in samples collected in April and August may indicate loss of Al from April samples. A previous study at this site reported
Al concentrations in filtered groundwater of 2.5 mg/L (Miller, 2001).
Table 2
Groundwater composition for wells within zone of contamination (samples collected August 2005).
Analytea Units MW-1R MW-19 MW-20 MW-5 MW-9 MW-10 MW-12 MW-13
As lg/L 1155 ± 17 152 ± 2 45 ± 0.7 53 ± 0.5 274 ± 2 845 ± 17 484 ± 5 410 ± 3
As(III) lg/L <1 <1 <1 <1 <1 108 10 14
Mn lg/L 7 ± 0.2 8 ± 0.2 <1 2 ± 0.07 <1 <1 1 ± 0.9 <1
Al lg/L 165 ± 4 225 ± 6 36 ± 1 225 ± 4 167 ± 22 335 ± 7 109 ± 6 65 ± 2
Fe lg/L 18 ± 0.01 11 ± 0.01 15 ± 0.01 18 ± 0.01 13 ± 0.01 7 ± 0.01 31 ± 0.01 37 ± 0.01
Na mg/L 2 ± 0.04 3 ± 0.1 <0.1 2 ± 0.06 11 ± 0.4 15 ± 0.4 5 ± 0.1 4 ± 0.2
Ca mg/L 21 ± 2 12 ± 1 1 ± 0.5 8 ± 0.9 5 ± 0.5 8 ± 0.8 3 ± 0.2 1 ± 0.09
Mg mg/L 5 ± 0.14 3 ± 0.1 <0.1 2 ± 0.1 2 ± 0.07 2 ± 0.09 2 ± 0.05 1 ± 0.06
K mg/L 2 ± 0.05 1 ± 0.06 <0.1 1 ± 0.01 1 ± 0.03 1 ± 0.05 2 ± 0.05 2 ± 0.08
Cl mg/L 4 ± 0.2 5 ± 0.1 10 ± 1 6 ± 1 20 ± 1.4 27 ± 1.6 11 ± 2 9 ± 0.6
SO4 mg/L as SO4 20 ± 2 15 ± 0.6 19 ± 1 11 ± 2 9 ± 0.3 18 ± 1.3 17 ± 3 12 ± 0.7
Br mg/L 2 ± 0.1 5 ± 0.2 <0.1 2 ± 0.4 <0.1 <0.1 <0.1 <0.1
TOC mg/L 11 12 6 11 21 14 6 5
pH – 6 6 5 5 5 5 4 NM
NM = not measured.
a All samples (except for TOC samples) were filtered through 0.22 lmmixed cellulose ester (Millipore) filters after delivery to Caltech. Standard deviations are reported for
triplicate analyses. Nitrate and NO2 were measured for all samples but NO

3 was not detected and NO

2 was detected only at MW-19 at 2 mg/L.
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The mineralogy of the source area soils is dominated by quartz,
which was observed by SEM/EDS to occur as euhedral grains (10–
50 lm) with sparse surface coatings containing mostly Al, Si and
Ca (example grain shown in Fig. 4). Notably, no Fe was detected
by EDS, although Fe is commonly present as a surface coating on
soil minerals. Microscale observations are generally consistent
with the bulk soil composition, which was determined to be 95%
SiO2 with 1.4% CaO, 0.7% Al2O3, 0.6% Fe2O3 and 0.44% MgO. The
amount of 3050B-extractable Fe, Al and Mn in the source area soils
were low compared with a NIST reference sandy soil, similar to a
previous survey that also found Florida soils to be depleted in these
elements (Chen and Ma, 1998) (Table 3).
Total As contents (determined by XRF) in two source area soil
samples were 180 (S27) and 280 (S3) mg/kg, respectively, consis-
tent with previous measurements. These values are substantially
elevated relative to background As levels in Florida soils, which
are characterized by a geometric mean of 0.4 mg/kg with an esti-
mated upper limit for the background As content of 7.0 mg/kg
(Chen et al., 2001).Concentrations of 3050B-extractable As were approximately
80% of the total As concentrations determined by XRF on whole
soils (Table 4). In a modified sequential extraction, a substantial
fraction of the As associated with the solids was extracted by
ammonium sulfate and ammonium phosphate, indicating that dis-
solution of the solid carrier phase is not a prerequisite for As mobi-
lization. The distribution of As released in different sequential
extraction steps was similar for the 0–250 and 63–250 lm size
fractions, though this comparison is complicated by the incomplete
(75%) recovery in the sequential extraction as compared with the
single 3050B extraction. Exhaustive batch extractions consisting
of 14 consecutive washes with background groundwater (each at
a soil-solution ratio of 1:10) resulted in the leaching of 92% of
the 3050B-extractable As and 79% and 92% of the 3050B-extract-
able Fe and Mn, respectively.
Comparable results were obtained in a previous study of soils
from the southeastern USA that had been contaminated by
As2O3; approximately 50% of the total extractable As was released
from the soil by extraction with ammonium sulfate and ammo-
nium phosphate (Yang and Donahoe, 2007). Comparison of
Fig. 4. Characterization of source area soils. Top: Representative SEM image and EDS analyses of sample S3. Left panel: As K-edge XANES of S3 and S27 compared with
reference spectra of As(III)-oxide (precipitated with Ca(OH)2 and CaCO3) and a natural sample of As(V) in travertine; dashed lines indicate characteristic absorption energies
for As(III)-O and As(V)-O bonding. Bottom panel: As EXAFS of S3 (solid line) and least-squares best fit (dashed line). Fit results: 4 oxygen atoms (fixed) at 1.67 Å (varied
r2 = 0.0011 Å2) with As–O tetrahedral multiple scattering (MS) at 3.01 Å; 2 Al or Si atoms at 3.22 Å (fixed r2 = 0.0045 Å2).
Table 3
3050B extractable contents of Al, Fe, and Mn in soils (dry weight basis).
Element Units Source area soils NIST sandy soila 40 FL soilsa
S27 S3
Al g/kg 2.6 14 25.4 1.8
Fe g/kg 0.006 0.002 30.1 0.83
Mn mg/kg 97 76 441 26.2
a Chen and Ma (1998).
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acid rain (SAR) solution indicated that, in low pH soils, the amount
of As leached by SAR corresponded closely to the sequential extrac-
tion steps that did not involve any reduction (i.e., reductive disso-
lution) of the soil matrix (Qi and Donahoe, 2009).
The oxidation state of As in two source area soils was deter-
mined by XANES analysis of the bulk soil. The energy of maximumTable 4
As contents (mg/kg) in source area soils (dry weight basis).
Method Sample
S3 (April 2005) whole s
XRF 280
3050B extraction 206
Sequential extraction Sum all steps
Ammonium sulfate (step 1)
Ammonium sulfate (step 2)
Ammonium phosphate (step 3)
Ammonium phosphate (step 4)
3050B on residue
a Samples not size-fractionated before analysis or extraction.
b Mean value ± standard deviation for triplicate analyses.absorption is indicative of As oxidation state (e.g., Foster, 2003).
Soil XANES spectra show that As is present predominantly in the
+V oxidation state, as indicated by the absorption maximum at
11.875 keV (Fig. 4). There is no evidence in XANES spectra for
adsorption at lower energies that would indicate the presence of
other As oxidation states. Quantitative EXAFS analysis of one sam-
ple (S3) indicated the arsenate geometry of tetrahedral coordina-
tion of As to 4 oxygen atoms and weak backscattering from
atoms beyond the O coordination shell (Fig. 4). Second-neighbor
features were fit with a combination of multiple scattering from
the arsenate tetrahedra and a second shell of Si or Al atoms (which
cannot be distinguished as backscatterers). The structural results
are consistent with sorbed arsenate on the surface of Al-oxide sur-
face coatings and/or aluminosilicate minerals. A previous study
also found that As was generally disseminated on the surface of
fine-grained soil particles; analysis of rare As-rich particles by
XANES demonstrated the presence of As(V) (Yang and Donahoe,
2007). Thus the speciation of As in the solid phase further supportsoila S27 (April 2005) S27 (July 2006)b
Whole soila 63–250 lm 63–500 lm 0–250 lm 63–250 lm
180 110
144 108 105 124 105
93 79
11 ± 0.6 11 ± 0.8
6.1 ± 0.5 5.3 ± 0.2
8.6 ± 2.4 5.1 ± 0.8
8.2 ± 1.8 4.3 ± 1.1
59 ± 5.7 54 ± 5.4
g/
L] 2.0
2.5
A.G. Fitzmaurice et al. / Applied Geochemistry 24 (2009) 2152–2162 2159the hypothesis of in situ As(III) oxidation to As(V) and lack of asso-
ciation with Fe-oxide phases. In many other environments, of
course, Fe-oxide phases are known to be key contributors to As
retention in soils (Smedley and Kinniburgh, 2002; Cances et al.,
2005, 2008).Solids Concentration [g/L]
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Fig. 6. Dissolved As concentrations in suspensions of source area soil (S27)
equilibrated with background groundwater at varying soil-solution ratios in batch
experiments (d) and static column experiments (.). Experimental conditions:
batch experiments – S27 collected July 2006, 0–250 lm size fraction, synthetic
groundwater (44 lMNaCl, 75 lMCaSO4, and 82 lMMgSO4, buffered to pH 5.2 with
10 mM pyridine), rotated 28 rpm at 12.5 C in the dark for 3 d, in triplicate; static
column experiments – S27 collected April 2005, 63–500 lm size fraction, MW-2
groundwater collected April 2005, 300 g saturated with 100–150 mL, left 12.5 C in
the dark for 4 d, repeated six times and in triplicate.4.2.2. Vertical distribution of As content in sediment cores outside
the source area
In contrast to the source area soils, As contents (as determined
by both total elemental analysis and 3050B extraction) in sedi-
ments collected both within the area of the As plume (ASB cores)
and upgradient of the source area (BSB cores) were generally with-
in the range expected for uncontaminated Florida soils (Fig. 5). In
the surficial sediments, 3050B-extractable As was actually slightly
lower in the ASB than in the BSB cores despite the elevated As con-
centrations in groundwater at the locations of the ASB cores. This
indicates that the surficial aquifer sediments have a limited capac-
ity for As sorption under in situ conditions.
Sediments collected within the JBF were enriched in As relative
to the surficial sediments both within and upgradient of the plume.
Both the 3050B-extractable and total As contents appeared to be
higher in the JBF sediments collected within the plume than in
those collected upgradient of the plume. However, these differ-
ences were in the range of the variability observed among replicate
samples from an individual core. Total As contents were higher
than 3050B-extractable As contents; this difference was somewhat
more pronounced for the BSB cores than for the ASB cores.4.3. Batch and column studies of As mobilization from source area soil
Source area soil was equilibrated in batch systems with back-
ground groundwater at varying soil-solution ratios for 3 d. Dis-
solved As concentrations of up to 700 lg/L were observed in the
equilibrated groundwater; between 1% and 15% of the 3050B-
extractable As was released from the source area soils (Fig. 6).
Also shown in Fig. 6 are the results of a static column experi-
ment, in which soil was equilibrated with background groundwa-
ter for a period of 4 d. The equilibrated solution was then
allowed to drain from the column and replaced with fresh back-
ground groundwater. In six consecutive treatments, the As concen-
tration in the effluent was 2100 ± 200 lg/L with no systematic
variation over the course of the experiment. This As concentration
corresponds to release of 0.7 ± 0.06 mg/kg of As from the soil (or
0.5% of the 3050B-extractable As). The As concentrations in the sta-Solid-associated As [mg/kg]
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Fig. 5. Distribution of total As content (closed symbols) and 3050B-extractable As
content (open symbols) with depth (a) in BSB cores collected upgradient of the
source area and (b) in ASB cores collected within the As plume. The depth of the
Jackson Bluff Formation (JBF) layer at each boring location is also identified.
Symbols: (s, d) ASB-1 or BSB-1, (5, .) ASB-2 or BSB-2, (h, j) ASB-3 or BSB-3.tic column effluent are consistent with those observed in the
plume near the source area at wells MW-1 and MW-1R.
In flow-through columns run under saturated conditions, As
concentrations in the effluent varied depending on the flow condi-
tions (Fig. 7). At a flow rate of 5 mL/h (region I), the As concentra-
tion in the effluent stabilized at 1400 lg/L, a concentration
comparable to that observed in the groundwater plume near the
source area.
With increasing flow rate, the As concentration in the effluent
increased over time and did not reach a stable value within 16 h
(region II); the maximum As concentration observed in the effluent
at a flow rate of 20 mL/h was 2400 lg/L. This increase in As con-
centration may be attributable to the increased mobilization of col-
loidal particles under conditions of increased shear. In contrast, if
the release of As from the solid phase were controlled by the kinet-
ics of reaction at the solid–water interface, the As concentration in
the effluent would have been expected to have decreased with
increasing flow rate as a constant mass flux was increasingly di-
luted (Schnoor, 1990). Additionally, a constant As concentration
in the effluent would have been expected if the release of As from
the solid phase were transport-controlled.
After the no-flow period of 48 h (region III), no further increase
in the effluent As concentration was observed. This is consistent
with the observations in the static column experiments, in which
effluent As concentrations were comparable. It would be expected
that colloidal particles released by shear forces under the flow con-
ditions of region II would have been recaptured by attachment to
the soil under the no-flow conditions of region III. With re-initia-
tion of the flow at 5 mL/h (region IV), the As concentration in the
effluent gradually decreased to a concentration of 1500 lg/L, sim-
ilar to that observed at the end of the initial flow period (region I).4.4. Sorption of As onto sediment from the surficial aquifer and the JBF
Batch experiments were conducted to assess the capacity of
surficial aquifer and JBF sediments for sorption of As(V), the prin-
cipal oxidation state of As both in the groundwater and in source
area soils. Sediment samples (core BSB-3, 0–125 lm size fraction)
were equilibrated for 36 h in background groundwater spiked with
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Fig. 7. Concentrations of As in the eluant of a column packed with source area soil
and eluted with simulated groundwater under saturated conditions. The column
was run at 5 mL/h for 24 h (region I), 20 mL/h for 16 h (region II), at no flow for 48 h
(region III), and at 5 mL/h for 24 h (region IV). Experimental conditions: S27
collected July 2006, 0–250 lm size fraction, synthetic groundwater (44 lM NaCl,
75 lM CaSO4, and 82 lMMgSO4, buffered to pH 5.2 with 10 mM pyridine), pumped
upward through column packed with 220 g of soil, 12.5 C in the dark.
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2160 A.G. Fitzmaurice et al. / Applied Geochemistry 24 (2009) 2152–2162As(V). Under these conditions, substantially greater sorption was
observed with the JBF sediment than with the surficial aquifer sed-
iment (Fig. 8). Neither sediment exhibited a clear saturation, but
the maximum observed value of solid-associated As (for the range
of experimental conditions examined) was 114 mg/kg for the JBF
sediment and only 22 mg/kg for the surficial aquifer sediment, a
ratio of 5.2:1. Notably, the JBF sediment was also enriched in Fe
and Al compared with the surficial aquifer sediment at ratios of
3.7:1 for Fe and 30:1 for Al based on total elemental analysis by
XRF.
The effect of surface area on As(V) sorption was investigated in
batch experiments with size-fractionated JBF sediments (14–15 m,
core ASB-1). In sieved fractions, the 0–63 lm fraction had a BETDissolved As [mg/L]
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Fig. 8. Concentrations of solid-associated As as a function of dissolved As
concentrations for 30 g/L suspensions of background sediments (core BSB-3, 0–
125 lm size fraction) equilibrated with background groundwater (MW-2 collected
July 2006) spiked with As(V). Solid-associated As was calculated as the difference
between the total As concentration in the system (based on the As spike plus the
ambient As content of the solid) and the measured dissolved As concentration.
Symbols: (s) surficial aquifer sediment (4.0–4.3 m depth; negligible ambient As
content), (d) JBF sediment (16.0–16.2 m depth; ambient As content 9.6 mg/kg).
Error bars correspond to standard deviations of triplicate analyses. Experimental
conditions: 0.75 g in 25 mL, rotated end-over-end at 12.5 C in the dark for 36 h in
triplicate.surface area of 10.7 m2/g and an ambient As content of 24.1 mg/
kg. The 63–125 lm size fraction had both a lower BET surface area,
4.8 m2/g, and lower ambient As content, 4.7 mg/kg. Normalizing
for surface area, the 0–63 lm fraction was enriched in As com-
pared to the 63–125 lm fraction by a ratio of 2.3:1. In the sorption
experiments, the sorption capacity of the 0–63 lm fraction was
substantially greater than that of the 63–250 lm fraction on a
per mass basis (Fig. 9a) but very similar when normalized for sur-
face area (Fig. 9b).4.5. Hydrologic considerations
Although the hydrology of the Tyndall site is not fully character-
ized, four aspects of the site hydrology should be considered in the
interpretation and integration of the field and laboratory observa-
tions. The first aspect is infiltration in the source area, the second is
transport within the surficial aquifer, the third is infiltration and
dilution downgradient of the source area, and the fourth is the
integrity of the JBF as a confining layer.
The topography of the Tyndall site and the corresponding
hydraulic gradients are variable across the site. In the source area
itself, the topography is quite flat with an estimated hydraulic
gradient of only 0.001. The groundwater table is also shallowDissolved As [mg/L]
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Fig. 9. Concentrations of solid-associated As as a function of dissolved As
concentrations for 30 g/L suspensions of JBF sediments (core ASB-1, depth 14.0–
14.9 m) equilibrated with background groundwater spiked with As(V). Solid-
associated As was calculated from the difference between the total As concentration
in the system (based on the As spike plus the ambient As content of the solid) and
the measured dissolved As concentration. Symbols: (s) 0–63 lm fraction (ambient
As content 24.1 mg/kg or 2.25 lg/m2), (d) 63–125 lm fraction (ambient As content
4.7 mg/kg or 0.98 lg/m2). Error bars correspond to standard deviations in triplicate
analyses. Experimental conditions: 0.50 g in 16.67 mL, rotated end-over-end at
12.5 C in the dark for 36 h.
A.G. Fitzmaurice et al. / Applied Geochemistry 24 (2009) 2152–2162 2161(approximately 1.5 m bgs). Thus heavy precipitation would be ex-
pected to result in substantial overland flow (i.e., runoff) as well as
in infiltration. After a precipitation event, high temperatures, par-
ticularly in spring and summer months, would drive evaporation
and capillary rise of As-contaminated groundwater. These pro-
cesses would tend to retard the transport of As from the source
area and could be a basis for the observed persistence of As despite
the ease of leaching of As from the source area soils observed in the
static and flow-through column experiments.
One well immediately downgradient of the source area (MW-7
not shown in Fig. 2 but located between MW-1 and MW-5) was
drilled through the JBF and into the underlying Intracoastal Forma-
tion. Well logs indicate that the JBF is approximately 2.5 m thick at
this location. The water table elevation at MW-7 is lower than at
nearby wells completed in the surficial aquifer thus indicating a
potential downward hydraulic gradient. Low to non-detectable
As concentrations at MW-7, however, indicate that As-contami-
nated groundwater is not penetrating through the JBF near the
source area.
Away from the source area, specifically downgradient of well
MW-10, the hydraulic gradient increases by about a factor of 10.
Between MW-10 and MW-17, the evolution of the 10 and
1000 lg/L contours in As concentrations over time (Figs. 2 and 3)
indicate that the extent of As contamination (as defined by the
10 lg/L contour) is stable or even retreating and that the mass of
As in the surficial groundwater (corresponding to the 1000 lg/L
contour) has declined. Comparison of the As contents of surficial
aquifer sediments within and upgradient of the As plume indicate
that As is not being sequestered in the surficial aquifer sediments;
this inference is supported by the batch sorption experiments con-
ducted in the laboratory. The apparent reduction in the mass of As
in the surficial aquifer may be attributable to the partial excavation
of As-contaminated soils in the source area and a consequent de-
crease in source strength. Infiltration of rainwater into the aquifer
downgradient of the source area could lead to dilution of As con-
centrations in the plume. It is also possible that, in this area, the
integrity of the JBF as a confining layer is compromised. Since the
conclusions regarding the stability of the As plume are based only
on observations from wells completed in the surficial aquifer (with
the exception of MW-7), the possible penetration of the As plume
into the Intracoastal Formation could provide an additional expla-
nation for the apparent stability of the As plume in the surficial
aquifer.5. Conclusions
This study examined potential geochemical controls on As fate
and transport, such as kinetic limitation of As mobilization and
the sequestration of As through sorption and/or precipitation reac-
tions, at a site with persistent As contamination in soil and ground-
water. Such geochemical controls were examined in laboratory
experiments to aid in the interpretation of two specific field obser-
vations: (1) the persistence of As in source area soils decades after
the discontinuation of the use of As2O3 as a herbicide and (2) the
apparent stability of the plume of As-contaminated groundwater.
Experimental results, however, suggest that the persistence of
As in the source area cannot be explained by geochemical controls,
as is often assumed, but may be the result of limited infiltration
(i.e., hydrologic control). Column experiments with source area soil
generated aqueous As concentrations comparable to those ob-
served in groundwater near the source area. A substantial fraction
of the As could be leached from the source area soil with back-
ground groundwater, or moderate leaching conditions, indicating
that the As in the source area soil is geochemically labile. Because
the amount of extractable Fe and Mn in source area soils was lowcompared with typical soils, Fe- or Mn-reducing conditions, which
are often responsible for As mobilization (Ravenscroft et al., 2009
and references therein), are not required to mobilize As from the
source area.
Likewise, experimental results did not support a geochemical
mechanism to explain the apparent stability of the As-contami-
nated groundwater plume. Batch sorption experiments showed
that surficial aquifer sediments sorbed As(V) much less than sedi-
ments from the JBF, a presumed confining layer, which suggested
that As sorption by surficial aquifer sediments is not a primary
retention mechanism. This limited capacity of the surficial aquifer
sediments for As(V) sorption is consistent with the similar As con-
tents observed for surficial aquifer sediments within the As plume
and upgradient of the plume (i.e., background conditions). Sorption
to JBF sediments may contribute to As sequestration, although in-
creased As contents in JBF sediments within the As plume area
compared to upgradient background JBF sediments was not ob-
served. The competence of the JBF as a confining unit far downgra-
dient of source area soils has not been examined, and may be a
factor in the apparent stability of the As plume.
The assessment of natural attenuation as a remedial option for
As contamination in groundwater often focuses on potential geo-
chemical mechanisms for sequestration. Studies at other sites have
demonstrated the importance of sorption and precipitation pro-
cesses involving Fe, Mn, Al and S for As sequestration and attenu-
ation. This study suggests that possible hydrologic controls should
also be carefully considered in assessing the apparent mobility and
sequestration of As in the subsurface, particularly in settings that
are depleted in the elements that can contribute to the immobili-
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The behavior of As in the subsurface environment was examined along a transect of groundwater mon-
itoring wells at a Superfund site, where enhanced reductive dechlorination (ERD) is being used for the
remediation of groundwater contaminated with chlorinated solvents. The transect was installed parallel
to the groundwater flow direction through the treatment area. The ERD technology involves the injection
of organic C (OC) to stimulate in situ microbial dechlorination processes. A secondary effect of the ERD
treatment at this site, however, is the mobilization of As, as well as Fe and Mn. The concentrations of
these elements are low in groundwater collected upgradient of the ERD treatment area, indicating that,
in the absence of the injected OC, the As that occurs naturally in the sediment is relatively immobile.
Batch experiments conducted using sediments from the site inoculated with an Fe(III)- and As(V)-reduc-
ing bacterium and amended with lactate resulted in mobilization of As, Fe and Mn, suggesting that As
mobilization in the field is due to microbial processes.
In the areas of the transect downgradient of the ERD treatment area, however, the concentrations of OC,
As, Fe and Mn in the groundwater are not elevated relative to background levels. The decrease in the dis-
solved concentration of OC can be attributed to mineralization by microorganisms. The losses of As, Fe
and Mn from the dissolved phase must presumably be accompanied by their uptake onto aquifer solids,
but chemical extractions provided evidence only for the enrichment of Fe(II). Nor could sorption of As(III)
onto sediments be detected by X-ray absorption spectroscopy (XAS) against the background of native As
in the sediments, which was present as As(V).
 2009 Elsevier Ltd. All rights reserved.
1. Introduction
The mobilization of naturally-occurring (or geogenic) As poses a
serious threat to human health, particularly in south and southeast
Asia, where rural populations are heavily dependent on alluvial
aquifers for drinking water (Nordstrom, 2002; Smith et al., 2002).
Arsenic mobilization in these settings is generally attributed to
reductive dissolution of Fe-bearing carrier phases, specifically
Fe(III) oxyhydroxides, and the concomitant release of associated
As (Amirbahman et al., 2006; Berg et al., 2001; Harvey et al.,
2002; Huang and Matzner, 2006; McArthur et al., 2001; Nickson
et al., 2000; Shimada, 1996; Swartz et al., 2004; Welch et al.,
2000). Various sources have been proposed for the organic C (OC)
needed to support the reductive dissolution process, including ter-
restrial organic matter, hydrocarbons migrated from natural
sources, and anthropogenic sources of fresh OC derived from agri-
culture and inadequate sanitation practices (Harvey et al., 2002,
2006; McArthur et al., 2004; Rowland et al., 2006).
Similar processes may occur in industrialized countries as a re-
sult of inadvertent or intentional inputs of anthropogenic OC. Inad-
vertent inputs include petroleum hydrocarbons released from
leaking storage tanks or pipelines (Ghosh et al., 2003; Johnson
and Schreiber, 2003) and organic-rich leachates generated within
solid waste landfills (Delemos et al., 2006; Keimowitz et al.,
2005; Pinel-Raffaitin et al., 2007; Reisinger et al., 2005; Stollen-
werk and Colman, 2003). Organic C has also been intentionally
introduced into the subsurface to stimulate enhanced reductive
dechlorination (ERD), the in situ bioremediation of chlorinated
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organic solvents (e.g., Scheutz et al., 2008). The possibility that this
process could mobilize naturally-occurring As has already been
recognized and demonstrated in laboratory microcosms (McLean
et al., 2006), but its occurrence in a field setting has received only
passing mention (Suthersan and Horst, 2008).
The stimulation of microbial reduction of As(V) and Fe(III) by a
variety of organic substrates has been demonstrated in numerous
laboratory studies. The rate of microbial reductive dissolution of
Fe(III)-containing solids has been shown to depend on various fac-
tors including the composition and crystallinity of the solid phase,
the microbial strain, the type of organic substrate and other envi-
ronmental conditions (Albrechtsen et al., 1995; Benner et al.,
2002; Bonneville and Van Cappellen, 2004; Cooper et al., 2005;
Cummings et al., 1999; Lovley and Phillips, 1986a,b; Lovley et al.,
1989; Roden, 2006; Rowland et al., 2007). Microbial species have
different inherent capacities for reducing As(V) and/or Fe(III) and
different responses to stimulation by added organic substrates.
Therefore, in mixed microbial communities, preferential growth
of certain species in response to biostimulation may change the
pattern of As(V) and/or Fe(III) reduction over time. The microbial
reduction of As(V) and/or Fe(III) is not necessarily accompanied
by As or Fe mobilization. Reduced As(III) and/or Fe(II) can also re-
main associated with the solid phase through sorption (Campbell
et al., 2008; Cummings et al., 1999; Lee et al., 2005; Zobrist et al.,
2000), precipitation of authigenic solids including Fe(II) arsenate
or As sulfides (Bostick and Fendorf, 2003; Huang and Matzner,
2006; Keimowitz et al., 2007; Lee et al., 2005; O’Day et al., 2004),
or the transformation of Fe minerals (e.g., ferrihydrite to magne-
tite) with subsequent As sequestration in the authigenic mineral
(Tufano et al., 2008). In many cases, the microbially-mediated
reductive dissolution of Fe(III) oxyhydroxides containing As as a
sorbed or co-precipitated species has been found to result in the
accumulation of Fe(II) and As, either as As(III) or As(V), in solution
(Islam et al., 2004; Nickson et al., 2000; Swartz et al., 2004). Labo-
ratory studies have shown, however, that the extent of As release
under such conditions is influenced by the type of Fe(III) oxyhy-
droxide initially present and the capacity of the microorganisms
for Fe(III) and/or As(V) reduction (Tufano et al., 2008).
Microorganisms capable of As(V) and Fe(III) reduction are ubiq-
uitous in soils and sediments, and As and Fe mobilization into sed-
iment porewater and groundwater is generally attributed to
microbial activity (Albrechtsen et al., 1995; Cooper et al., 2005;
Cummings et al., 1999; Zobrist et al., 2000). It is commonly, though
not exclusively, observed that As-enriched groundwaters or pore-
waters also contain elevated concentrations of Fe and Mn, which
is consistent with a reductive mechanism for As mobilization (Is-
lam et al., 2004; McArthur et al., 2004; Nath et al., 2005; Nickson
et al., 2000; Swartz et al., 2004). This mechanism for As mobiliza-
tion presumes that naturally-occurring As in the subsurface is
associated with Fe(III) oxyhydroxides, as is often the case in allu-
vial aquifers (Welch and Lico, 1988a,b; Welch et al., 2000).
The coupled biogeochemical cycling of As and Fe influences not
only the mobilization of As but also its potential sequestration.
Geochemical conditions that allow the oxidation of Fe(II) and pre-
cipitation of Fe(III) oxyhydroxides would also tend to promote As
sequestration (Bednar et al., 2005; Espana et al., 2005; Fukushi
et al., 2003; Huang and Matzner, 2006; Roberts et al., 2004; Wilkie
and Hering, 1996). Such processes could allow the natural attenu-
ation of As mobilized by anthropogenically-introduced OC. Even in
the absence of oxidation, As can be sequestered by sorption onto
aquifer minerals (Smedley and Kinniburgh, 2002).
Here, the processes of both As mobilization and sequestration
are examined at a field site, where OC has been introduced as part
of an ERD remediation strategy. Mobilization of As and Fe is ob-
served downgradient of the OC inputs, but migration of As and
Fe appears to be limited by natural attenuation processes. In this
study, field observations are combined with laboratory studies of
As and Fe mobilization and characterization of sediments to ex-
plain the effects of OC inputs on the coupled biogeochemical cy-
cling of As and Fe.
2. Site background
The field study was conducted at the former Ft. Devens, a mili-
tary base that was closed in 1996 and is located 56 kmwest of Bos-
ton, MA, USA. The site was listed as a Superfund site in 1989
(USEPA, 2005). In one area of the Devens site, designated Area of
Contamination (AOC) 50 (Fig. 1), sources of groundwater contam-
ination include two World War II fueling systems, a drywell, and
a tetrachloroethane (PCE) drum storage area. These historic
sources (which were eventually removed) created an approxi-
mately 1000 m long organic contaminants plume in groundwater.
Despite operation of an in situ soil vapor extraction system from
1994 to 1996 and intermittent operation until 1999 and excavation
of the drywell and adjacent soil in 1996, the groundwater contains
elevated concentrations of volatile organic compounds (VOCs)
including PCE, trichloroethene (TCE), 1,1-dichloroethene (1,1-
DCE), cis-1,2-dichloroethene (cis-1,2-DCE), vinyl chloride (VC),
1,2-dichloropropane, methylene chloride, 1,2-dichloroethane, and
benzene; PCE has been found in groundwater in the source area
at concentrations in excess of 30,000 lg/L (Horst et al., 2002).
Between December 2001 and June 2002, an ERD pilot test was
conducted for remediation of chlorinated solvent contamination.
Molasses was injected into the saturated zone (at a depth of
35.1–41.1 m) approximately 503 m downgradient of the source
area (denoted ERD Pilot on Fig. 1A). After this initial (and largest)
molasses injection, monthly injections were initiated in October
2004 at the injection wells (denoted IW) shown in Fig. 1B and con-
tinued through the sampling event in 2006. Molasses was intro-
duced as a source of bioavailable organic C to support microbial
growth but also served as a source of N and S, which are typically
0.9% and 0.7% by weight on a dry matter basis, respectively
(Wythes et al., 1978).
Sediments at the site are mainly composed of fine sand with silt,
and some medium to coarse sand (Horst et al., 2002). Near the ERD
pilot test area, fine to coarse sand, gravel/cobble, and silt are also
important at 21.3–30.5 m depth. The sediments are mainly com-
posed of quartz, illite, kaolinite and illite-montmorillonite.
Groundwater flow from the AOC 50 source area is generally SW
toward the Nashua River (USEPA, 2004). At the ERD pilot test area,
the depth of the water table is 18.3 m below ground surface (bgs).
The monitoring wells downgradient of the ERD pilot test area are
screened over a depth interval from 38.1–41.1 m bgs. The lower
bound of the screened interval corresponds to the boundary be-
tween the glacio-fluvial deposits and the glacial till, along which
the PCE plume appears to migrate.
3. Experimental
3.1. Field sampling
Four sediment borings (SB-1, SB-2, SB-3 and SB-4) and 4 moni-
toring well sediment cores (SMW-1, SMW-2, SMW-3 and SMW-4)
were collected in April 2006 using sonic drilling at locations shown
in Fig. 1B. Borings were drilled from the ground surface to a depth
of approximately 44.2 m; sections of core material 0.3 m in length
were isolated by slicing the core and pushing a 5 cm outside diam-
eter (OD) plastic acetate tube 0.3 m into the end of the core, slicing
the other end of the section to isolate the sample, capping both
ends of the tube, and securing the caps with duct tape. This proce-
dure was intended to limit the exposure of aquifer material to
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atmospheric O2. Sample cores collected from 21.3 to 44.2 m were
stored in a dark and cool (4 C) place, shipped to Caltech within
24 h in a cooler packed with ice, and frozen immediately upon
arrival.
Groundwater was sampled on May 16–19, 2006 at monitoring
wells shown in Fig. 1. Four new monitoring wells (SMW-1–-4)
were developed on May 15, 2006; the other wells were part of
an existing monitoring network. In May 2006, groundwater sam-
pling commenced at the well located upgradient of the molasses
injection area (MW-7) and continued from wells with the least
As contamination (based on previous monitoring data) to the most
As-contaminated wells, closest to the molasses injection wells (IW-
1–-5 in Fig. 1).
Each monitoring well was purged and sampled via low stress-
low flow (generally <1 L/min) purging and sampling procedures.
A submersible pump was lowered to the midpoint (39.6 m) of
the screened interval of the well (38.1–41.1 m). The pump speed
was adjusted so that there was little or no water-level drawdown
(<0.1 m) during purging. During well purging, groundwater levels
and pumping rates were monitored. The indicator field parameters
temperature, pH, Eh and dissolved O2 were measured using a flow-
through cell (YSI 85), turbidity with a DRT-15CE Turbidimeter and
specific conductance with a Waterproof ECTestr (Eutech Instru-
ments). Purging was considered complete and sampling begun
after all the indicator field parameters had stabilized as indicated
by three consecutive measurements (taken every 3–5 min) within
the following limits: turbidity (10% for values >1 NTU), DO (10%),
specific conductance (3%), temperature (3%), pH (±0.1 unit), Eh
(±10 mV).
Sample containers were prepared at Caltech; when appropriate,
preservatives were added to sample containers before the field
sampling trip. Collected samples were stored on ice in a cooler
and shipped daily to Caltech. Holding times, preservation and stor-
age methods are listed in Table 1. Note that 0.45-lm in-line filters
AOC 50
N
ERD 
Pilot
0 200 m100
A
B
Fig. 1. Ft. Devens site. (A) map view showing source of chlorinated solvent contamination (AOC50) and ERD pilot area. (B) Blowup of ERD pilot area (from A) showing location
of injection wells (filled triangles), sediment borings (gray open circles), and sampled monitoring wells (gray filled circles and gray open circles in SMW-1–-4). Irregular gray
lines correspond to surface topography.
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(VOSS) were used when collecting samples for analysis of metals
and determination of As speciation. Field duplicate samples were
collected at wells 10, 11 and 12 (suffixes of monitoring desig-
nations given in Fig. 1).
To confirm available information on groundwater flow veloci-
ties, this parameter was independently measured using Passive
Flux Meters (PFMs) by EnviroFlux LLC under the direction of K.
Hatfield (Univ. of Florida). Details of the method are available else-
where (Annable et al., 2005; Hatfield et al., 2004). The PFMs were
constructed to fit the 4 new monitoring wells (SMW-1–-4). The
PFMs were 1.5 m length each with partitions at 0.3-m intervals.
Two PFMs were installed for each well to match the 3-m screened
intervals. The PFMs were deployed in late October 2006, left in the
wells for 1 week, and retrieved in early November 2006.
3.2. Chemicals and analytical methods
All chemicals were reagent grade or higher, used without fur-
ther purification, and obtained from the following suppliers:
HNO3, HCl, H3PO4, CaSO4 (J.T. Baker), OmniTrace Ultra HNO3, CaCl2,
FeCl2 (EMD Chemicals), NaOH (EM Science), NaAsO2, Na2HAsO4,
EDTA, NaCl (Sigma), ammonium acetate, acetic acid, methanol
(BDH), 1,10-phenanthroline, Na2SiO3.9H2O, H2O2 (Alfa Aesar),
MgCl2 (Aldrich), MES (MP Biomedicals), formaldehyde (VWR).
Solutions were prepared with 18.2 MX deionized water (Millipore
Milli-Q system) and stored in plastic containers that had been
washed with 3% HNO3. All volumetric flasks had been washed with
3% HNO3 and rinsed several times with deionized water prior to
use. Disposable 50-mL Falcon tubes were used for batch reactors.
Total concentrations of As, Fe and Mn were determined by ICP-
MS (Hewlett–Packard 4500). Total Fe and Fe(II) were determined
using the colorimetric 1,10-phenanthroline method (Standard
methods 3500-Fe B, Clesceri et al., 1999) with a UV–Visible spec-
trophotometer (Cary 480) at 510 nm. Arsenic speciation was deter-
mined by quantifying As(III) and As(V) using coupled liquid
chromatography (LC) and ICP-MS; As(III) and As(V) were separated
using an HPLC column (Hewlett Packard 1100 series) with a 3-mM
phosphate mobile phase (pH 6.0) at 0.9 mL/min flow rate and the
HPLC outflow was directly connected to ICP-MS for As measure-
ment. Major cations and anions were quantified by ion chromatog-
raphy (Dionex DX-500), sulfide and NO3 =NO

2 by colorimetry, and
alkalinity by titration. Total and dissolved organic C (TOC/DOC)
concentrations were determined by the persulfate oxidation meth-
od (Clesceri et al., 1999) with an Aurora TOC analyzer (Model
1030).
3.3. Sediment extraction experiments
Sediment core samples were defrosted, sectioned, and homoge-
nized inside a N2 glove box. Sediment adjacent to the capped ends
of the core samples (i.e., within a few cm of the cap) was discarded.
Sub-samples were then refrozen for later use in extraction and
mobilization experiments. Water content was determined gravi-
metrically for each sediment sample (Table 2).
3.3.1. EPA 3050B extractions
Sediment sub-samples were extracted following the EPA 3050B
extraction method (USEPA, 1996), which is not a total digestion but
is designed to estimate ‘‘environmentally available” metal contents
of sediments. The extractions were conducted on 1–2 g (wet
weight) sediment and can be briefly described as follows: digestion
at 95 ± 5 C with 10 mL of 1:1 HNO3 for 10–15 min and with 5 mL
of concentrated HNO3 for 2 h; digestion with 30% H2O2 (added in
approximately 1-mL increments until the reaction was complete)
and heating to reduce the volume to approximately 5 mL; dilution
to 50 mL volume with H2O and centrifugation at 3000 rpm for at
least 10 min to separate any remaining particulate matter; dilution
of supernatant with 2% (v/v) HNO3 for ICP-MS analysis. Throughout
the digestion procedure, the vessel was loosely covered and the
bottom of the vessel was always covered with solution.
3.3.2. Sequential extraction of As and extraction of Fe(II)
For these extractions, all sample handling was performed in the
N2 glove box. Sequential extractions were performed by adding the
extractants listed in Table 3 to 1 g of wet sediment in a modifica-
tion of a published method (Wenzel et al., 2001). After each spec-
ified time interval, suspensions were centrifuged at 3000 rpm for
10 min and the supernatant was carefully removed with a pipette
for solution analysis. Each extraction step was followed by a wash
step. The extractants and corresponding washes were pooled for
each step, and samples were diluted 10-fold with 2% HNO3 prior
to ICP-MS analysis.
Table 1
Information on groundwater sample collection,a preservation and analysis.
Analyte Methodb Sample volume Preservation (4 C) Holding time Test type
NO2 and NO3 SM 4500-NO3-E 125 mL HDPE None 48 h Colorimetric
Sulfide SM4500D 125 mL HDPE 0.25 mL 5 mM NaOH and 0.5 ml 1 M Zn Acetate 7 days Colorimetric (glove box)
Sulfate EPA 300.0A 125 mL HDPE None 28 days IC
Org carbon– Dissolved SM5310C 120 mL Amber Glass Filter through 0.2 lm upon return None Catalytic oxidation
Org carbon– Total SM5310C 120 mL Amber glass 0.5 ml 1.2 M H2SO4 28 days Catalytic oxidation
Fe SM 3500 Fe-D 125 mL HDPE 0.5 ml 2.5 M HCl 6 months Colorimetric
As speciation 250 mL HDPE 3.35 ml 0.1 M EDTA, 10.8 ml 2 M acetic acid 3 months LC-ICP/MS
Metals (Si, As, Mn, Fe) EPA 200.8 250 mL HDPE 1 ml 2.5 M HNO3 6 months ICP/MS
a Samples were filtered in the field using an in-line 0.45 lm filter (VOSS in-line filter).
b All methods denoted ‘‘SM” refer to Standard Methods (Clesceri et al., 1999). All methods denoted ‘‘EPA” refer to USEPA methods (USEPA, 1999).
Table 2
Water content of sediment samples.
Sediment
core
Depth (m) H2O (%) Sediment
core
Depth (m) H2O (%)
SB-1 41.1 21.5 SMW-4 41.1 22.4
SB-1 42.7 20.5 SMW-4 42.7 23.1
SB-2 41.1 22.9 SMW-2 35.1 16.8
SB-2 42.7 19.3 SMW-2 36.6 11.7
SB-4 35.1 12.6 SMW-2 38.1 13.5
SB-4 36.6 16 SMW-2 39.6 14
SB-4 38.1 14.6 SMW-2 41.1 23.7
SB-4 39.6 17.8 SMW-2 42.7 18.4
SB-4 41.1 11.8 SMW-3 41.1 24.6
SB-4 42.7 17.3 SMW-3 42.7 23.4
SMW-1 41.1 22.2 SMW-3
compositea
21.5
SMW-1 42.7 19.3
a SMW-3 composite is a mixture of homogenized sediment samples from depths
of 39.6, 41.1 and 42.7 m collected at SMW-3.
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For extraction of Fe(II), 1 g of wet sediment was extracted with
0.5 M HCl for 10 h in the dark as previously described (Dixit and
Hering, 2006). Supernatants were separated from residual
sediments by centrifugation (3000 rpm, 10 min) and analyzed for
dissolved Fe(II) and Fe(III) colorimetrically using the 1,10-phenan-
throline method.
3.4. Mobilization experiments
Sediment collected at the far-field well SMW-3 at depths of
39.6, 41.2 and 42.7 m was homogenized in the glove box and 1 g
of wet sediment was added to 20 mL of synthetic groundwater (Ta-
ble 4). Suspensions were amended with either or both 10 mM Na
lactate or 2% (v/v) formaldehyde (as final concentrations). All sus-
pensions were inoculated with 0.2 mL of a culture of Shewanella sp.
strain ANA-3 (obtained from D.K. Newman) that had been incu-
bated anaerobically in LB medium at 30 C in the dark for 24 h.
Cells were at stationary phase at the time of inoculation, and the
estimated initial cell density in the inoculated suspensions was
107 cells/mL. Inoculated suspensions were incubated at 15 C in a
cold room with shaking at low speed (Labline Environ Shaker,
model 3527). Triplicate samples were prepared for each treatment
and time point. At each time point, individual batch reactors were
sacrificed and supernatants were separated from residual sedi-
ments for analysis by centrifugation at 3000 rpm for 10 min.
3.5. X-ray absorption spectroscopy (XAS)
Sediment samples from borings were selected for X-ray Absorp-
tion Spectroscopy (XAS) characterization and kept frozen until
analysis. Cores were defrosted in a N2-atmosphere, and a sample
from the center of the core was taken and homogenized. In a N2-
atmosphere glovebox, 0.5 mg of sample was ground to a fine
powder, loaded into Teflon sample holders, sealed with Kapton
tape, and quenched in liquid N2. Data were collected at Stanford
Synchrotron Radiation Laboratory (SSRL) on BL11–2 (3 GeV, 80–
100 mA). During data collection, samples were held at liquid He
temperature (4–8 K). Fluorescence spectra were collected using a
30-element Ge solid-state array detector. For XANES, 3–5 succes-
sive scans were collected and averaged to obtain sufficient sig-
nal/noise. No change in oxidation state of As was detected during
XAS data collection. Spectral background was subtracted using
the pre-edge absorption and normalized to the average post-edge
absorption (fluorescence/incident energy).
4. Results and discussion
To assess the effects of molasses injection on the occurrence
and mobility of As, Fe and Mn, groundwater composition was
examined along a transect of wells installed along the direction
of groundwater flow up- and down-gradient of the molasses injec-
tion area (Fig. 1B). Sediments from borings were characterized by
chemical extraction and spectroscopic analysis to assess the
amount, speciation, and potential for release and sequestration of
As, Fe and Mn. Batch experiments were conducted to assess the po-
tential for microbially-mediated mobilization of As, Fe and Mn.
4.1. Groundwater composition
Analysis of samples collected in May 2006 at MW-7, upgradient
of the molasses injection area for the pilot ERD test, demonstrated
that the ambient groundwater is low in total, dissolved As (<1 lg/
L), Mn (0.1 mg/L), and Fe (<0.1 mg/L) with a SO24 concentration of
16.4 mg/L. Parameters measured at MW-7 in the field included
temperature (12.5 C), pH (5.9) and Eh (+105 mV). As a comparison,
uncontaminated groundwater in the Cape Cod (MA) aquifer is also
mildly acidic (pH 5.7) with undetectable As and Fe concentrations
and SO24 concentrations of approximately 8 mg/L (Savoie et al.,
2004).
Immediately downgradient of the molasses injection area, a dis-
tinct change in groundwater composition was observed. This was
particularly apparent in the decrease in field-measured Eh (which
dropped below 100 mV) as well as a decrease in SO24 concentra-
tion and increase in the concentrations of total dissolved As, Fe and
Mn (Fig. 2). Maximum concentrations of As and Fe were observed
at well 10, while the maximum Mn concentration was observed
farther downgradient at well SMW-2. Below SMW-2, As and Fe
concentrations declined sharply, though still exceeding the back-
ground values at MW-7; Mn concentrations declined more gradu-
ally. The pattern in Fe(II) concentrations (not shown) corresponded
to that observed for total dissolved Fe. The maximum Fe(II) con-
centration was observed at well 10, where it constituted 58% of
the total dissolved Fe concentration. At all other wells, the contri-
bution of Fe(II) to total, dissolved Fe was higher (ranging from 71 to
100%).
Along the transect, pH values ranged from 5.7 to 6.7. Sulfide was
not detected except at well MW-1 (0.62 mg/L), the closest well
downgradient of the molasses injection area, which is reasonable
Table 3
Sequential extraction procedure for As in sediments.a
Step Target phases for As speciation Extractant SSRb Wash step
1 Non-specifically sorbed 0.05 M (NH4)2SO4: 4 h, 20 C 1:25 15 mL H2O
2 Specifically sorbed 0.05 M (NH4)H2PO4: 16 h; 20 C 1:25 15 mL H2O
3 Amorphous and poorly crystalline hydrous
oxides of Fe and Al
0.2 M NH4-oxalate buffer, pH 3.25: 4 h (dark), 20 C 1:25 0.2 M NH4-oxalate buffer, pH 3.25: 10 min
(dark), SSR 1:15
4 Well crystallized hydrous oxides of Fe and Al 0.2 M ammonium oxalate buffer + 0.1 M ascorbic acid, pH
3.25: 30 min, 96 ± 3 C
1:25 0.2 M NH4-oxalate buffer, pH 3.25: 10 min
(dark), SSR 1:15
5 Residual phases (excluding silicates) HNO3/H2O2c
a All sample handling up to step 5 was performed under N2-atmosphere.
b SSR: solid–solution ratio.
c Same as 3050B extraction.
Table 4
Synthetic groundwater composition.
Constituent Concentration (M)
NaCl 3.53  103
CaSO4 1.71  104
CaCl2 1.77  104
MgCl2 1.19  104
Na2SiO39H2Oa 3.20  104
MESb 1.00  102
pH 6.1c
a Silicon AA standard (sodium metasilicate nonahydrate, lot #3602128, product
#ASI1KW, Ricca Chemical Co.,) in deionized water.
b MES = 4-morpholineethanesulfonic acid.
c pH units.
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given that elevated Fe(II) concentrations would be expected to lead
to sulfide precipitation. In contrast, NO3 and/or NO

2 were detected
only in the farthest downgradient well 8 (1.2 mg/L as NO3 ).
The concentrations of TOC (Fig. 2) and DOC (not shown) also
exhibited maximum values in the intermediate wells along the
transect. In all samples measured, DOC concentrations were
90 ± 6% of TOC concentrations. The increase in TOC immediately
downgradient of the molasses injection site likely reflects the
intermittent injection schedule. Like Fe, As and Mn, TOC decreased
from its maximum value farther along the transect. However, TOC
remained somewhat elevated even in wells SMW-3, SMW-4 and
12, returning to non-detectable levels only in the farthest down-
gradient well (8).
At well 8, background conditions appeared to be re-estab-
lished, as indicated by non-detectable Fe and Mn, SO24 concentra-
tion (17.9 mg/L) comparable to that at the upgradient well MW-7,
and Eh > 150 mV. The total, dissolved As concentration was 2.2 lg/
L, well below the drinking water standard of 10 lg/L.
4.1.1. Arsenic speciation in groundwater
Both As(III) and As(V) were detected in most groundwater sam-
ples. Arsenic(III) could be detected in samples collected from all
wells except the upgradient well MW-7 and the farthest downgra-
dient well 8, where total As concentrations were also quite low.
Arsenic (V) was undetectable in well MW-7 and in well 11 and
all wells farther downgradient. In the wells MW-1 through
SMW-2, the concentrations of As(III) and As(V) were approxi-
mately equal except for well 10, where As(III) was predominant
(78%).
In the wells closest to the molasses injection area (MW-1, MW-
3 and MW-5), methylated As species were also detected. Although
these species were not quantified, an LC-ICP-MS chromatogram of
groundwater collected fromwell MW-1 (Fig. 3) indicates that a sig-
nificant fraction of As was present as dimethylarsinic acid (DMA)
and suggests that monomethylarsonic acid may also have been
present. The occurrence of DMA in the groundwater at Ft. Devens
was unexpected because there is no known source of organic
arsenical compounds at the site. The microbial conversion of inor-
ganic As to MMA and DMA has, however, been observed in fresh-
water sediments (Nicholas et al., 2003) and may have been
stimulated by the molasses injections.
4.2. Sediment characterization
The changes in the dissolved concentrations of inorganic con-
stituents observed in groundwater collected along the well tran-
sect imply some corresponding changes in the composition of
the aquifer material along the flow path. Increases in dissolved
concentrations of an inorganic constituent imply its mobilization
from, and hence depletion in, the solid phase. Conversely, de-
creases in dissolved concentrations imply sequestration into, and
hence enrichment in, the solid phase. To examine these processes,
selected sediments collected along the transect were subjected to
various extraction procedures and examined by XAS.
4.2.1. Sediment extractions
Sediment samples were collected at various depths during the
construction of new monitoring wells (SMW-1–-4) or at sediment
boring locations near existing wells (SB-1 near the upgradient well
MW-7, SB-2 near MW-5, SB-3 near 10 and SB-4 near 11)
(Fig. 1B). Extractions following EPA method 3050B were performed
on sediments collected along the transect at and just below the
depth of the screened interval of the wells (38.1–41.1 m) and at
nd
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Fig. 2. May 2006 groundwater composition (A) sulfate and total, dissolved Mn, (B)
TOC and total, dissolved As and Fe determined by ICP-MS. Wells are ordered in the
direction of groundwater flow. TOC was not measured for MW-1 and MW-5 on the
samples collected in May 2006; the TOC values shown for these wells are from a
monitoring survey conducted in September 2005 by Arcadis G&M Inc. nd = not
detected. Error bars indicate standard deviation of triplicate samples. Field
duplicate samples show good agreement for analytes shown here.
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Fig. 3. LC-ICP-MS chromatogram showing the presence of DMA and possibly MMA
in addition to inorganic As(III) and As(V) in wells close to the molasses injection
area. Sample from well MW-1 collected May 19, 2006.
74 Y.T. He et al. / Applied Geochemistry 25 (2010) 69–80
Author's personal copy
depths ranging from 34.2–42.7 m for selected locations (SB-4 near
well 11 and SMW-2). 3050B-extractable As, Fe, and Mn showed
no meaningful trends along the transect (Fig. 4). It is likely that
the reservoir of 3050B-extractable As, Fe and Mn in the sediments
is sufficient to obscure any small changes that might occur as a re-
sult of mobilization or sequestration. Some trends in 3050B-
extractable As, Fe, and Mn were observed as a function of depth
(Fig. 5). For all three elements, higher 3050B-extractable concen-
trations were found in the deeper sediments. This pattern is consis-
tent with the change in the appearance of the sediment from sand
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Fig. 4. 3050B-extractable (A) As, (B) Fe, and (C) Mn in core samples from 41.2 m
(135 ft) and 42.7 m (140 ft) along the well transect. No samples were collected near
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Extractions performed on wet sediment with water contents listed in Table 2. Error
bars correspond to standard deviation of triplicate samples.
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Y.T. He et al. / Applied Geochemistry 25 (2010) 69–80 75
Author's personal copy
to silt and silty clay in the deepest sediments and is thus likely to
be related to the mineralogical characteristics of the sediment.
In contrast, the HCl-extractable Fe(II) did show a pattern along
the transect with the highest value at the intermediate location of
well SMW-2 (Fig. 6). The HCl-extractable Fe(II) contents are much
lower than the 3050B-extractable Fe contents and thus may more
readily exhibit a signature of sequestration.
The speciation of As in the solid phase was also examined along
the transect and as a function of depth at one location using a
sequential extraction procedure (Fig. 7). Although such methods
provide only an operational definition of speciation, it appears that
As is primarily extracted by non-reductive dissolution with ammo-
nium oxalate (step 3, which targets As associated with amorphous
and poorly crystalline hydrous oxides of Fe and Al) and reductive
dissolution with ammonium oxalate and ascorbic acid (step 4,
which targets As associated with well crystallized hydrous oxides
of Fe and Al). Lesser amounts of As were extracted by ammonium
phosphate (step 2, which targets specifically sorbed As) or by the
HNO3/H2O2 (step 5, which targets As associated with residual
phases though excluding silicate minerals) corresponding to the
3050B extraction method. Negligible amounts of As (<1%) were ex-
tracted by ammonium sulfate (step 1, which targets non-specifi-
cally sorbed As). Recoveries in sequential extractions (sum of
steps 1–5) corresponded to 92 ± 11% of the 3050B-extractable As.
Similar results were observed in sequential extractions of samples
collected along the well transect at 41.1 m or at different depths at
SB-4 (near well 11).
4.2.2. Spectroscopic characterization
Sediment samples collected along the well transect were exam-
ined by XAS to assess directly the oxidation state of As in the solid
phase. XANES spectra obtained for sediment samples were com-
pared with spectra for a number of reference As(III) and As(V) com-
pounds and sorption samples and with several As-sulfide minerals.
Except for one sample from core SMW-4 (42.7 m depth), the
XANES spectra from all core samples were very similar and indi-
cated that As was present as As(V) in the sediments (Fig. 8). The
appearance of most of the samples was also quite similar (brown,
silt and silty clay, trace fine sand, stiff) and distinct from the
appearance of the 42.7-m sample from SMW-4 (gray, silt and silty
clay, trace fine sand, stiff). Comparison of the XANES spectrum of
this sample with reference compounds indicated a mixture of
As(V) and As sulfide. The energy of maximum absorption of the
As-sulfide component is similar to that of reference arsenopyrite
and As-bearing hydrothermal pyrite (Foster et al., 1998; Savage
et al., 2000), suggesting a detrital origin for this component in
the sediment.
4.3. Mobilization of As, Fe, and Mn in batch experiments
The possible influence of microbial activity on the mobilization
of As, Fe and Mn from Devens sediments (collected from the soil
boring at well SMW-3 at depths of 39.6, 41.1 and 42.7 m and
homogenized before use) was investigated in batch systems inoc-
ulated with Shewanella sp. strain ANA-3, a known Fe(III)- and
As(V)-reducing bacterium (Malasarn et al., 2008). Experiments
were conducted with and without addition of lactate as an exoge-
nous organic C source and with and without formaldehyde to
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inhibit microbial activity. Substantial release of As, Fe and Mn was
observed over time in the experiments stimulated with lactate,
though the patterns of release differed somewhat for As, Fe and
Mn (Fig. 9). Iron concentrations increased linearly over time, while
the Mn concentration showed a distinct plateau after about 20 h.
The rate of As release appeared to decrease slightly over the course
of the experiment (120 h). The Mn concentration at the plateau
corresponded to 25% of the 3050B-extractable Mn; over the course
of the experiment, the As concentration reached 33% of the 3050B-
extractable As, but the Fe concentration reached only 4% of the
3050B-extractable Fe. It is, of course, quite reasonable that only a
fraction of the 3050B-extractable metal content would be released
in the microbial incubations. Very little release was observed when
formaldehyde was added; the addition of lactate had little or no ef-
fect in the presence of formaldehyde. In the absence of lactate,
some initial release of As and Fe was observed but concentrations
did not increase over time. In contrast, a steady increase in Mn con-
centration was observed over time. These observations suggest
that native organic C present in the sediments and/or residual or-
ganic C transferred with the inoculum supported this level of
microbial activity.
Determination of the speciation of As and Fe released into solu-
tion indicated that all dissolved Fe was present as Fe(II), consistent
with field observations. All dissolved As was present as As(III),
which contrasts with field observations of the co-occurrence of
As(III), As(V) and DMA in some samples. However, the activity of
the microorganism used for the inoculation is not necessarily the
same as that of the ambient microbial community. The nature
and loading of the organic substrate (i.e., lactate vs. molasses)
may also influence microbial activity.
The stimulation of release of As, Fe and Mn by lactate in the
presence of the model organism ANA-3 indicates that As, Fe and
Mn are present in the sediments in forms that are susceptible to
dissolution by microbial activity. It also suggests that exogenous
organic C can strongly stimulate microbial activity. Although the
activity of the native microbial community was not assessed in
Fig. 8. Arsenic XANES spectra of Fort Devens core sediments compared with a
reference spectrum of arsenopyrite. Dashed lines show the characteristic absorp-
tion energy for As in arsenopyrite and pyrite (11,869 eV), and As(V) bonded to O
(11,875 eV). SMW-3 (composite) is sediment homogenized from three depths (39.6,
41.2 and 42.7 m).
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these experiments, the freezing and thawing of the sediments is
likely to have depressed this activity.
4.4. Evidence for natural attenuation of As and possible mechanisms
for As sequestration
The initial (and largest) molasses injection at Devens was per-
formed as a pilot test in December 2001 through June 2002; subse-
quent injections were performed on a monthly basis starting in
October 2004. The estimated groundwater flow velocity based on
tracer experiments is89 m/a. This is consistent with an estimated
groundwater flow rate of 101 m/a calculated using the average
Darcy velocity of 0.083 m/d determined from the passive flux me-
ters (data not shown) and assuming a porosity of 0.3. The travel
time from the injection area to well 11 (located just downgradi-
ent of the toe of the dissolved As plume in May 2006 (SMW-2) and
61 m from injection area) is approximately 0.6 a (assuming a
groundwater flow velocity of 101 m/a). Since 4.5 a has elapsed be-
tween the initial molasses injection and the May 2006 groundwa-
ter sampling, some effect of the pilot molasses injection (e.g., a
signature of a conservative species co-injected with the OC) could,
in principle, be observed approximately 450 m downgradient of
the injection wells by May 2006 (i.e., seven times farther downgra-
dient than well 11).
It is clear from the field observations, however, that the TOC sig-
nature of the molasses injection does not persist across the entire
transect; rather the signal is strongly attenuated downgradient of
well SMW-2. Concentrations of TOC, As and Fe are low (though
above background levels) at wells 11, SMW-3 and SMW-4 and
essentially at background levels at the farthest downgradient well,
8. Notably, Mn concentrations are observed to be elevated farther
downgradient than those of either As or Fe. Loss of OC as a result of
mineralization is expected in this setting and is likely to be the pri-
mary reason that OC is not detected at the end of the transect
(though some retardation due to sorption cannot be excluded).
Field observations and laboratory mobilization experiments
indicate that As, Fe and Mn are mobilized in response to the molas-
ses injections and that mobilization is associated with reduction of
these elements, presumably coupled to microbial oxidation of OC.
As the groundwater moves downgradient, however, these species
are apparently sequestered, presumably by processes of sorption
and/or precipitation.
The contents of HCl-extractable Fe(II) in the sediments along
the transect show an enrichment at well SMW-2 suggesting that
Fe(II) is sequestered into the solid phase in this vicinity. XANES
analyses indicate that As in the solid phase in sediments from both
background and sequestration zones is present as As(V) (with the
exception of one sample with detrital sulfides), even though
As(V) and As(III) are nearly evenly distributed in the groundwater.
This may be indicative of preferential sorption of As(V), precipita-
tion of an As(V)-containing solid phase, or oxidation of As(III) to
As(V) at the surface of aquifer minerals. The amount of As removal
from groundwater required to lower the dissolved concentrations
in the plume to background levels is less than the average As con-
centration present naturally in the sediments. Thus, As(III) sorbed
from the contaminated groundwater may be below detection by
XAS relative to native As(V). In addition, laboratory experiments
with field sediments indicate some capacity for abiotic oxidation
of sorbed As(III) to As(V) after sorption from solution, coupled to
Mn reduction (Choi et al., 2009). This capacity is limited, however,
and less than 30% of the As(III) sorbed in laboratory experiments
was oxidized to As(V).
Sorption of both As(III) and As(V) with Devens sediments was
examined in batch and column experiments (Choi et al., 2009). In
batch studies, the extent of sorption at pH 6 was similar for As(III)
and As(V). In column studies, somewhat greater retardation was
observed for As(V) than for As(III). Reversibility of sorption was ob-
served in column studies; addition of Fe(II) to As(III)-containing
column influent solutions increased As sorption but also desorp-
tion during wash-out resulting in minimal net effect on As
sequestration.
If Fe(II) in the groundwater plume were to undergo oxidation to
Fe(III), the precipitation of Fe(III)-containing solids, principally
Fe(III) oxyhydroxides, would be expected to result in effective
sequestration of As (Espana et al., 2005; Roberts et al., 2004). Iro-
n(II) could also be oxidized by reaction with native Mn(III,IV) oxide
minerals present in the sediments, which would compete with
As(III) oxidation, but the oxidative capacity of the Devens sedi-
ments appears to be quite limited (Choi et al., 2009; He and Hering,
2009). Introduction of oxidants, however, could be an effective
means to augment the natural attenuation of As.
5. Conclusions
The Ft. Devens case study shows that As is mobilized under ERD
conditions designed to remediate contamination by chlorinated
solvents. Under ambient conditions (i.e., at well MW-7 upgradient
of the molasses injection area), As, Fe and Mn concentrations in
groundwater are low. The As that occurs naturally in the aquifer
sediments as As(V) is relatively immobile. Reducing conditions
are generated by the introduction of OC (here molasses) leading
to elevated concentrations of As, Fe and Mn in a mobilization zone
(roughly corresponding to wells MW-1, MW-3, MW-5, 10, SMW-
1 and SMW-2). Consistent with these field observations, naturally-
occurring As was also observed to be released from aquifer
sediments in laboratory batch experiments inoculated with a
known As(V)- and Fe(III)-reducing microbe and stimulated by
addition of lactate.
The distance between SMW-2 (downgradient edge of mobiliza-
tion zone) and 11 is approximately 9 m, and over the short dis-
tance, both Fe and As concentrations dropped about two orders
of magnitude. The sudden decline of the concentrations of As, Fe
and Mn indicates a transition to an apparent sequestration zone
(roughly corresponding to wells 11, SMW-3 and SMW-4). Low
TOC concentrations observed within this zone can be attributed
to mineralization of OC by microorganisms. Although the losses
of As, Fe and Mn from the groundwater must presumably be
accompanied by their uptake onto aquifer solids, no enrichment
could be detected in the 3050B-extractable contents of these ele-
ments in the sediments, nor could sorbed As(III) be detected with
bulk XAS. However, the content of HCl-extractable Fe(II) was en-
riched in sediments collected at SMW-2. The most likely mecha-
nism for As, Fe, and Mn sequestration is sorption onto aquifer
sediments. Although the most effective sequestration mechanism
for As would involve oxidative precipitation of Fe(III) oxyhydrox-
ides and concurrent As sorption or co-precipitation, this process
could not be demonstrated on the basis of the field observations
and/or sediment characterization.
Natural attenuation processes appear to be effective in limiting
the migration of As at this site. However, continuing OC inputs
would be expected to mobilize additional As, Fe and Mn in the sub-
surface and could eventually overwhelm the natural attenuation
capacity of the system. This makes the loading of OC over the
ERD remediation period a critical factor determining whether nat-
ural attenuation will be sufficiently protective or whether contin-
gency measures will need to be implemented. The ERD operation
at this site was conducted over 4.5 a. This time frame would have
allowed approximately 50 pore volume flushes between SMW-2
(downgradient edge of the ERD treatment/mobilization zone) and
11 (upgradient edge of the sequestration zone) based on the
seepage velocities measured by the PFMs. That background condi-
78 Y.T. He et al. / Applied Geochemistry 25 (2010) 69–80
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tions (with low concentrations of As, Fe and Mn) continue to pre-
vail in the farthest downgradient well along the study transect is
an indication of the robustness of natural attenuation at this site.
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Mechanisms of rotenone-induced proteasome inhibition
Arthur P. Chou a, Sharon Li a, Arthur G. Fitzmaurice a, Jeff M. Bronstein a,b,*
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1. Introduction
The etiology of Parkinson’s disease (PD) remains unclear
although it may involve mitochondria dysfunction and environ-
mental toxins such as pesticides (Beal, 2003; Brown et al., 2006).
The pesticide rotenone has been extensively studied because it is a
mitochondria complex I inhibitor. Chronic rotenone infusion in
rats results in nigrostriatal dopaminergic degeneration, signs of
oxidative stress in the brain, andmotor dysfunction (Betarbet et al.,
2000; Fleming et al., 2004; Sherer et al., 2003). These animals also
developed alpha-synuclein positive intraneuronal inclusions that
resembled Lewy Bodies, the pathological hallmark of PD (Betarbet
et al., 2000).
The reason for the relatively selective toxicity to nigral neurons
following systemic administration of rotenone is not clear.
Complex I impairment can lead to compromised cell respiration,
loss of mitochondrial membrane potential, and generation of free
radicals such as superoxide anion (O2
) and hydrogen peroxide
(H2O2) (Barrientos and Moraes, 1999; Kudin et al., 2008). At low
rotenone concentrations (5 nM), ATP production is not significant-
ly altered (Betarbet et al., 2006). It is possible that rotenone
generates oxidative stress, which is compounded by the increased
production of reactive oxygen species (ROS) from dopamine
metabolism making dopaminergic neurons particularly vulnera-
ble. The exact pathophysiology of how oxidative stress leads to cell
death is controversial. One potential downstream effector is the
cellular ubiquitin proteasome system (UPS).
The UPS is responsible for degrading damaged proteins and has
been implicated in the etiology of PD (Kitada et al., 1998; Leroy
et al., 1998; McNaught et al., 2002). Studies by our group and
others have demonstrated that treatment of cells with rotenone
leads to proteasomal dysfunction (Betarbet et al., 2006; Shamoto-
Nagai et al., 2003; Wang et al., 2006). However, although several
mechanisms have been proposed, including decreased ATP levels,
acrolein-modification of proteasome subunits, and induction of
oxidative stress (Hoglinger et al., 2003; Shamoto-Nagai et al.,
2003), the exact mechanism by which rotenone causes inhibition
of the proteasome remains unclear.
Since rotenone, a complex I inhibitor, can cause many of the
pathological features of PD in rats and complex I dysfunction has
been associated with PD in humans, it is important to determine
the mechanisms by which rotenone acts. One known effect of
rotenone-induced toxicity is reduced UPS activity. The aim of this
study was to evaluate the mechanisms by which rotenone inhibits
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the proteasome. A better understanding of these mechanisms
could provide important insights into the pathological processes
underlying PD. We found that rotenone likely acts through
multiple mechanisms including oxidative stress, nitric oxide
(NO) production and possibly microtubule dysfunction. These
processes, and possibly others, led to increased degradation of UPS
20S subunits.
2. Methods
2.1. Chemicals
All compounds were purchased from Sigma–Aldrich (St. Louis,
MO), ChemService (West Chester, PA), EMDChemicals (Gibbstown,
NJ), or Dojindo Molecular Technologies (Kumamoto, Japan).
2.2. Proteasome activity measurement
UPS activitywasmeasured as previously described (Wang et al.,
2006). Briefly, human embryonic kidney (HEK) and neuroblastoma
SK-N-MC cells were grown in DMEM/F12 supplemented with 10%
FBS and 1% Pen/Strep and passaged every 2–3 days. HEK and SK-N-
MC cells transfected with the EGFP-degron fusion protein (GFP-U)
were grown in the same media supplemented with 400 mg/mL of
geneticin for selection. UPS activity was measured in HEK and SK-
N-MC cells by quantitating the level of EGFP-degron fusion protein
that is selectively degraded by the proteasome, using flow
cytometry (Bence et al., 2001). We chose to use these cell lines
since SK-N-MC cells are neuronal-like and HEK cells are non-
neuronal. In some experiments, cells were also stainedwith 10 mg/
mL of propidium iodide for 30 min at room temperature to detect
dead cells. After PI staining, cells were trypsinized and triturated
before analysis using a Beckman XL-MCL flow cytometer. Cells
were gated for GFP-U measurement by forward and side scatter,
and fluorescence was expressed relative to vehicle control. In
experiments examining the effects of anti-oxidants on the toxicity
of rotenone, fluorescence was expressed as a percent of the
increase in fluorescence caused by rotenone (anti-oxidant GFP-
U  control GFP-U)/(rotenone GFP-U  control GFP-U).
Proteasome chymotryptic activity (20S) was also measured in
cell homogenates by the conversion of N-Suc-LLVY-AMC (100mM,
Sigma) into the fluorescent compound AMC by active protease
cleavage. Epoxomicin (5mM, Sigma) or lactacystin (5mM) was
used to estimate total proteasome activity and fluorescence was
measured using a Wallac multi-plate reader.
2.3. Oxidative stress measurement
Oxidative stress was measured by quantitating the oxidation of
carboxy-DCF (Invitrogen) in untransfected HEK cells. Cells were
loaded with 10 mM of carboxy-DCF for 1 h. The media containing
the fluorescent probe was then removed and new media contain-
ing the treatment compound was added and incubated for 2 h
before being analyzed by flow cytometry as previously described
(Wang et al., 2006). Nitric oxide was quantitated using the NO-
specific dye DAF-FM acetate (20mM, Invitrogen) and assayed in a
similar manner as carboxy-DCF.
2.4. Western blot analysis
Cells were harvested and lysed in PBS containing 0.1% (vol/vol)
Triton, 5 mM EDTA and protease inhibitor cocktail (Complete-
mini; Roche Applied Science, Indianapolis, IN, USA). Cells were
then sonicated for 3–5 s while kept cold on ice, followed by
centrifugation for 20 min at 10,000 rpm at 4 8C. Protein concen-
tration was determined by Bradford dye binding assay (Bio-rad,
Hercules, CA). Equal volume of 2 SDS loading buffer (125 mM
Tris, pH 6.8, 5% (wt/vol) SDS, 2.5 mg/mL Bromophenol Blue, 25%
(vol/vol) glycerol) was added to samples and boiled for 5 min prior
to loading. Proteins were separated by SDS-polyacrylamide gel
using a 6% stacking phase and 12% separating phase. Proteins were
then transferred to a Protran nylon membrane (Schleicher and
Schuell, Dassel, Germany) using a wet transfer method. Mem-
branes were blocked in PBS with 0.1% (vol/vol) Tween 20 (Sigma,
St. Louis, MO, USA) and 5% non-fat dry milk for at least 1 h.
Membranes were washed and then probed with a mouse antibody
to proteasome a-subunit 1, 2, 3, 5, 6 and 7 (Affiniti, UK) overnight
at 4 8C. Membranes were washed and then probed with anti-
mouse secondary antibody (Amersham Biosciences, UK) for 1 h at
room temperature. Membranes were washed a final time before
detection by ECL plus (Amersham Biosciences, UK). Each wash
consisted of 5–10-min washes in PBS plus 0.1% (vol/vol) Tween 20.
2.5. Quantitative real-time RT-PCR (qRT-PCR)
To measure proteasome mRNA levels, SK-N-MC cells were
treated with 0, 10, or 100 nM of rotenone in fresh media for 48 h.
Total RNA was isolated using RNAwiz (Ambion) according to the
manufacturer’s instructions and was reverse-transcribed to cDNA
with SuperScript First Strand Synthesis System for RT-PCR
(Invitrogen) using oligo-dT primers. Relative cDNA levels were
quantitated by real-time PCR using SYBR-Green (SYBR-green
master mix, Applied Biosystems) as reporter dye on an ABI PRISM
7700 at the UCLA Sequencing and Genotyping Core. Proteasome
cDNA levels were standardized to the levels of GAPDH and
quantitated by the relative Ct method (2DDCt). Vehicle treated
cells were used as the calibrator. Primers were designed with
Primer3 software (Table 1).
2.6. Statistical analysis
Statistical analysis was performed with GraphPad Prism
software. Unless otherwise specified, values are expressed as
mean  SEM. The level of significance is shown as *p < 0.05 or
**p < 0.01. Statistical significance was determined using one-way
ANOVAwithDunnett’s or Bonferroni’smultiple comparison post-test.
3. Results
3.1. Proteasome inhibition by mitochondria inhibitors
HEK and SK-N-MC cells expressing GFP-U were exposed to
various concentrations of rotenone to determine its dose–response
relationship with UPS inhibition (Fig. 1A). Rotenone significantly
lowered UPS activity at doses as low as 10 nM and lowered it
Table 1
Oligonucleotide PCR primers used to measure proteasome subunit mRNA.
Gene Sense 50–30 Anti-sense 50–30
PSMA1,C2.BC022372 CCATGTTTCGAAATCAGTATGAC TTCAATGCAACCAAAACTGC
PSMB1,C5.BC000508 CAATTCATACGCGGGATAGC CATCAAGTCCACCGATGATG
PAMB7,Z.BC000509 TCTGCGTCATCAGCAAGAAC GCCATTCAGGAAGTGTCCAT
GAPDH.BC013852 ACCACAGTCCATGCCATCAC ACAGCAACAGGGTGGTGGA
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further at higher concentrations. Similar results were obtained
using other pesticides that inhibit complex I including pyridaben
and fenazaquin (data not shown).
Oxidative stress generated by complex I inhibition has been
postulated to be the main determinant of the ability of rotenone to
lower UPS activity. In order to further dissect the mechanisms of
rotenone, we tested other inhibitors of the mitochondrial electron
transport chain (ETC). Complex III inhibition (antimycin A, 2 mg/
mL) resulted in a 232% increase in GFP-U (Fig. 1B). Rotenone at
100 nM and antimycin A at 2mg/mL would be expected to inhibit
100% their respectivemitochondrial respiratory complexes. On the
other hand, complete inhibition of complex IV by 2 mM potassium
cyanide (KCN), or ATP depletion by 10 mM2-deoxyglucose (2-DG),
did not result in proteasome inhibition (Fig. 1B). Interestingly,
complex IV inhibitors and 2-DG have been shown not to increase
ROS in contrast to complex I and III inhibitors (McLennan and Degli
Esposti, 2000). These data support the hypothesis that rotenone
induces oxidative stress which leads to UPS inhibition. We further
tested the contribution of ROS to proteasome inhibition by
exposing cells directly to oxidants that do not directly alter
mitochondrial function and to anti-oxidants. Cells were exposed to
H2O2, oxidant tert-butyl hydroperoxide (tBH), and iron chloride
(FeCl2, not shown) for 24 h but all failed to inhibit UPS activity
(Fig. 1B). Some but not all anti-oxidants attenuated rotenone-
induced (100 nM) UPS inhibition (Fig. 2A) but this did not correlate
with their ability to reduce ROS (measured by DCF fluorescence,
Fig. 2B) adding further doubt that oxidative stress is the primary
mechanism for rotenone’s UPS inhibitory activity.
3.2. Reactive nitrogen species (RNS) and proteasome activity
Given that ROS did not appear to account for the ability of
rotenone to inhibit the proteasome, we examined the possibility
that rotenone induces the generation of RNS and these lead to UPS
inhibition. We first tested the effect of the NO donor SNAP and the
peroxynitrite donor SIN-1 on UPS activity and found that both lead
to 26S proteasome inhibition (Fig. 3A). Furthermore, the NO
synthase inhibitor L-NMMA attenuated the ability of rotenone to
inhibit UPS activity by 20% (Fig. 3A). We confirmed that rotenone
induces NO formation by measuring DAF fluorescence and found
that rotenone (100 nM) induced an increase in RNS in a similar
manner as the NO donor SNAP (Fig. 3B). Proteasome inhibition by
SNAP was very potent, causing a 334% increase in GFP-U
fluorescence at 1 mM. We also found that RNS can directly affect
protease activity by using a 20S proteasome assay. NO and
peroxynitrite donors added directly to cell homogenates led to a
decrease in 20S activity (Fig. 3C). Taken together, these observa-
tions suggest that NO and peroxynitrite can contribute to
rotenone-induced UPS inhibition possibly by nitration of protea-
some subunits.
3.3. Microtubule dysfunction and proteasome activity
In addition to the direct effects of rotenone on mitochondrial
respiration, it has also been shown to interfere with microtubule
assembly at concentrations as low as 20 nM (Ren et al., 2005). We
hypothesized that rotenone may inhibit UPS activity via its ability
to alter microtubule assembly. To test this, we exposed GFP-U
expressing SK-N-MC cells to the specific microtubule assembly
Fig. 1. Inhibition ofmitochondrial respiration, oxidative stress and 26S UPS activity.
HEK cells were exposed to rotenone (complex I), antimycin A (2 mg/mL, complex
III), KCN (2 mM, complex IV), 2-DG (10 mM, ATP depletion), and the oxidants tBH
and H2O2 (100 mM) for 24 h and GFP-U fluorescence (26S UPS activity) was
measured. Increased GFP-U indicates decreased UPS activity. In (B) 100 nM
rotenone was used. N = 8 per data point. Statistics by one-way ANOVA with
Dunnett’s multiple comparison post-test (*p < 0.05, **p < 0.01).
Fig. 2. (A) Beta-hydroxy toulene (BHT) and catalase, but not other anti-oxidants,
attenuated rotenone’s UPS inhibitory effects. HEK cells were treated with 100 nM
rotenone in combination with the various anti-oxidants for 24 h before being
analyzed by flow cytometry. GFP-U is expressed as a percent of the increase in GFP-
U caused by rotenone alone. A value of 100% would indicate no effect on rotenone,
and 0% would indicate a complete reversal of rotenone’s effects (N = 5–9). (B) BHT
and Trolox-C attenuated the formation of peroxides caused by 100 nM rotenone as
measured by DCF fluorescence (N = 4–11 per data point). Note that although both
reduced ROS produced by rotenone, only BHT attenuated UPS inhibition.
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inhibitor nocodazole for 48 h and found that it caused proteasome
inhibition at 10 mM, the concentration needed to cause complete
depolymerization of tubulin (Liao et al., 1995) (Fig. 4).We have also
found a similar effect of carbendazem (another microtubule
inhibitor) on proteasome activity providing evidence that altering
microtubules may be a mechanism by which rotenone alters
proteasome function.
3.4. Rotenone lowers proteasome subunit levels
Our data suggest that ROS, RNS and MT dysfunction contribute
to the UPS inhibition induced by rotenone but the mechanism
through which these processes lower protease activity is unclear.
One possibility is that the proteasome components are damaged by
oxidation and/or nitration leading to their degradation. To test this
possibility, we measured 20S proteasome activity and immunore-
activity in rotenone-treated lysates. We found that rotenone
caused a reduction in the 20S proteasome activity and a dose-
dependent decrease in proteasome a-subunit immunoreactivity
(Fig. 5A and B). To assess whether the observed decrease in
proteasome levels were due to decreased synthesis, we performed
qRT-PCR tomeasure proteasomemRNA levels. RT-PCR ofa- andb-
subunits all showed the same level of expression regardless of
rotenone treatment (data not shown). These data suggest that
rotenone increases proteasome subunit degradation but does not
alter synthesis.
Fig. 3. (A) NO donor SNAP and peroxynitrite donor SIN-1 cause 26S proteasome
inhibition in SK-N-MC cells. Inhibiting NO synthase with L-NMMA attenuated
rotenone’s ability toe inhibit the UPS (N = 6). (B) Rotenone-inducedNO formation as
measured by DAF staining (N = 6). (C) The NO donor SNAP and peroxynitrite donor
SIN-1 inhibited 20S proteasome activity in cell homogenates (N = 8).
Fig. 4. Inhibition of microtubule assembly by nocodazole resulted in 26S UPS
activity as measured by GFP-U fluorescence (N = 4, *p < 0.05).
Fig. 5. Rotenone decreased the 20S proteasome activity and immunoreactivity. SK-
N-MC cells were treated with rotenone for 48 h and the cell homogenate collected
and assayed for the 20S proteasome activity (A, N = 9–11) and immunoreactivity (B,
N = 4). Both 20S proteasome activity and immunoreactivity measured by Western
blot (a-subunits) were significantly lower at 100 nM or more rotenone.
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4. Discussion
In this study, we examined the mechanisms by which
rotenone inhibits proteasome activity and found that it likely
involves multiple processes that appear to include mitochon-
drial inhibition, oxidative stress, RNS, microtubule assembly,
and increased degradation of proteasome subunits. We propose
that the unique toxicity of rotenone is due to a combination of
these pathways, most of which have been implicated in the
pathogenesis of PD.
Oxidative stress in part appears to contribute to the actions of
rotenone. Compounds that inhibited mitochondrial respiration
and also induced the generation of ROS (complex I and III
inhibitors) led to proteasome inhibition. Blocking mitochondrial
complex IV did not cause the generation of ROS nor did it inhibit
the proteasome (Liu et al., 2002; Turrens and Boveris, 1980).
Furthermore, the involvement of ROS in the actions of rotenone is
supported by the fact that some anti-oxidants attenuated
rotenone-induced proteasome inhibition. This is consistent with
a previous report that demonstrated that a-tocopheral attenuated
rotenone-induced (5 nM rotenone) proteasome inhibition (Betar-
bet et al., 2006). In our study, some anti-oxidants could only
protect rotenone-induced inhibition (100 nM) by approximately a
third suggesting that other mechanisms are at play at this
concentration. Furthermore, we did not find a good correlation
with the ability of anti-oxidants to lower ROS and protect against
rotenone-induced UPS inhibition (Fig. 2). In contrast to the study of
Berarbet et al., we did not see any protective qualities of a-
tocopheral but these differences may be due to the differences in
the concentration of and the length of exposure to rotenone.
Induction of RNS is also likely to contribute to the toxicity of
rotenone. RNS inhibited the proteasome both in cells and directly
in cellular homogenates using NO and perinitrate donors. Based on
DAF staining, rotenone stimulated NO production and the NOS
inhibitor L-NMMA attenuated the effects of rotenone on protea-
some activity. Although DAF staining may not be specific for NO,
taken together with experiments using an NO and perinitrate
donor and a NOS inhibitor, it is possible that RNS induced by
rotenone play at least a partial role in inhibiting proteasome
activity. Osna et al. reported that nitrative stress in the form of NO
or peroxynitrite can inhibit the proteasome in vitro (Osna et al.,
2004) but nitrated proteasome subunits following rotenone
treatment could not be detected (Shamoto-Nagai et al., 2003)
although others have found that oxidation or nitration of UPS
subunits can alter protease activity (Szweda et al., 2002) for
review.
A potential thirdmechanism for the ability of rotenone to cause
proteasome inhibition is via the disruption of microtubules as
demonstrated by the ability of nocodazole to also inhibit the UPS.
We have also found that carbendazim, another MT inhibitor, also
leads to UPS dysfunction (data not shown). Nocodazole signifi-
cantly inhibited the UPS at concentrations that causes almost
complete MT depolymerization. The ability of rotenone to inhibit
microtubule assembly is well established even at 10 nM (Ren et al.,
2005, but it is likely that rotenone concentrations need to be closer
to 0.2–1 mM to cause MT depolymerization similar to that of
10 mM nocodazole, Srivastava and Panda, 2007, #1516). Interest-
ingly, MT dysfunction has been shown to induce selective
dopaminergic cell death in primary cultures (Ren et al., 2005).
The association of MT and the UPS has not been well studied but it
has been shown that Parkin, an E3 ligase linked to PD, binds to
tubulin and alters its degradation (Ren et al., 2003). It is possible
that UPS components are associated with MT and disassembly of
MTs leads to impaired proteasome activity but more work is
needed to establish causality between the ability of rotenone to
alter MT assembly and decrease UPS activity.
We found that ROS, RNS and MT assembly are involved in
rotenone’s proteasome inhibitory activity but themolecular events
that lead to reduced protease activity remains unclear. We do
know that the decrease in UPS activity is not simply reflecting a
decrease in cell viability since some toxins kill cells but do not lead
to decreased UPS activity (Wang et al., 2006). Importantly, we did
find that proteasome subunit immunoreactivity was decreased
following rotenone treatment. Changes in proteasome immunore-
active protein were not caused by decreased transcription of the
subunits and therefore it is likely that the decreased protein level
was caused by increased degradation of proteasome subunits.
Considering the likely involvement of ROS and RNS in rotenone’s
actions, it is possible that rotenone causes increased degradation of
proteasome subunits by oxidation or nitration of the proteasome.
This observation is in contrast to that by Shamoto-Nagai and
coworkers who found no changes in the amount of proteasome
protein (Shamoto-Nagai et al., 2003) and instead suggests that
acrolein-modification of the proteasome subunits is the cause for
lowered proteasome activity. Additional studies need to be
performed to directly test the effects of UPS subunit oxidation
and nitration on its degradation.
In summary, we have found several pathological processes that
can account for rotenone’s effects on the UPS. Synergistic action of
these processes is an attractive hypothesis for the toxicity of
rotenone and the pathogenesis of PD.
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1. Introduction 
1.1 Clinical and pathological aspects of Parkinson’s disease  
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder, affecting 
millions of people worldwide (Dorsey, Constantinescu et al. 2007). While some cases of 
familial PD have been reported, the etiology of most cases is still unknown. Significant 
progress in understanding the pathophysiology of PD has been made from genetic and 
epidemiologic studies that have implicated defects in a few key biological processes as 
potential final common pathological pathways. 
PD is a progressive motor disorder characterized by death of dopaminergic neurons in the 
region of the brain called the substantia nigra pars compacta although other areas of the 
central and peripheral nervous system are involved (Braak, Del Tredici et al. 2003). The loss 
of dopaminergic neurons in PD leads to motor symptoms that include akinesia (inability to 
initiate movement), bradykinesia (slowness of movement), resting tremor, and balance 
problems. Non-motor symptoms can include cognitive impairments, mood disturbances, 
sleep dysfunction, gastrointestinal problems, and dysautonomia. PD is a progressive 
disorder and despite several effective therapies that treat many of the symptoms, there are 
no treatments that alter disease progression. Uncovering the causes of PD is likely necessary 
to find effective disease modifying therapies.  
The pathological hallmark of PD is the presence of Lewy bodies, which are cytosolic 
inclusions with several molecular components although -synuclein (-syn) is the 
predominant protein (Spillantini, Schmidt et al. 1997). Lewy bodies also contain ubiquitin, a 
polypeptide that targets proteins to the ubiquitin proteasome system (UPS) for degradation.  
1.2 Genes versus environment 
Despite the elucidation of approximately 18 genes in familial PD and the identification of 
multiple risk factor genes using genome wide association studies on thousands of patients, 
only a small fraction of PD risk has been accounted for (Hardy 2010). Thus, environmental 
factors almost certainly play a major role in the pathogenesis of PD.  
One of the first important clues that the environment may contribute to the pathogenesis of 
PD came in 1982 from the observation that a street drug contained a contaminant called 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) which caused almost overnight a 
clinical syndrome resembling PD. It was subsequently found that MPTP killed 
dopaminergic neurons by being converted enzymatically to MPP+, specifically entering 
dopamine neurons via the dopamine transporter, and inhibiting complex I in the 
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mitochondrial respiratory chain. Notably, the chemical structure of the MPTP metabolite 
MPP+ is similar to paraquat, a commonly used pesticide. These and other observations led 
to a series of epidemiologic studies probing pesticides as potential contributors to the 
etiology of PD. 
Although genetics hasn’t found the cause of 95% of PD cases, the identification of specific 
genes and their functions have provided important clues into pathological processes that 
appear to be involved in non-genetic forms of PD. For example, mutations in the -syn gene 
led to the finding that -syn is the major component of Lewy bodies. Mutations in other 
genes have identified dysfunction of protein degradation (the UPS and autophagy) as 
possibly being involved in the pathogenesis of PD. Since other PD genes are involved in 
mitochondrial function and MPTP inhibits oxidative respiration, mitochondrial dysfunction 
also has been implicated in the pathogenesis of PD. We believe that environmental toxins 
may increase the risk of PD by causing dysfunction in these cellular processes. Here, we will 
review the evidence that pesticides are associated with the development of PD and the 
mechanisms by which they might act. 
2. Pathophysiology of Parkinson’s disease 
2.1 Lewy bodies and -synuclein homeostasis 
Lewy bodies are the pathological hallmark of PD and the major component of these 
intracytosolic inclusions is -syn (Spillantini, Schmidt et al. 1997). -Syn exists in multiple 
forms including soluble monomers, oligomers and fibrils. The multimeric forms appear to 
be the toxic species and their formation is dependent on several factors including amino acid 
substitutions due to mutations in its gene, -syn concentration, and the presence of 
dopamine and dopamine adducts (Li, Lin et al. 2005; Mazzulli, Armakola et al. 2007; Burke, 
Kumar et al. 2008). Exogenous factors such as pesticides have also been reported to increase 
-syn aggregation. Given that -syn aggregation appears central to the pathogenesis of PD 
and pesticides appear to promote this process via a variety of mechanisms, we will briefly 
discuss -syn homeostasis. 
2.1.1 -Synuclein  
-Syn is a predominantly neuronal protein that was first implicated in the development of 
Alzheimer’s disease. The identification of three mutations—A53T, A30P, and G188A—in its 
gene in a few families with dominantly-inherited PD led to the finding that fibrillar -syn is 
the major component of Lewy bodies not only in these patients but also in sporadic PD 
(Nussbaum and Polymeropoulos 1997; Spillantini, Schmidt et al. 1997; Kruger, Kuhn et al. 
1998; Trojanowski, Goedert et al. 1998; Giasson, Jakes et al. 2000). Overexpression of normal -
syn by gene multiplication causes fairly typical PD (Farrer, Kachergus et al. 2004), and people 
who have an -syn promoter that confers a higher level of expression are at higher risk of 
developing PD (Pals, Lincoln et al. 2004; Mueller, Fuchs et al. 2005). Thus, increased levels of 
normal -syn increases one’s risk of getting PD and if it is high enough, it causes it. 
Importantly with respect to this review, certain pesticides can cause -syn levels to increase 
providing a theoretical mechanism to contribute to PD (see below for individual pesticides). 
Furthermore, pesticides can directly increase the rate of -syn fibril formation adding another 
method they can contribute to the pathogenesis of PD (Uversky, Li et al. 2001). 
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2.1.2 Ubiquitin-proteasome system dysfunction in Parkinson’s disease 
-Syn concentrations are determined by the relative amount of its expression and 
degradation, and the higher the concentration, the more likely it is to form aggregates. Both 
the ubiquitin-proteasome system (UPS) and autophagy have been shown to degrade -syn. 
The soluble form appears to be degraded by the UPS while the lysosomal pathway appears 
to degrade aggregated forms of the protein (Liu, Corboy et al. 2003; Cuervo, Stefanis et al. 
2004; Zhang, Tang et al. 2008; Mak, McCormack et al. 2010). The UPS is a highly regulated 
ATP-dependent degradative multi-subunit pathway that helps clear the cell of damaged, 
misfolded or otherwise unneeded proteins. Proteins are targeted to the UPS by ubiquitin-
activating enzymes (E1), ubiqutin-conjugating enzymes (E2), and ubiquitin-protein ligases 
(E3). Once polyubiquitinated, proteins are recognized by the 19S regulatory complex of the 
26S proteasome and translocated to the 20S complex for degradation. Finally, ubiqutin is 
recycled via thiol proteases called deubiquitinating enzymes, which fall into the ubiquitin 
carboxyl-terminal hydrolase (UCH) or ubiquitin-specific processing protease (UBP) families 
(Goldberg 2003). 
Three known genetic causes of PD involve aspects of UPS function. Parkin gene mutations 
cause autosomal recessive PD and is an E3 ubiquitin ligase necessary for targeting proteins 
for degradation. UCH-L1 gene mutations cause autosomal dominant (AD) PD and UCH-L1 
is necessary for the recycling of ubiquitin. Finally, -syn is a substrate for the UPS and 
mutations and duplication of its gene cause AD PD. There is also evidence that UPS 
dysfunction is involved in sporadic PD. Reduced UPS activity has been found in brains of 
PD patients (McNaught and Jenner 2001) and some investigators have found that 
administration of UPS inhibitors to rodents can recreate some of the features of PD although 
these models remain controversial (Bove, Zhou et al. 2006; Kordower, Kanaan et al. 2006; 
Manning-Bog, Reaney et al. 2006; McNaught and Olanow 2006; Schapira, Cleeter et al. 2006; 
Zeng, Bukhatwa et al. 2006). Finally, we have found that several commonly used pesticides 
inhibit the UPS and are associated with an increased risk of developing PD (Wang, Li et al. 
2006; Chou, Maidment et al. 2008). 
2.1.3 Autophagy and Parkinson’s disease 
Autophagy is a cellular process that involves protein and organelle degradation. 
Dysfunction of autophagy has long been known to be involved in disease but only 
recently has been implicated in the pathogenesis of PD. Gaucher’s disease is an autosomal 
recessive lysosomal storage disease caused by mutations in its gene that lead to 
dysfunction of autophagy and are associated with a marked increased risk of developing 
typical PD with Lewy bodies (Aharon-Peretz, Rosenbaum et al. 2004; Neumann, Bras et al. 
2009; Sun, Liou et al. 2010). Another autosomal recessive Parkinsonian disorder (PARK9) 
is caused by a mutation in another lysosomal gene, ATP13A2 (Ramirez, Heimbach et al. 
2006). PINK1 has also been shown to be a modifier of autophagy and mutations in its 
gene cause PD with Lewy bodies (PARK6) (Narendra, Jin et al. 2010; Samaranch, Lorenzo-
Betancor et al. 2010). Additional evidence for a role of autophagy in PD comes from 
studies of sporadic PD brains where increased numbers of autophasomes have been 
described (Anglade, Vyas et al. 1997).  
α-Syn clearance is likely carried out by both the UPS and autophagy. Large aggregates of α-
syn proteins are likely degraded by macroautophagy but soluble α-syn can undergo 
degradation via an alternate lysosomal pathway, chaperone-mediated autophagy (CMA) 
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(Massey, Zhang et al. 2006). α-Syn has also been found to inhibit lysosomal macroautopaghy 
and oligomers are resistant to CMA adding further support for a possible role of protein 
degradation dysfunction in the pathogenesis of PD (Martinez-Vicente, Talloczy et al. 2008).  
2.2 Mitochondrial dysfunction and oxidative stress 
The role of mitochondrial dysfunction in the pathophysiology of PD was first suggested by 
the discovery that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a neurotoxin 
selective for nigral dopaminergic neurons, acts through inhibition of complex I of the 
electron transport chain. MPTP is converted by monoamine oxidase (MAO-B) to its toxic 
metabolite 1-methyl-4-phenylpyridinium (MPP+), which is rapidly concentrated by 
dopaminergic neurons into the mitochondria and produces cell death (Langston, Ballard et 
al. 1983; Chiba, Trevor et al. 1985; Javitch, D'Amato et al. 1985; Gainetdinov, Fumagalli et al. 
1998). This discovery led to the findings that complex I activity is reduced not only in brains 
of PD patients but also in peripheral mitochondria (Schapira, Cooper et al. 1990; Haas, 
Nasirian et al. 1995). Furthermore, mutations in some genes that code for mitochondrial 
associated proteins can cause PD (e.g. DJ1 and PINK1) and chronic systemic administration 
of complex I inhibitor (rotenone) in rodents reproduces many of the clinical and 
pathological aspects of PD (Betarbet, Sherer et al. 2000).  
It is still unclear what are the downstream targets of mitochondrial dysfunction. ATP 
depletion is not necessary in the rotenone rodent model for its toxicity but the generation of 
reactive oxygen species (ROS) appears to be essential. ROS are known to oxidize DNA, 
lipids and proteins to cause cellular damage. Interestingly, ROS from complex I inhibition 
leads to UPS inhibition (Chou, Li et al. 2010). Furthermore, the formation of ROS from 
complex I inhibition likely contributes to the Lewy-like bodies observed in the rotenone 
model (Betarbet, Canet-Aviles et al. 2006).  
2.2.1 Aldehyde dehydrogenase (ALDH) inhibition 
Another form of mitochondrial dysfunction implicated in PD involves the inhibition of 
aldehyde dehydrogenase 2 (ALDH2), a mitochondrial ALDH. This enzyme is responsible 
for the detoxification of aldehydes that could otherwise modify proteins. For example, the 
lipid peroxidation product 4-hydroxy-2-nonenal (HNE) is detoxified by ALDH2 and 
increased HNE has been reported in post mortem PD brains as adducts (Yoritaka, Hattori et 
al. 1996) and as a component of Lewy bodies (Castellani, Perry et al. 2002). Furthermore, 
HNE has been shown to prevent -syn fibrillation and form -syn oligomers, which are 
toxic to primary mesencephalic cultures (Qin, Hu et al. 2007). Another ALDH2 substrate, the 
dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL), has also been reported to 
induce -syn aggregation and be toxic to dopaminergic neurons (Burke, Kumar et al. 2008). 
ALDH involvement in the pathogenesis of PD is not yet well established but preliminary in 
vitro and epidemiology studies have implicated this enzyme as a possible mediator of some 
pesticides’ toxicity (see benomyl below). 
2.3 Altered dopamine homeostasis 
Conventional wisdom in the pathophysiology of PD is that dopaminergic neurons are 
selectively vulnerable, although more recent evidence suggests that neuronal loss is more 
widespread. One hypothesis for this possible vulnerability is via the metabolism of 
dopamine itself (Hastings 2009).  
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Dopamine and its metabolites are toxic and dopamine adducts have been shown to stabilize 
-syn oligomers. DOPAL, a substrate for ALDH2, is particularly toxic. Interestingly, 
DOPAL is formed by the enzyme MAO-B and blocking this enzyme with specific drugs 
appears to alter the progression of PD (Olanow, Rascol et al. 2009). Thus, alterations in 
levels of dopamine or its metabolites might contribute to neuronal loss. Increased levels of 
VMAT2, a vesicular transporter that lowers cytosolic dopamine levels, lowers the risk of 
developing PD (Glatt, Wahner et al. 2006). Further support for altered dopamine 
homeostasis in PD comes from a recent report that polymorphisms in the dopamine 
transporter (DAT) gene in combination with pesticide exposure also increases the risk of PD 
(Ritz, Manthripragada et al. 2009). 
Taken together, dysfunction of several cellular processes appears to contribute to the 
pathogenesis of PD. Aggregation of -syn (oligomerization and possibly fibril formation) is 
the leading candidate for the final common pathway for neurons to die in PD. There is 
evidence that pesticides cause dysfunction in many of these processes providing potential 
mechanisms for their toxicity (Figure 1).  
 
 
Fig. 1. Proposed pathophysiology of Parkinson’s disease. 
3. Epidemiology of Parkinson’s disease 
3.1 Environment and Parkinson’s disease 
Over the past two decades, several epidemiologic studies have identified a number of 
environmental factors that are associated with an altered risk of developing PD. Smoking 
tobacco is almost universally found to be associated with a lower risk of developing the 
disease (Ritz, Ascherio et al. 2007). Caffeine and alcohol consumption have also been 
associated with a reduced risk of PD (Hellenbrand, Seidler et al. 1996). Since all of these 
addictive behaviors are associated with reduced incidence, it has been proposed that they 
may be surrogate markers for a common behavioral phenotype of pre-clinical PD patients 
rather than these exposures all being protective. The use of nonsteroidal anti-inflammatory 
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drugs has also been found to reduce the risk of PD suggesting inflammation may be 
somehow involved in its pathogenesis (Wahner, Bronstein et al. 2007). 
A number of studies have found strong associations between an increased risk of PD and 
rural living, well-water consumption, farm occupations, and pesticide exposure. These 
reports have been reviewed extensively by others so we will not review all the studies here 
(Le Couteur, McLean et al. 1999; Di Monte 2003; Alavanja, Hoppin et al. 2004; Kamel and 
Hoppin 2004; Li, Mink et al. 2005; Brown, Rumsby et al. 2006). The association with pesticide 
exposure has been the most provocative association with developing PD to date although 
almost all of these reports were based on self-reporting pesticide exposure (i.e. potential 
recall bias) and the diagnosis of PD was not confirmed (Gartner, Battistutta et al. 2005). 
Despite these weaknesses, a meta-analysis of case–control studies obtained a combined odds 
ratio (OR) for PD risk of 1.94 (95% CI, 1.49–2.53) (Priyadarshi, Khuder et al. 2000). 
Subsequent studies reported OR of up to 7.0 (Brown, Rumsby et al. 2006). 
Recently, the issue of potential recall bias was mitigated by determining pesticide exposure 
in a prospective manner. Petrovitch et al reported an increased risk of developing PD in 
Japanese-American men who worked on a plantation and were exposed to pesticides 
(Petrovitch, Ross et al. 2002). Similarly, Ascherio et al found a 70% increased risk of 
developing PD in those who reported significant pesticide exposure (Ascherio, Chen et al. 
2006). These reports add support for a true association between pesticides and PD but still 
are limited in that they did not identify individual toxins and dose response relationships 
could not be determined. 
3.2 Specific pesticides as risk factors 
There are a few ongoing studies that address both the issue of recall bias and are identifying 
specific pesticides that confer an altered risk of developing PD. The Agricultural Health 
Study (AHS) is a prospective study, including 84,740 private pesticide applicators (mostly 
farmers) and their spouses recruited in 1993-97 in Iowa and North Carolina. Pesticide 
exposure was self-reported but felt to be reliable. The diagnosis of PD was also self-reported 
but later confirmed by direct examination. The first report from this study found an 
association between PD with increasing lifetime days of use of any pesticide but no specific 
pesticide could be definitely implicated due to lack of statistical power (Kamel, Tanner et al. 
2007). Recently, the investigators reported that PD was associated with rotenone (OR 2.5, 
95% CI 1.3, 4.7) and paraquat use (OR 2.5, 95% CI 1.4, 4.7) (Tanner, Kamel et al. 2011). The 
strength of this study is that it is prospective, the diagnosis was confirmed by examination, 
and specific toxins were identified. The primary weakness of this study is that they have 
only 110 cases limiting their power to test a number of pesticides individually and in 
combinations. The small number of cases also limits their ability to test gene-environment 
interactions. One additional limitation was that quantitation of pesticide exposure, types of 
exposure and length of exposures were self-reported. Despite these shortcomings, this study 
adds strong epidemiological evidence that pesticides are associated with an increased risk of 
developing PD, especially for rotenone and paraquat.  
Ritz and colleagues at UCLA have taken another approach to identifying specific pesticides 
that are associated with an altered risk of PD. We took advantage of the California Pesticide 
Use Reporting database and Geographic Information System land-use maps to estimate 
historical exposure. All commercial pesticide applications have been recorded by 
compound, quantity, and specific location since 1974. Thus, individual subject exposures 
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can be approximated by using their residential and occupational addresses for the past 37 
years. In this Parkinson’s Environment Gene (PEG) study, neurologists specializing in 
movement disorders went into the field to confirm the diagnosis in over 350 incident PD 
cases in the central California valley where pesticides are applied liberally and the risk of 
PD appears to be increased (Ritz and Yu 2000; Kang, Bronstein et al. 2005). A similar number 
of age and sex matched control subjects were also recruited from the same communities. In 
addition to several lifestyle and medical assessments, DNA and serum samples were also 
obtained.  
Individual pesticides were investigated in the PEG study based on previous reports 
implicating the agents as possibly involved in the pathogenesis of PD based on previous 
epidemiologic and/or laboratory studies. Maneb and paraquat were investigated because 
administration of pesticides to rodents produces a nice model of PD (see below). Estimates 
for maneb and paraquat exposures incurred between 1974 and 1999 were generated based 
on their residence. Exposure to both pesticides within 500m of their homes increased PD 
risk by 75% (95% CI 1.13, 2.73). Subjects aged ≤ 60 yo were at much higher risk of 
developing PD when exposed to either maneb or paraquat alone (odds ratio (OR) = 2.27, 
95% CI: 0.91, 5.70) or to both pesticides in combination (OR = 4.17, 95% CI: 1.15, 15.16) 
(Costello, Cockburn et al. 2009). PEG investigators have found similar associations with 
organophospate pesticides—diazinon (OR 1.73, CI 1.23, 2.45) and chlorpyrifos (OR 1.50, CI 
1.04, 2.18) (Manthripragada, Costello et al. 2010)—and ziram (OR 3.01, CI 1.69, 5.38). In 
subjects ≤ 60 yo, exposure to both ziram and paraquat had a 6-fold increase in risk of PD (CI 
1.94, 18.33) (Wang, Costello et al. 2011). It is important to note that all estimates of exposures 
were not dependent on subject recall for total exposure or duration of exposure. Recent 
exposure to pesticides (1990 to 1999) was not generally associated with an increased risk of 
PD consistent with the theory that PD pathology likely starts several years before it 
manifests itself clinically.  
The population is exposed to pesticides in a variety of ways, not just inhalation from 
spraying and crop dusters. Gatto et al. looked at five pesticides that were likely to be 
detected in well water (Gatto, Cockburn et al. 2009). Although local well water was not 
analyzed, these pesticides were identified based on their solubility, half-lives, and 
adsorptive properties. These included organophosphates (diazinon, dimethoate, 
chlorpyrifos), a carbamate (methomyl), and a sulfite ester (propargite). Excluding those who 
did not consume well water, potential inhalation and ingestion of each pesticide was 
associated with 23-57% increased risk of PD. Consuming well water potentiated this effect to 
a 41-75% increased risk. Up to a two-fold increase was observed for those who consumed 
water with the highest potential contamination of at least one of these pesticides. Finally, 
those with PD were found to have consumed well water an average of 4.3 years longer than 
controls. Because PEG has enrolled over 350 cases, we have statistical power to test gene-
environment interactions. Not surprisingly, the risk of developing PD in pesticide-exposed 
subjects is clearly altered based on the subject’s genetic background (see below). 
3.3 Gene-environment interactions 
Gene–environment interaction analyses for pesticides and PD have been rare due to small 
sample size and difficulty obtaining exposure data (Deng, Newman et al. 2004; Elbaz, 
Levecque et al. 2004; Kelada, Checkoway et al. 2006; Hancock, Martin et al. 2008). Elbaz et al 
found that pesticides had a modest effect in subjects who were not CYP2D6 poor 
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metabolizers, had an increased effect in poor metabolizers (approximately twofold), but 
poor metabolizers were not at increased PD risk in the absence of pesticide exposure (Elbaz, 
Levecque et al. 2004). Hancook et al found a gene-environment association in PD for 
pesticides and nitric oxide synthase 1 polymorphisms (Hancock, Martin et al. 2008). Kelada 
et al described a very modest risk of developing PD with specific dopamine transporter 
(DAT) alleles but a 5.7 fold increase (CI 1.73-18.53) in developing PD in subjects with 
occupational exposure to pesticides. These studies added proof of concept that the effect of 
environmental exposures on the risk of developing PD is at least partially dependent on 
one’s genetic background (Kelada, Checkoway et al. 2006). Unfortunately, exposure 
assessments were very limited in all of these studies and individual toxins could not be 
determined.  
Gene-environment analysis in Ritz’s PEG study has only recently begun but has already 
revealed intriguing results. We replicated the DAT polymorphism’s interaction with 
pesticide exposure described by Kelada et al for at least maneb and paraquat (Ritz, 
Manthripragada et al. 2009). Unexposed subjects with more susceptibility alleles had a 30% 
increased risk of developing PD whereas exposed subjects had an almost five-fold increased 
risk (OR = 4.53; 95% CI, 1.70-12.1). Importantly, there was a gene dose effect as well. In a 
similar manner, variations in PON1, the gene that encodes Paraoxonase 1 that metabolizes 
chlorpyrifos and diazinon, potentiated the increased PD risks associated with these 
organophosphates (Manthripragada, Costello et al. 2010).  
For example, diazinon was associated with a 73% increased risk of PD (CI 1.23, 2.45) but the 
risk increases to 267% (CI 1.09, 6.55) in individuals who carry PON1 risk alleles. Variations 
in the dinucleotide repeat sequence (REP1) within the α-syn promoter appear to alter the 
risk to paraquat exposure (Gatto et al., 2010). Finally, we have preliminary evidence that 
variations in ALDH2 gene potentiate the increased risks associated with dithiocarbamates 
and other pesticides that inhibit ALDH activity (Fitzmaurice, Rhodes et al. 2010).  
Clearly, the number of potential gene-environment interactions is enormous but we have 
clear proof of concept that these interactions need to be considered to truly understand 
environmental risks in PD. It will take very large sample sizes and good exposure analysis 
to obtain a better understanding of the many potential interactions that confer the bulk of 
PD risk factors. Alternatively, a candidate gene approach coupled with a better 
understanding of the pharmacokinetics and toxicity of specific pesticides may allow us to 
test gene-environment interactions using smaller sample sizes.  
4. From association to causality - do pesticides cause PD and if so, how? 
Epidemiological studies have clearly established the association between pesticide exposure 
and the development of PD. The possibility that this association represents causality has 
been strengthened by recent studies that addressed the problem of recall bias and have 
demonstrated a dose-effect relationship. Now that some individual pesticides have been 
implicated, mechanistic studies could be pursued. These studies are reviewed within the 
context of our current understanding of the pathophysiology of PD.  
4.1 Rotenone 
Rotenone is produced naturally in roots of certain plant species such as the jicama vine. It 
is a widely used domestic garden pesticide and because it is degraded by the sun in a 
matter of days, users tend to spray rotenone frequently. Rotenone is also a well-
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characterized, high-affinity, specific inhibitor of complex I of the mitochondrial 
respiratory electron transport chain. Low complex I activity had been reported to be 
associated with PD both in brain and peripheral mitochondria but it wasn’t known 
whether this is causal or a surrogate marker for something else. To further investigate 
this, Greenamyre and colleagues chronically administered the complex I inhibitor, 
rotenone, systemically into rodents. Some of these rats developed selective dopaminergic 
neuronal death as well as many of the motor features of PD. Importantly, neurons 
developed intracytoplasmic inclusions that were found to contain α-syn (Betarbet, Sherer 
et al. 2000). α-Syn pathology in the gastro-intestinal tract has also been described in the 
rotenone model similar to that seen in PD (Drolet, Cannon et al. 2009). Even small 
amounts of rotenone delivered intragastrically reproduces many of the same features 
described in rats given rotenone subcutaneously but in this model, the various stages of 
PD are reproduced in a progressive manner (Pan-Montojo, Anichtchik et al. 2010).  
The mechanisms of rotenone toxicity are not completely clear but likely are more 
dependent on oxidative stress than energy failure (Sherer, Betarbet et al. 2002). The 
downstream targets of rotenone-induced oxidative damage are likely vast but the UPS 
appears to be one of them (Betarbet, Canet-Aviles et al. 2006; Wang, Li et al. 2006; Chou, Li 
et al. 2010). 
Until recently, there have not been convincing epidemiologic reports linking rotenone 
exposure to PD. Dhillon et al reported an over 10 fold increase in risk although this study 
was limited because exposures were self-reported (Dhillon, Tarbutton et al. 2008). The 
Agricultural Health Study did find a 2.5 fold increased risk with prospective questionnaires 
adding further support for rotenone as a PD risk factor (Tanner, Kamel et al. 2011). 
Furthermore, many organic farmers in the 1970s used rotenone as a natural pesticide and a 
number of them have developed PD at a young age although scientific confirmation of these 
anecdotal reports is lacking. Other pesticides that are complex I inhibitors are used even less 
frequently than rotenone so little is known about associations with PD although one would 
predict a similar effect. 
4.2 Paraquat 
One of the first pesticides investigated for its potential link to PD was paraquat due to its 
structural similarity to MPTP, the drug that caused acute Parkinsonism in drug addicts. 
MPTP kills dopaminergic neurons by being metabolized to MPP+ by MAO-B, entering 
dopamine cells via the dopamine transporter and then inhibiting complex I in the 
mitochondrial respiratory chain. Paraquat is ubiquitously used as an herbicide to control 
weed growth and exposure to paraquat is associated with an increased risk of PD 
(Hertzman, Wiens et al. 1990; Semchuk, Love et al. 1992; Liou, Tsai et al. 1997).  
Additional support for paraquat increasing the risk of PD comes from animal studies. Mice 
infused with paraquat for three consecutive weeks exhibit dopamine cell loss and cytosolic 
α-syn aggregates (Brooks, Chadwick et al. 1999; Manning-Bog, McCormack et al. 2002; 
McCormack, Thiruchelvam et al. 2002). The mechanism by which paraquat causes 
dopamine cell death is not clear. Since it is structurally very similar to MPTP, it was 
presumed that paraquat acted in a similar manner. Surprisingly, unlike MPP+, paraquat is 
not a substrate for the dopamine transporter and does not inhibit complex I except at very 
high concentrations (Richardson et al 2005). Paraquat toxicity does appear to be dependent 
on increasing oxidative stress and its action as a redox-cycler appears likely involved in its 
toxicity (McCormack, Atienza et al. 2005). 
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4.3 Dithiocarbamates (maneb and ziram) 
Dithiocarbamates (DTCs) are a class of some of the most commonly used organic fungicides. 
They are classified into 2 groups based on whether there is a carbonyl (group 1) or hydrogen 
on the nitrogen carbamate. Most DTCs are complexed with metals including zinc (e.g. ziram 
and zineb), iron (e.g. ferbam) and manganese (e.g. maneb). DTCs first became relevant to 
PD researchers in 1985 when Corsini et al found that diethyldithiocarbamate pretreatment 
enhanced MPTP toxicity in mice (Corsini, Pintus et al. 1985). They proposed that 
diethyldithiocarbamate would potentiate MPTP toxicity by inhibiting superoxide dismutase 
since they believed at that time that MPTP acted primarily as a redox cycler. Thiruchelvam 
et al. later reported that maneb potentiated the toxicity of paraquat preferentially in the 
nigrostriatal dopaminergic system (Thiruchelvam, Brockel et al. 2000; Thiruchelvam, 
McCormack et al. 2003). Furthermore, maneb and paraquat exposure was found to 
exacerbate α-synucleinopathy in A53T transgenic mice (Norris, Uryu et al. 2007).  
The animal models using maneb and paraquat were intriguing but it was only recently that 
an association between maneb and paraquat exposures and PD were reported (Costello, 
Cockburn et al. 2009). Similar to the animals studies, residential exposure to maneb and 
paraquat exposure together is associated with a 114% increased risk of newly diagnosed PD. 
Furthermore, the risk of PD was increased to 317% for cases ≤ 60 yo. Neither pesticide alone 
was associated with PD but there were few subjects with maneb only exposure so that the 
true effect for maneb alone could not be assessed. When both occupational and residential 
exposures are taken into account, subjects exposed to maneb and paraquat alone had a 126% 
and 50% increase in risk of developing PD respectively but for exposure to maneb and 
paraquat together, the risk increased to 8.75x (CI 2.3-33.2) in the younger group (Wang, 
Costello et al. 2011). These epidemiologic data taken together with the animal data are quite 
compelling that these pesticides truly increase the risk of PD.  
As mentioned above, DTCs are a large group of fungicides with similar structures. We 
identified another DTC, ziram, in an unbiased screen to identify pesticides that inhibit the 
proteasome (Wang, Li et al. 2006). Maneb and some other DTCs were also found to inhibit 
the UPS but at higher concentrations (Chou, Maidment et al. 2008). Ziram selectively killed 
dopaminergic neurons in primary cultures and increased -syn levels in the remaining 
neurons. Systemic administration of ziram alone into mice caused progressive motor 
dysfunction and dopaminergic neuronal damage (Chou et al 2008). Furthermore, subjects 
exposed to ziram alone had a 201% (CI 1.69, 5.38) increase of risk of developing PD and a 
598% (CI 1.95, 18.3) increased risk when exposed with paraquat in subjects ≤ 60 yo (Wang, 
Costello et al. 2011). These data add further support for the role of DTCs as a causal risk 
factor for PD. 
It is still not completely clear how DTCs act biologically. We have found that they do not 
increase oxidative stress and therefore are unlikely acting through the mitochondrial 
respiratory chain (Wang, Li et al. 2006). DTCs clearly inhibit the UPS and their potency 
depends on whether they contain a tertiary or a secondary amino group. Ziram was studied 
extensively given its high potency to inhibit the UPS and we found that it acts by interfering 
with the ubiquitin E1 ligase with an IC50 of 161 nM (Chou, Maidment et al. 2008). Zhou et al 
reported that maneb also inhibited the UPS but at higher concentrations (IC50 of approx. 6 
μM) and increased protein carbonyls suggesting increased oxidative stress (Zhou, Shie et al. 
2004). We also found that maneb inhibits the UPS at much higher concentrations than ziram 
but we did not find evidence of oxidative stress. Differences may very well be due to 
differences in the techniques used since we used an in vitro 26S UPS assay and DCF 
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fluorescence to detect ROS and Zhou et al used an in vitro 20S UPS assay and protein 
carbonyl immunohistochemistry for detection of oxidative stress. Recently, we have found 
that both maneb and ziram inhibit ALDH2 at environmentally-relevant concentrations, 
adding another potential mechanism of toxicity, especially to dopaminergic neurons 
(Fitzmaurice, Rhodes et al. 2010). Since ziram does not contain manganese, it is very 
unlikely that it is the manganese in maneb that confers its toxicity as some have suggested. 
4.4 Benomyl 
Another important fungicide implicated in PD pathogenesis is the benzimidazole 
compound benomyl. It was developed as a microtubule inhibitor and is sprayed on fruits, 
nuts, and leaves to prevent fungal growth. Preliminary findings from the PEG study 
revealed benomyl exposure increased PD risk by 138% (CI 1.33, 4.27) (Fitzmaurice, Rhodes 
et al. 2010). 
Benomyl metabolizes spontaneously into another fungicide (carbendazim) and 
enzymatically into several thiocarbmate compounds. We have shown that benomyl and 
carbendazim are UPS inhibitors, although they are not as potent as ziram (Wang, Li et al. 
2006; Fitzmaurice, Ackerman et al. 2010). Furthermore, benomyl has also been reported to 
inhibit mitochondrial ALDH (Staub, Quistad et al. 1998). Although these studies focused on 
hepatic ALDH, we recently reported that benomyl exposure reduced ALDH2 activity ex vivo 
in rat neuronal suspensions (Fitzmaurice, Ackerman et al. 2010). We have also found that 
exposure to benomyl or one of its ALDH2-inhibiting metabolites (S-methyl-N-
butylthiocarbamate, or MBT) causes dopaminergic neuronal death in vitro, while the UPS-
inhibiting metabolite (carbendazim) does not. These findings, combined with the 
observation that DTCs also inhibit ALDH2, suggest that ALDH2 inhibition may be an 
important mechanism in pesticide toxicity with respect to PD. 
The toxicity of ALDH2 inhibition is likely due to the accumulation of toxic aldehydes. We 
would predict that ALDH2 inhibition would lead to increased levels of DOPAL and HNE 
adducts and preliminary studies in primary cultures support this hypothesis. Furthermore, 
the loss of dopaminergic neurons due to benomyl was attenuated by co-treatment with the 
MAO-B inhibitor pargyline which decreases DOPAL formation (Fitzmaurice, Ackerman et 
al. 2010). Since DOPAL and HNE accumulation have been reported to induce α-syn 
aggregation (Burke, Kumar et al. 2008), these findings support ALDH2 inhibition as an 
important mediator of pesticide toxicity in PD.  
5. Summary 
The causes of PD are not completely understood but both genetic and epidemiologic studies 
suggest that dysfunction of one or more biological processes lead to -syn aggregation and 
neuronal death. Epidemiologic studies have clearly shown PD to be associated with 
pesticide exposure and specific pesticides conferring at least some of this increased risk have 
recently been identified. The fact that administration of pesticides to animals recapitulates 
many of the behavioral and pathological features of PD provides evidence that the 
associations found in epidemiologic studies are causal. Elucidating the mechanisms of 
pesticide toxicity in mammals not only strengthens the hypothesis that exposure to these 
toxins can increase the risk of developing PD, but also furthers our understanding of the 
pathophysiology of the disease in general. It is clear that the list of pesticides discussed in 
this chapter is not complete and that pesticides are not the only environmental toxins that 
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alter the risk of PD, but the preponderance of evidence taken together supports an 
important role of pesticides in the pathogenesis of PD. A better understanding of these 
issues will take us one step closer to a cure. 
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